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ABSTRACT 
GENETIC, METABOLIC, AND HISTOPATHOLOGICAL STUDIES OF 
PARTICLE-ASSOCIATED RESPIRATORY ALTERATIONS 
Mohamed Mohamedy Ghanem 
Cytochrome P450s (CYPs) form a superfamily of enzymes crucial for the 
oxidative metabolism of a wide variety of endogenous and exogenous (xenobiotic) 
compounds. Cytochrome P4501A1 (CYP1A1) is a member of the CYP1A subfamily that 
is involved in pulmonary carcinogenesis. CYP1A1 metabolizes polycyclic aromatic 
hydrocarbons (PAH), such as benzo[a]pyrene in cigarette smoke into DNA-binding 
reactive metabolites resulting in gene mutation and carcinogenesis. Silicosis and coal 
workers’ pneumoconiosis (CWP) are two pulmonary diseases associated with 
occupational exposure to silica and coal dust (CD), respectively. Most coal miners are 
smokers or ex-smokers and epidemiologic studies of coal dust carcinogenesis are 
confounded by the presence of both cigarette smoke and respirable particles. To clarify 
the nature of this interaction, we investigated the hypotheses that (1) CYP1A1 induction 
and activity (EROD) are inhibited by CD and silica. (2) CYP1A1 inhibition by particle 
exposure is associated with changes in the cellular populations in the exposed lung. 
Western blot analysis, immunofluorescent-labeling, bronchoalveolar lavage fluid 
analysis, biochemical assays, and histopathology were used to evaluate our hypotheses. 
Because of a current debate about using the rat to extrapolate particle-induced pulmonary 
alterations to humans, the rabbit silicosis and sheep CWP model, were also used. The 
results indicate that (1) CYP1A1 induction and its metabolic activity (EROD) were 
suppressed by CD exposure in rats and sheep; and by silica in rabbits (2) CYP1A1 
expression was reduced in alveolar epithelial cells by CD or silica exposure (3) silica and 
CD increased the size (hypertrophy) and number (hyperplasia) of alveolar type II cell 
with reduction of CYP1A1 expression in these cells (4) CD particles induced dose-
dependent pulmonary inflammation, manifested by recruitment of alveolar macrophages 
and polymorphonuclear leucocytes (5) CD particles induced the preapoptotic Bax protein 
expression in alveolar epithelial cells and triggered apoptosis (6) inhibition of apoptosis 
and Bax by the caspase inhibitor, Q-VD-OPH, did not alter CYP1A1 induction (7) 
suppression of CYP1A1 induction was associated with pulmonary inflammation. These 
findings are consistent with the hypothesis that CYP1A1 induction and its metabolic 
activity are inhibited by particle exposure and associated with pulmonary inflammation. 
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CHAPTER 1 
GENETIC, METABOLIC, AND HISTOPATHOLOGICAL STUDIES OF 
PARTICLE-ASSOCIATED RESPIRATORY ALTERATIONS 
INTRODUCTION 
 One of the most biologically important enzymatic systems involved in the 
metabolism of xenobiotics in the lung is cytochrome P450. Cytochrome P450s (CYPs) 
are monooxygenases that activate molecular oxygen necessary for oxidative metabolism 
of different internal or external lipophilic xenobiotics (Barker et al, 1992; Hasler et al, 
1999) producing less lipophilic substances,  thus facilitating their excretion (Mucci et al, 
2001). Some CYP members, such as CYP1A1 are induced by substrates, such as 
polycyclic aromatic hydrocarbons (PAHs). Unfortunately the induced CYP1A1 may 
metabolize the PAH into highly reactive intermediates. For example, a CYP1A1-
dependent enzymatic process can metabolize the PAH benzo(a)pyrene in cigarette smoke 
into the highly carcinogenic metabolite, benzo(a)pyrene diol epoxide (BPDE) (Bjelogrlic 
et al, 1993). This reactive intermediate covalently interacts with DNA nucleotide bases, 
particularly guanine and adenine, producing DNA adducts with potential ensuing 
mutations of important genes. Cells with damaged DNA may be removed by apoptosis 
(programmed cell death) (Venkatachalam et al, 1993). Alternatively, if a permanent 
mutation occurs in a critical region, an oncogene may be activated, or a tumor suppressor 
gene, such as p53 may be inactivated (Wang et al, 1995).  The excessive presence of such 
mutational events leads to aberrant cells with loss of normal growth control and, 
ultimately, to cancer (Liang et al, 2003).  
Pulmonary xenobiotic metabolism is currently a subject of extensive research 
from the standpoints of genetic and metabolic aspects because of our increasing 
exposures to foreign respirable compounds that may alter and modify the metabolic 
activity and expression of pulmonary enzymatic systems. The lung, being exposed to air 
is a target organ frequently exposed to xenobiotics via inhalation (Pairon et al, 1994). 
Examples of lung diseases associated with respirable foreign particulate inhalation are 
coal workers’ pneumoconiosis (CWP), bronchitis, emphysema, and silicosis (Green and 
Vallyathan, 1998; Kleinerman et al, 1979). CWP is an occupational lung disease 
associated with inhalation of poorly soluble respirable dust (Schins and Borm, 1999). It 
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may occur as a simple form or a complicated form known as progressive massive fibrosis 
(PMF) (Yeoh and Yang, 2002). In the simple form, only macules (<0.5 cm in diameter) 
appear in the lung and these consist mainly of dust-laden macrophages (Castranova, 
2000). In the complicated form, PMF, the lesion is irregular coal dust-laden, fibrotic 
masses with haphazardly arranged collagen fibers associated with compromised lung 
functions (Castranova and Vallyathan, 2000). 
At least one epidemiological study stated that lung cancer risk in smoking miners 
is not statistically different from, or even less than, other smoking populations (Costello 
et al, 1974). Although silica has been classified as carcinogenic by the International 
Agency for Research in Cancer (IARC, 1997), lung cancer was almost absent in lungs 
concomitantly exposed to silica and chemical carcinogens, such as PAH (Cocco et al, 
2001).  Attempts to determine the carcinogenic effect of coal dust and silica exposure in 
miners may be invalid because smoking miners are exposed to a mixture of the 
carcinogenic PAHs in cigarette smoke and the respirable insoluble particles that may 
modify chemical carcinogenesis. If respirable particles modify chemical carcinogen 
metabolism in the lung, epidemiologic studies of respirable particles in smoking miners 
may need to control respirable particles and smoking as modifiers rather than covariables.  
Extrapolating from a rat model to determine the human response to inhaled 
particles is controversial (Mauderly, 1997), particularly when Nikula et al (1997) showed 
a difference in particle retention and pulmonary response to inhaled respirable 
particulates between rats and primates.  
In this study, we investigated the hypothesis that pulmonary CYP1A1 induction 
by the model PAH, beta-naphthoflavone, is inhibited by respirable coal dust and silica. 
To overcome limitations of any specific animal model, we have investigated this 
hypothesis in rats, rabbits, and lambs. In addition, we have investigated changes in lung 
cell populations and their changing CYP1A1 expression after particle exposure. Finally, 
we investigated the association between altered CYP1A1 expression and particle 
associated apoptosis, caspase inhibition, Bax expression and inflammation. 
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OBJECTIVES 
The objectives of this study were to: 
1- Establish a relationship between coal dust or silica inhalation and deposition in 
the lung and CYP1A1 induction. 
2- Establish a relationship between particle exposure and histopathological changes 
associated with deposition of these particles in lung alveoli, such as alveolar type 
II cell hyperplasia and hypertrophy and pulmonary inflammation. 
3- Establish a relationship between particle-associated pulmonary changes and the 
pattern of CYP1A1 expression in lung alveolar cells. 
4- Investigate these relationships in different animal models including rats, rabbits, 
and lambs. 
5- Investigate the association of apoptosis, caspase inhibition, Bax expression, and 
inflammation with regulation of CYP1A1 expression by pulmonary exposure to 
respirable particles. 
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CHAPTER 2 
REVIEW OF LITERATURE 
1-Cytochrome P450s (CYPs) 
1.A. Introduction  
CYPs are membrane-bound heme-containing proteins (hemeproteins) resulting 
from expression of a gene superfamily containing about 1000 members that is found in 
all species ranging from prokaryotes to plants and animals (Hasler et al, 1999, Mckinnon, 
2000).  The letter P means a pigment that produces a broad absorption band with a peak 
of 450 nm (Omura and Sato, 1964; Remmer and Merker, 1965).  Although the name 
cytochrome is a misnomer, because these are enzymes and not pigments, it has been 
established as a nomenclature for these proteins (Mckinnon, 2000).  These proteins 
comprise a class of monooxygenases or mixed function oxidases, which activate 
molecular oxygen necessary for oxidative metabolism of a diversity of lipophilic organic 
materials (Barker et al, 1992; Hasler et al, 1999).  
CYPs play vital roles in catalyzing biological reactions involved in drug and 
xenobiotic metabolism, steroid hormone biosynthesis, oxidation and metabolism of 
unsaturated fatty acids (Kawajiri and Fujii-Kriyama, 1991; Hasler et al, 1999, Petersen et 
al, 1991). The human CYP1A subfamily, which is the most extensively studied of these 
enzyme systems, consists of 2 functional genes: CYP1A1, which is involved in the 
metabolism of PAHs, and CYP1A2, which is involved in the metabolism of arylamine 
(Peterson et al, 1991). 
1.B. History and Background 
The first experimental evidence relating to CYP was documented in 1955 by 
Axelrod and Brodie et al, who identified an enzyme system in the endoplasmic reticulum 
of the liver that was able to oxidize xenobiotic compounds. In 1958, Garfinkel detected a 
carbon monoxide binding pigment in liver microsomes which had an absorption 
maximum at 450nm (Figure 1) during their spectrophotometric studies. This 
characteristic absorbance peak has been used since then as the signature of P450 proteins;  
i.e. the name P450 was derived from this property of the pigment. Because this 
absorbance was unique to CYPs among all hemeproteins (except nitric oxide synthase), it 
was used for specrtophotometric identification and quantification of CYPs activity. CYPs 
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remained a spectrophotometric puzzle until they were unveiled by Omura and Sato 
(1962, 1964) who identified the pigment as a hemeprotein. Soon after that, Estabrook et 
al (1963) demonstrated the role of adrenal cortex P450 hydroxylation of progesterone 
using the classic photochemical action spectrum technique developed by Otto Warburg 
(1949). By using the same methods, Cooper et al (1965) confirmed that P450s occurring 
in liver microsomes metabolize drugs and other xenobiotics. 
 
Figure 1. Absorbance spectrum of reduced form of CYP showing the maximum peak at 
450 nm (Adapted from Thomas and Gillham, 1989). 
CYPs enzymes have a wide tissue distribution as they have been isolated from 
many different mammalian tissues, including liver, kidney, lung, intestine, and adrenal 
cortex (Hasler et al, 1999). The amount of microsomal CYP in a human liver is 
comparatively high (e.g., ~7500 nmoles in a 1.5-kg liver). CYPs have also been isolated 
from insects, plants, yeast, and bacteria (Mckinnon, 2000). While CYPs are distributed in 
almost every organ, the types of CYPs in a tissue appear to be specific (Hasler et al, 
1999). Ten families and 16 subfamilies of human CYPs have been identified, and their 
structure, function and regulation have been investigated. The contribution of each 
individual isoform of human CYPs to the metabolism and bioactivation of different 
carcinogens has been extensively studied by using gene- or cDNA-directed expression of 
CYPs and human liver microsomes in conjunction with specific antibodies (Kawajiri and 
Fujii-Kriyama, 1991).  
1.C. Structure of CYPs 
CYPs are hemeproteins that consist of a protein (the apoprotein or apoenzyme) 
and a heme moiety, called iron-protoporphyrin IX (Testa, 1995). This porphyrin is not 
only present in all CYP enzymes, but also in other hemeproteins -and enzymes such as 
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hemoglobin, myoglobin, catalase and most peroxidases. The protein component of the 
enzyme varies greatly from one enzyme/isozyme to the other.  Therefore, differences in 
isozyme properties, such as molecular weight (approximate range 45 to 60 kDa), 
substrate and product specificities, and sensitivity to inhibitors could be attributable to 
this variation in protein.  
The structure of the prosthetic heme of CYP is portrayed in Figure 2 (Testa et al, 
1995). An iron cation is bound to the four pyrrole nitrogens.  Two additional non-
porphyrin ligands in axial positions, the fifth ligand X and the sixth ligand Y, are also 
shown. The X is the thiolate ligand, the chiral orientation of the heme shown in the 
Figure 1 is that found in CYP. The detailed structure of protoporphyrin IX has been 
revealed by X-ray crystallographic studies (Caughey and Ibers, 1977).  Cytochrome 
P450cam, a soluble bacterial enzyme, showed comparable results by crystallographic 
examination (Poulos, 1988 and 1991; Poulos and Raag, 1992, Poulus et al 1986).  
 
Figure 2. The structure of iron-protoporphyrin IX, the prosthetic heme of CYPs (Adapted 
from Pasta, 1995). 
The fifth ligand to the iron cation (X) is a thiolate group that occurs near the 
carboxyl end of the protein from an essential cysteine.  This ligand binds to the central 
heme by an extraordinary strong iron-sulfur bond, which is indispensible for the catalytic 
activity of CYPs (Black and Coon, 1985; Collman et al, 1976; Poulos and Raag, 1992; 
Silver and Lukas, 1982; Ruf et al, 1979.  
The composition of the sixth ligand (Y) is controversial. Some years ago, a 
number of investigators demonstrated that this ligand was not a strong nitrogen-
containing ligand, but a weaker, oxygen-containing one (Dawson et al, 1982; White and 
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Coon, 1982).  This decision was based on the observation of a hydroxyl group, either 
from an adjacent amino acid residue or a water molecule (Kumaki and Nebert, 1978). 
Recently, the sixth ligand has been described as a hydroxyl group related to a tyrosinyl 
residue located near the heme, while in cytochrome P450cam (bacterial enzyme) it 
appears to be a water molecule (Janig et al, 1984; Poulos and Raag, 1992; Poulos et al, 
1986).  
The significance of the liganded heme in CYPs structure is extremely important. 
It can exist in different electronic states (either ferric or ferrous oxidation state) which are 
responsible for many of the properties of CYP, most significantly for the binding of 
ligands and the activation of molecular oxygen (Testa, 1995).  
1.D. Nomenclature of CYP Genes and Proteins 
It has been recommended that CYP genes be named according to the following 
rules (McKinnon, 2000; Nelson et al, 1996): 
-The root symbol CYP for cytochrome P450 
-An Arabic number for the cytochrome P450 family 
-A capital letter for the subfamily; and 
-An Arabic number for the individual gene 
-When describing a CYP gene, all letters and numbers should be written in italics 
-When describing a CYP protein, all letters and numbers should be in non-italicized 
form. 
For example, CYP1A1 is the gene encoding CYP1A1 where: 
CYP: is the cytochrome P450 
1: is the CYP family, 
A: is the subfamily (expression of this particular subfamily is induced by aromatic 
hydrocarbons) 
1: is the individual gene. 
 It is estimated that the various CYP families diverged from one another  more 
than 1.2 billion years ago (McKinnon, 2000); consequently, any enzyme in a particular 
CYP family is less than 40% similar to any enzyme from another CYP family at the 
amino acid level (Nebert et al, 1987). In addition, the subfamilies diverged from one 
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another about 400 million years ago. Any 2 enzymes within the same subfamily generally 
share more than 55% amino acid similarity (Nebert et al, 1987). It is noteworthy that the 
nomenclature system was based upon the evolutionary relationships among CYP 
enzymes and not on substrate profiles because some CYPs from the same family have 
different substrate profiles or physiological functions (McKinnon, 2000). 
1.E. Functions and Mechanism of Actions of CYPs 
CYPs are known to catalyze reactions such as epoxidations, hydroxylations, N-, 
S-, and O- dealkylation, sulfoxidations, dehalogenations, N-oxidations, and many other 
reactions (Groves, 1985). The iron protoporphyrin IX center is the primary reactive site 
for these reactions. Seven sequential catalytic steps have been associated with CYPs-
catalyzed reactions, which can be summarized as follows: (1) Substrate binding, (2) 
Reduction of the CYP from resting (ferric) to the ferrous state, (3) Formation of a ferrous 
CYP-dioxygen complex by binding of molecular oxygen, (4) Transfer of a second 
electron to the complex producing a peroxoiron (III) complex, (5) Protonation and 
cleavage of the O-O bond with the formation of reactive iron-oxo species, (6) Oxygen 
atom transfer from this oxo complex to the bound substrate, (7) Dissociation of the 
product. Therefore, CYPs function as monooxygenases  (Hayaishi, 1962) or mixed 
function oxidases (Mason, 1957) by incorporating one of the two oxygen atoms of an O2 
molecule into a wide variety of lipophilic substrates with concomitant reduction of the 
other oxygen atom by two electrons to H2O (Hasler et al 1999) as shown in the following 
CYP-dependent oxygenation reaction: 
NADPH + O2 + AH2 + H+               NADP+ + AHOH + H2O 
Ortiz de Montellano (1995) reported that some extrahepatic human CYPs have 
key roles in maintaining homeostasis and signal transduction as well as drug metabolism. 
For example, lungs and nasal tissues contain a considerable amount of CYP, and these 
sites may be important in the oxidation of xenobiotics entering the respiratory system. 
Renal CYPs may have a significant role in processing compounds generated in the 
kidneys or transported there from the liver. Moreover, one of the extrahepatic tissues with 
an important CYP activity is the small intestine (Orton and Parker, 1982) where CYP3A4 
is abundant (Tamburini et al, 1984). It plays a major role in the metabolism of many 
orally administered drugs (Hardwick et al, 1987; Reddy et al, 1986). As a consequence, it 
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may considerably inactivate these drugs and reduce their bioavailability. The functions of 
CYPs in different human subfamilies are shown in Table 1 (Hasler et al, 1999). 
CYP isoform Metabolic functions 
CYP1A and B Polycyclic hydrocarbons. Nitrosamines  
CYP2A Drugs. Alcohols. Steroids 
CYP3A Drugs. Antibiotics. Flavenoids 
CYP4 ω-oxidation fatty acids 
CYP5 Thromboxane synthase 
CYP7A 7α-Hydroxylase. Bile Acids 
CYP8A and B Prostacyclin Synthase. Bile Acids 
*CYP11A and B Cholesterol side-chain cleavage. Aldosterone synthesis 
CYP51 Cholesterol Biosynthesis. 14-demthylase 
*CYP40 Vitamin D3- 1α Hydroxylase 
*CYP27 Bile Acid Synthesis 
CYP26 Retinoic Acid Hydroxylase 
*CYP24 Vitamin D degradation 
CYP21 Progesterone 21-Hydroxylase 
CYP19 Estrogen Biosyhthesis. Aromatase 
CYP17 Steroid 17 α-Hydroxylase. Steroid C17/21 Lyase 
Table 1: The human CYP subfamilies and their metabolic functions. An asterisk 
next to an isoform indicates mitochondrial enzymes. (Adapted from Hasler et al, 1999). 
1.F. Biological Importance of CYPs and Their Role in Carcinogenesis 
CYPs are important in the metabolism of xenobiotics and in the critical steps of 
steroid hormone biosynthesis.  Because of these important roles, the regulation and 
mechanism of these enzymes have occupied a central place in the interests of 
pharmacologists and toxicologists.  Accordingly, it was not surprising that when 
recombinant DNA technology emerged, CYPs were one of the first classes of enzymes to 
be cloned.  The CYP1A1 cDNA (Kawajiri et al, 1986) and gene (Jaiswal et al, 1985a, 
1985b; Kawajiri et al, 1986) have been cloned, sequenced, and localized on chromosome 
15 near the MPI locus (Hildebrand et al, 1985).  
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Carcinogens that enter the body by different routes are metabolized by two major 
enzymatic systems: phase I and phase II enzymes (Mucci et al, 2001). Generally, phase I 
enzymes function by attaching specific groups to the compound thereby producing 
intermediate metabolites that are usually more reactive and carcinogenic than the original 
compound. Phase II enzymes also act to attach additional groups.  These modifications 
detoxify or inactivate the reactive intermediate and prepare them for breakdown or 
excretion in a less lipophilic form (Mucci et al, 2001). 
Human lung cancer often involves exposure to procarcinogens mainly contained 
in cigarette smoke, although the association of cigarette smoking with lung cancer differs 
by histological types. Most chemical procarcinogens require activation by Phase I 
enzymes, CYPs, to become reactive electrophilic forms that exert toxic or carcinogenic 
effects. Thus, CYPs are the key enzymes responsible for the initial metabolism of various 
procarcinogens present in our environment. Although several species of CYPs have been 
linked to lung carcinogenesis, CYP1A1 is one of the most important.  It is expressed in 
human lung tissue and can metabolize PAHs in cigarette smoke such as benzo[a]pyrene 
(Hasler et al, 1999). In addition to its role in the production of electrophilic intermediate 
metabolites, CYP1A1 is also involved in the formation of highly reactive oxygen free 
radical species, such as hydroxyl radicals or superoxides as byproducts. These alterations 
may result in toxic responses or cellular damage and eventual carcinogenesis (Hasler et 
al, 1995). 
1.G. The Inducibility of CYPs 
 Some of the CYP enzymes can be induced by substrate binding, thereby allowing 
the cells to adapt to changes in their chemical environment and maintain homeostasis 
(Denison and Whitlock, 1995). Drug and xenobiotic metabolism can be altered by 
induction of CYPs and other metabolizing enzymes. For example, the tolerance to 
barbiturates is a common body reaction associated with induction of drug metabolizing 
enzymes (James and Whitlock, 1999). Similarly, chemical carcinogenesis may be 
attenuated or inhibited by enzyme induction that increases the rate of detoxification 
(James and Whitlock, 1999). Consequently, enzyme induction can be a protective 
mechanism by which the cells metabolize the lipophilic compounds; otherwise they will 
accumulate to deleterious levels that overcome the defense mechanisms. By contrast, 
                                                                            11
induction can be disadvantageous in some instances. The enzyme induced by one 
substrate may increase the metabolism of a drug leading to attenuation of drug effects 
(Guengerich, 1997). Moreover, CYPs induction may lead to toxicity or neoplasia as a 
result of the oxygenation of PAHs (PAHs), present in cigarette smoke and other 
combustion products, producing highly reactive electrophiles called arene oxides that 
bind covalently to the cellular macromolecules resulting in carcinogenesis (Conney, 
1982; Miller and Miller; 1981; Phillips, 1983)  
2-Cytochrome P450 1A1 (CYP1A1) 
(Family 1, subfamily A, polypeptide 1) 
2.A. Introduction 
CYP1A1, an inducible CYP (Hasler et al, 1995), is a member of the human 
P4501A subfamily which includes only 2 members, CYP1A1 and CYP1A2 (Ortiz de 
Montellano, 1995). These 2 isoforms have 70% similarity in their amino acid sequence 
(Ortiz de Montellano, 1995). In addition to liver (Whitlock, 1986; Issemann and Green, 
1990; Gottlicher et al. 1992), CYP1A1 has also been detected in lungs (Antilla et al, 
1991), placenta (Song et al, 1985), brain (Yun et al, 1998), and lymphocytes (Jaiswal et 
al, 1985b). CYP1A1 enzyme is involved in the metabolism of PAHs, whereas CYP1A2 
is involved in the metabolism of arylamines (Peterson et al, 1991). It has been 
demonstrated that high inducibility of CYP1A1 is considered a risk factor for lung cancer 
in tobacco smokers (Anttila et al, 2001; Ishibe et al, 2001).  Because smokers are 
exposed to carcinogenic PAHs, their CYP1A1 expression is induced (Willey et al, 1997).  
2.B. Genetic Polymorphisms of CYP1A1 
Since CYP1A1 participates in the biochemical activation of PAHs to produce 
mutagenic and carcinogenic derivatives, genetic polymorphism in CYP1A1 activity may 
alter susceptibility to PAH-associated diseases, such as lung cancer in smokers (James 
and Whitlock, 1999).  Phenotypic polymorphism in the inducibility of CYP1A1 was 
originally described by Kellermann et al (1973) when he found that 10 % of Caucasians 
showed much higher lymphocytic CYP1A1 activity after exposure to an inducer than the 
rest of the group. In genotyping studies, two closely linked polymorphisms of the 
CYP1Al gene have been demonstrated in Caucasian and Oriental populations (Hasler et 
al, 1995). These include a 3'-flanking region Msp1 site (also called m2 allele) and the 
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exon 7 Ile-Val substitution (Val allele). The m2 allele has been associated with increased 
CYP1A1 inducibility in some studies whereas the Val allele is associated with enhanced 
enzyme activity in vitro (Hayashi et al., 1991, 1992). A new CYP1A1 polymorphism has 
been observed among black populations called Msp I AA (Kawajiri, 1999) and has a 
striking association with breast cancer risk (Taioli et al, 1995; Taioli et al, 1999).  
2.C. Induction of CYP1A1 
 CYP1A1 induction was first discovered because it was observed that PAHs 
mediate their own metabolism. The studying of its induction mechanism was facilitated 
by several important observations (James and Whitlock, 1999). First, its induction is 
strong and evident compared to the background level. Second, the induction is affected 
by genetic polymorphisms, which made the genetic analysis possible. Third, CYP1A1 
induction has been demonstrated in cell cultures, which facilitates the gene transfer 
experiments. Experiments involving induction-defective mouse hepatoma cells 
demonstrated various groups of genes that synergistically contributed to the induction 
mechanism (Hankinson, 1995; Whitlock et al, 1996). It has been demonstrated that 
inducer binding was reduced in one mutant associated with low levels of aromatic (aryl) 
hydrocarbon receptor (AhR), which is an intracellular protein essential for the initiation 
of the induction process (Gonzalez et al, 1996; Okey, 1994). Another mutant defective in 
a protein called Ah receptor nuclear translocator (Arnt) showed disturbance of nuclear 
localization of liganded AhR (Whitlock et al, 1996). The studying of these mutants 
highlighted the possible role of different proteins in the mechanism of CYP1A1 induction 
(Hankinson, 1995; Whitlock et al, 1996).  
2.D. Mechanism of CYP1A1 Induction 
 It is well known that genomic DNA is associated with histones and other DNA-
binding proteins to form chromatin, whose basic units are called nucleosomes. Chromatin 
configuration plays a key role in gene expression in that the presence of nucleosomes 
represses transcription (Grunstein, 1997; Wu, 1997; Kadonaga, 1998; Struhl, 1998; 
Gregory and Horz, 1998). It is important that transcription factors such as AhR and Arnt 
gain access to their cognate recognition sites on the chromatin to overcome the repressive 
effect of nucleosomes on gene expression (James and Whitlock, 1999). In uninduced 
cells, the CYP1A1 enhancer/promoter region been suggested to be bound by nucleosome 
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according to indirect end-labeling analysis in mouse hepatoma cells (Morgan and 
Whitlock, 1992). The apparent cause of the low levels of CYP1A1 in uninduced cells is 
that the enhancer/promoter region is not accessible to transcription factors, particularly 
when the DNA binding sites are facing inward toward the histone (James and Whitlock, 
1999). The induction process is initiated by binding of the inducer, such as PAHs to the 
AhR, which is usually located in the cytoplasm complexed with hsp90 and the AhR-
interacting protein (AIP) (Ma and Whitlock, 1997). This binding results in the 
dissociation of the hsp90 and AIP followed by translocation of the AhR to the nucleus 
where it is conjugated with Arnt forming a heterodimer complex. The process of 
heterodimerization may be enhanced by phosphorylation at particular sites most probably 
on AhR (Career et al, 1992). The AhR/Arnt heterodimer binds to the xenobiotic 
responsive element (XRE) on the CYP1A1 enhancer region resulting in gene transcription 
(Figure 3) 
                                                                            14
 
Figure 3. CYP1A1 induction mechanism (Adapted from James and Whitlock, 1999). The binding of ligand to the AhR results in 
dissociation of the AhR-associated cytoplasmic proteins (Hsp90 and AIP) followed by translocation of AhR to the nucleus where it 
dimerizes with Arnt. AhR/Arnt heterodimer binds to the xenobiotic responsive element (XRE) at the enhancer region of CYP1A1 gene 
stimulating chromatin changes, binding of initiating complex and CYP1A1 induction. 
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2.E. The CYP1A1 Inducers 
Constitutive (background) expression of CYP1A1 is very low in contrast to the 
inducible expression which is extremely robust. Most CYP1A1 inducers are also 
substrates metabolized by that enzyme which suggest that the induction process is an 
adaptive reaction of the body to enhance the detoxification process, particularly with the 
low concentrations of the inducers (James and Whitlock, 1999). Inducers for CYP1A1 
are also ligands for the AhR, since most of the inducers, such as 2,3,7,8- 
tetrachlorodibenzo-p-dioxin (TCDD) have an extraordinary affinity for the AhR (Poland 
et al, 1986). Based on studies of structure-activity relationships, it was suggested that the 
AhR ligands are planar and interact with a hydrophobic pocket in AhR (Poland and 
Knotson, 1982). However, it was found that CYP1A1 expression can be mediated by the 
binding of compounds of different structure and lipophility to the AhR (Denison et al, 
1998). Ligands for AhR may include specific indoles and other compounds from ingested 
food which suggests a relationship between diet and cancer prevention because ingestion 
of inducer-containing food may enhance the detoxification or activation of other potential 
chemical carcinogens (Bjeldanes et al, 1991; Fahey et al, 1997).  Ligands for AhR also 
include PAHs, such as 3-methylcholanthrene, benzo(a)pyrene, polyhalogenated aromatic 
hydrocarbons, such as the 2,3,7,8-tetrachlorodibenzo p-dioxin (TCDD), and certain 
congeners of polyhalogenated biphenyls (Ke et al, 2001). 
2.F. The role of CYP1A1 in carcinogenesis 
The most commonly described mechanism of CYP1A1-mediated carcinogenesis 
involves the oxidation of benzo(a)pyrene (in cigarette smoke)  into the intermediate 
reactive metabolite, benzo[a]pyrene diol epoxide (BPDE) (Bjelogrlic et al, 1993; Liang et 
al, 2003). This unstable epoxide is able bind to the DNA nucleotide bases, mainly 
adenine and guanine, producing stable adducts (Figure 4) that result in DNA mutations 
(Szeliga and Dipple, 1998). When such a mutation involves a critical gene, such as p53, it 
can lead to lung cancer (Vogelstein and Kinzler, 1992; Denissenko et al, 1996; Wang et 
al, 1995). A positive correlation has been established between DNA adducts and human 
lung cancer (Denissenko et al, 1996). Denissenko and his co-workers demonstrated that 
the DNA adducts caused by BPDE are distributed along exons of the P53 gene in Hela 
cells and bronchial epithelial cells, particularly at guanine positions in codons 157, 248, 
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ad 273. These positions are the same main mutational hotspots observed in human lung 
cancer (Denissenko et al, 1996). 
 
Figure 4: Mechanism of carcinogenesis induced by CYP1A1-catalyzed reaction (Adapted 
from: Geacintov, NE: http://www.nyu.edu/projects/geacintov/images/WEB_Figures/WEB_PAH3.htm).  
2.G. Modification of CYP1A1 induction  
2.G.1. Effect of Nuclear Factor Kappa B (NF- κB) and Tumor Necrosis Factor- α  
(TNF- α) 
NF-κB is a pleiotropic transcription factor that plays important roles in the 
regulation of diverse physiological processes, such as inflammatory reactions, immune 
responses, cell proliferation, apoptosis, and developmental processes (Ke et al, 2001; 
Baldwin, 1996). NF-κB is a heterodimer which basically consists of a p65 (RelA) and a 
p50 (NF-κB -1) subunit, with RelA being the subunit conferring robust transcription 
activity. Some recent studies indicate a reciprocal inhibitory interaction between the AhR 
and NF-κB signaling pathways (Tian et al, 1999) which suggests that the NF-κB plays a 
key role in suppression of CYP1A1 expression by inflammatory responses associated 
with exposure to different agents. 
Four different mechanisms have used to describe the regulation of CYP1A1 
induction by NF-κB and TNF-α: (A) the interaction between NF-κB and the AhR 
repressor (AhRR), (B) the interaction between NF-κB and AhR itself, (C) the inhibition 
of histone acetylation of CYP1A1 promoter by NF-κB, and (D) the suppression of 
CYP1A1 transcriptional elongation by NF-κB. 
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2.G.1.a. Effect of NF-κB on aryl hydrocarbon receptor repressor (AhRR) 
 AhRR is a member of the bHLH/PAS superfamily of transcription factors that is 
associated with the repression of AhR function (Baba et al, 2001, Mimura et al, 1999). 
This polypeptide (AhRR) represses AhR’s function as a transcription factor by  
competing with it in forming a heterodimer complex with Arnt capable of binding to the 
XRE sequence. In addition, the expression of AhRR is induced by the AhR/Arnt 
heterodimer binding to an upstream XRE enhancer sequence; consequently regulation of 
AhR function is mediated by feedback inhibition of AhRR (Mimura et al, 1999). The 
AhRR gene has been localized to mouse chromosome 13C2, rat chromosome 1p11.2, and 
human chromosome 5p15.3 by fluorescence in situ hybridization analysis (Baba et al, 
2001). Screening of the promoter sequence of the AhRR revealed multiple enhancer DNA 
elements: three XRE sequences (at the -45, -388, and -1296 position), three GC box 
sequences (at -36, -53, and -58), and one NF-κB binding site (at -28) (Baba et al, 2001). 
Since the binding of NF-κB to its cognate enhancer sequence of the AhRR gene 
upregulates AhRR expression, it was suggested that NF-κB downregulates CYP1A1 
induction via repression of the AhR functional activity (Baba et al, 2001). This 
suggestion was supported by the suppressive effect of different cytokines, such as TNF-α, 
interleukin-1β, and interferon-γ on CYP1A1 induction (Barker et al, 1992, Calleja et al, 
1997) since NF-κB is an upstream regulator of these cytokines (Scheidereit, 1998).  
2.G.1.b. Direct Effect of NF-κB on AhR 
 Physical association between the RelA subunit of NF-κB and AhR has been 
demonstrated by an immunoprecipitation study (Tian et al, 1999). It was suggested that 
the non-activated AhR and NF-κB are retained in the cytoplasm and are kept apart by 
their association to their respective regulatory proteins [hsp90 associates with AhR 
(James and Whitlock, 1999) and IκB associates with RelA (Zhong et al, 1997)] resulting 
in compartmentalization.  Upon extracellular activation signals, such as TCDD or BNF 
for AhR, and TNF for NF-κB, the AhR and NF-κB subunits dissociate from their 
respective regulatory proteins and interact with each other by physical association (Tian 
et al, 1999) producing an inactive complex that prevents AhR from binding to the 
enhancer sequences of CYP1A1 (Ke et al, 2001).  This physical association could explain 
the downregulation of CYP1A1 induction by the activated NF-κB. 
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2.G.1.c. Effect NF-κB on Histone Acetylation at the CYP1A1 Promoter. 
 NF-κB has been demonstrated to inhibit the ligand-induced acetylation of histone 
H4 at the CYP1A1 promoter, especially around the TATA box region.  This prevents the 
AhR/Arnt heterodimer from binding to the XRE and results in downregulation of 
CYP1A1 expression (Tian et al, 2002).  This mechanism was illustrated by using the 
chromatin imunoprecipitation assay (Ke et al, 2001). Histone acetylation is known to 
enhance transcriptional activation (Strahl and Allis, 2002) which is brought about by 
assembly of the initiation complex (Ke et al, 2001). Silencing of gene expression has 
been associated with hypoacetylation.  Therefore, NF-κB-induced suppression of histone 
acetylation is associated with silencing of CYP1A1 gene expression. It has been 
suggested that the acetylation state of a histone is the result of 2 different intracellular 
processes; acetylation and deacetylation (Ke et al, 2001).  Accordingly, the inhibition of 
the acetylation of histone H4 at the CYP1A1 promoter could be attributed to either 
decreased histone acetyl transferase (HAT) activity or increased deacetylation by the 
histone deacetylase (Ke et al, 2001). 
2.G.1.d. TNF-α Suppresses CYP1A1 Transcriptional Elongation 
 Treatment of mouse Hepatoma (Hepa1c1c7) cells with dioxin resulted in an 
increase in the phosphorylation of the C-terminal domain of RNA polymerase II (Tian et 
al, 2003).  This phosphorylation is essential for CYP1A1 elongation. Treatment of the 
same cell line with TNF-α suppressed the phosphorylation of the C-terminus of RNA 
polymerase II, particularly at serine 2, resulting in interference with CYP1A1 elongation 
(Tian et al, 2003). 
2.G.2. Effect of Inflammation on CYP1A1 Induction 
 The effect of inflammation on CYPs has been extensively studied in rat 
hepatocytes (Morgan, 1997) which reflect responses detected in vivo in most cases 
(Morgan, 2001).  The response of the body to infection or inflammation has been 
associated in most cases with suppression of CYPs, particularly in liver (Morgan, 1997).  
It was suggested that the suppression of CYPs expression during inflammation is not an 
adaptive or homeostatic response, rather the priority of the liver to assign its 
transcriptional machinery for synthesis of specific proteins necessary for controlling the 
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systemic inflammatory response (Morgan, 1989).  However, different CYPs isoforms are 
regulated by different mechanisms and different cytokines (Morgan, 1997).  In 
extrahepatic tissues, the CYPs are preferentially regulated by different inflammatory 
stimuli (Morgan, 2001). For instance, CYP1A1 is downregulated in brain inflammation 
whereas CYP2E1 is upregulated in astrocytes (Tindberg et al, 1996).  Also the 
intracerebroventricular injection of bacterial lipopolysaccharides (LPS) suppresses 
CYP1A functional activity (Renton and Nicholson, 2000).  
2.G.2.a. Effect of the Reactive Oxygen Species 
 It has been demonstrated that incubation of human hepatocytes with human serum 
obtained during the acute phase of infection and inflammation or with rabbit serum from 
turpentine-injected rabbits decreased the CYP2A1-associated theophylline metabolism 
without a reduction in CYP1A1 and CYP2A1 protein level (El-Kadi, 2000). Such a 
reduction in the catalytic activity of these CYPs was partially prevented by addition of 
antioxidant and exacerbated by antioxidant inhibitors (El-Kadi, 2000). The 
downregulation of CYPs associated with oxidant injury is a response of the body to 
prevent further generation of reactive oxygen species and minimize tissue damage 
(Morgan, 2001). Reactive oxygen intermediates (ROI), such a H2O2 (hydrogen peroxide), 
that are generated during some inflammatory processes might interact with the CYP1A1-
associated Fe2+ resulting in heme destruction and enzyme inactivation (Karuzina and 
Archakov, 1994; Archakov et al, 1998). An alternative mechanism of CYP1A1-
downregulation by reactive oxygen intermediates is mediated via direct phosphorylation 
of the isoform by kinases resulting in inactivation of the CYPs (Rhee, 1999).  ROI, 
particularly oxygen radicals and hydrogen peroxides, stimulate protein kinase A (Suzuki 
et al, 1997), protein tyrosine kinase (Bae et al, 1997; Lowe et al, 1998), protein kinase C 
(Boyer et al, 1995), and mitogen-activated protein kinases (Goldstone and Hunt, 1997). 
The mechanism of the CYP1A1 inactivation by phosphorylation is not yet understood, 
although phosphorylation enhances the uncoupling of CYP1A1 from NADPH-dependent 
hydroxylation during xenobiotic metabolism (Mkrtchian and Andersson, 1990).  
2.G.2.b. Effect of Reactive Nitrogen Species 
 Nitric oxide is produced by the inducible NO synthase (iNOS) during 
inflammatory responses (Morgan, 1997b). Evidence of involvement of NO in regulating 
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phenobarbital-induced CYP2B1 has been provided by Khatsenko et al (1997) when he 
showed that the administration of the NG-nitro-L-arginine methyl ester (L-NAME), a 
nitric oxide synthase inhibitor, to rats simultaneously treated with Phenobarbital 
(CYP2B1 inducer) and lipopolysaccharide (LPS) prevented the down-regulation of 
CYP2B1 and CYP2B2 activity, mRNA, and protein. This relationship was further 
supported by Roberts et al (1998) who found that the in vitro incubation of CYP2B1 and 
peroxynitrite resulted in the nitration of tyrosines at either residue 190 or 203 or at both 
residues of CYP2B1 which coincided with a loss of 2B1-dependent activity. In addition, 
it has been demonstrated that the addition of nitric oxide to the V79-derived cell lines, 
which are known to constitutively express rat and human CYP1A1 and CYP1A2, 
inhibited the CYP1A1 activity in a dose-dependent manner (Stadler et al, 1994). 
 Different mechanisms of NO-associated CYP1A1 downregulation have been 
proposed. The most commonly accepted one is that nitric oxide binds to the heme moiety 
of the CYP1A1 forming an iron-nitrosyl complex in rat hepatic cells in a reversible 
phase, subsequently preventing the binding of oxygen which normally occurs at the 
catalytic site, and suppression of  CYP1A1 functional activity (Wink et al, 1993). The 
same study also showed irreversible inhibition of CYP1A1 and CYP2B1 activity due to 
destruction of the integrity of the primary structure of hemeprotein, resulting from the 
action of nitrogen oxides produced from the oxidation of nitric oxide by oxygen. Not 
only does nitric oxide inhibit the CYP1A1 activity, but also downregulates the CYP1A1 
expression by inhibition of CYP1A1 promoter activity as reported by studies on Hepa I 
cells (Kim and Sheen, 2002). 
2.G.2.c. Effect of Inflammatory Mediators on CYP1A1 Expression 
 The inflammatory mediators or cytokines that are released in inflammatory 
conditions play an important role in the suppression of CYPs and their mRNAs (Bleau et 
al, 2001). For example, interleukin-6 (IL-6) suppresses CYP1A1, 1A2, 2D, 3A4, and 
4A1, and IL-1β depresses 1A2, 2C11, 2D6, 2E1 and 3A in vitro (Fukuda et al, 1992; 
Trautwein et al, 1992; Donato et al, 1997; Parmentier et al, 1997). Moreover, TNF-α 
downregulates CYP1A1 by inhibiting its transcriptional elongation in mouse Hepatoma 
cells (Tian et al, 2002). 
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Therefore, in a broad sense, inflammation is mostly associated with 
downregulation of CYPs by changing the activity and expression levels of different 
isoforms.  
3-Anatomy, Histology and Physiology of Lung  
3.A. Anatomy of Lung 
 Lungs are paired organs that occupy a large space in the thoracic cavity. Each 
lung is encapsulated by a thin-film membrane called pleura where it is free to move 
within this pleural sac (Getty, 1975).  Generally, the lung has 2 lobes, the right and left, 
each one receives one of the major bronchi. It consists of a bronchial tree that starts with 
the major bronchi and ends in the terminal bronchioles (minute bronchi). Following the 
terminal bronchioles are the lung alveoli, which are sac-like structures (Figure 5) lined by 
respiratory epithelial cells and capillary endothelial cells. Lung alveoli are the major sites 
of gas exchange, where most of the blood capillaries are located.  
 
Figure 5: Schematic diagram showing the anatomical structure of lungs. The trachea 
bifurcates into right and left bronchi. Each major bronchus branches into smaller bronchi 
until ended by the terminal bronchioles.  The terminal bronchioles open into the alveolar 
duct which leads to the alveoli. The alveoli are sac-like structures consisting of an 
alveolar wall that encloses the alveolar lumen. The alveolar wall is lined by alveolar 
epithelium.  
(Adapted from: http://www.schoolscience.co.uk/content/4/biology/glaxo/pm3ast1.html) 
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3.B. Histology of Pulmonary Alveoli 
Lung parenchyma is composed of many different cell types (Figure 6) with 
different pulmonary functions (Sorokin, 1970). The alveolar epithelium consists of 2 
morphologically distinct cell types called alveolar type I cells (membranous 
pneumocytes) and alveolar type II cells (granular pneumocytes), which rest on a 
basement membrane (Dobbs, 1990, Castranova, 1988). The alveolar epithelial cells have 
tight intercellular junctions (Schneeberger, 1978). Alveolar type I cells appear long 
(squamous) with thin cytoplasmic extensions as indicated by transmission electron 
microscopy (Castranova et al, 1988). Alveolar type I cells comprise 96% of the epithelial 
surface area (Castranova et al 1988; Crapo et al, 1978) and 8-10 % of all lung cells 
(Crapo et al, 1978). These cells, being thin, facilitate and maximize gas exchange as they 
reduce the space between the air in alveolar spaces and the pulmonary blood capillaries 
(Castranova, 1988). On the other hand, AT-II cells are spherical (cuboidal) cells which 
are about 9 µm in diameter (Jones et al, 1982, Haies et al, 1981). This size is an 
intermediate size between the smaller endothelial cells and the larger macrophage and 
alveolar type I cells (Grapo et al, 1982; Crapo et al, 1978; Haies et al, 1981). These 
pneumocytes constitute 15 % of all lung cells (Dubbs, 1990) but cover less than 5 % of 
the alveolar surface (Dobbs, 1990, Castranova, 1988). Clara cells are a third type of 
epithelial cells present in lungs and are located at the end of the conducting airways near 
the alveolus and have important nonrespiratory functions (Devereux et al,, 1982). These 
cells are non-ciliated terminal bronchiolar epithelial cells containing extensive 
endoplasmic reticulum, abundant mitochondria and osmiophilic granules that distinguish 
them from other epithelial cells (Devereux, 1984; Plopper et al, 1980). The Clara cells 
have extremely high levels of xenobiotic metabolizing enzymes (Boyd, 1977). 
Other cells with important biological functions are the alveolar macrophages 
(AMs). They are considered as part of the innate immunological defense system because 
they migrate and attack inhaled particles shortly after exposure (Kleinman et al, 2003). 
AMs are free migrating cells localized on the surface of the small airways and alveoli 
(Weibel, 1973). The reaction of AMs to the inhaled particles consists of progressive 
attacking steps. Following recognition, the AMs phagocytize these foreign particles in 
phagolysosomes and try to digest them by releasing lysosomal enzymes into phagocytic 
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vacuoles (Myrvik and Evan, 1967). Eventually, the digested foreign substances are 
excreted to the outside medium. Contact of AMs with the inhaled foreign particles or 
bacteria, results in a release of superoxide anions (Sweeney et al, 1981), which can be 
monitored by the measurement of AM chemiluminescence (Miles et al, 1978; Castranova 
et al, 1980). 
 
Figure 6: Schematic diagram showing that cells of alveolar wall include AT-II, alveolar 
type I, fibroblast, macrophages and capillary endothelial cells (Adapted from: 
http://www.biology.arizona.edu/chh/problem_sets/lung_toxicology/02t.html.) 
3.C. Functions of Alveolar Epithelial Cells 
The alveolar type I and AT-II cells enclose a space called the alveolar space 
(Castranova, 1988). Alveolar type I cells, which constitute the majority of alveolar 
surface help the gas exchange between the pulmonary blood capillaries and the alveolar 
spaces. The AT-II epithelial cells are multifunctional pneumocytes (Castranova, 1988).  
One important function of AT-II cells, is to synthesize and secrete surfactant, 
which is a mucoid film surrounding the alveolar epithelium (Macklin, 1954). The 
alveolar lining material (surfactant) is composed of phospholipids, proteins, and 
carbohydrates (Dobbs and Mason, 1979; Brown and Longmore, 1981) and its major 
function is to reduce surface tension (Pattle, 1961).  A reduction of surface tension is 
biologically important because it reduces the work required for lung inflation, maintains 
alveolar stability and prevents alveolar edema (Clements et al, 1959; Stub, 1966). AT-II-
associated surfactant has been demonstrated to enhance phagocytosis and killing of 
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bacteria by alveolar macrophage (LaForce et al, 1973; Juers et al 1976). It also protects 
the lungs from potentially toxic inhaled particles (Wallace et al, 1985). 
A second prominent function of AT-II cells occurs during the recovery of lungs 
from oxidant injury (Castranova, 1988).  In contrast to type I cells, which are susceptible 
to oxidant injury, AT-II cells are resistant to oxidants and physical injuries (Cross, 1974; 
Crapo et al, 1982). Alveolar type I cells seem to be highly sensitive to the pulmonary 
toxicants because they were damaged first at a cellular level following pulmonary 
exposure to foreign toxicant (Weibel, 1974). This could be attributed to their relatively 
large surface area, which may approach 4500 µm2 (Haies et al 1981) and their attenuated 
cytoplasm (Miller and Hook, 1990). Following injury of alveolar type I cells, AT-II cells 
proliferate (hyperplasia) (Stanley et al, 1992) and differentiate into type I cells in order to 
repair the alveolar epithelium and maintain the alveolar architecture (Melloni et al, 1995; 
Adamson et al, 1988; Thet et al, 1984) as shown by pulse label experiments (Castranova 
1988). This is necessary because alveolar type I cells are incapable of dividing (Weibel, 
1974), and because they are terminally differentiated cells.  The process of differentiation 
of AT-II into type I cells occurs within 2 days of injury (Evans et al, 1973).  The 
resistance of AT-II cells to the oxidant injury is attributed to the transport of vitamin C 
(an antioxidant) into these cells.  Castranova et al (1983) demonstrated that AT-II cells 
contained a sodium-ascorbate cotransport system that allows the accumulation of the 
antioxidant ascorbate in AT-II cells, therefore increasing their resistance to oxidant 
injury. 
In addition to the aforementioned functions, AT-II cells also play an important 
role in the metabolism of foreign compounds (xenobiotics) such as drugs and 
environmental pollutants because of their content of CYP monooxygenase system 
(Devereux et al, 1979; Jones et al, 1983; Raboveskey et al, 1986; Baron and Kawabata, 
1983). They are rich in endoplasmic reticulum and sensitive to the exposure of toxic 
agents (Baron and Kawabata, 1983). Xenobiotic metabolism by AT-II cells is not 
restricted to inhaled foreign compounds but also includes circulating xenobiotics since 
these cells are in close proximity to capillary blood supply (Castranova, 1988). 
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Alveolar macrophages are migratory phagocytic cells located on the surface of the 
small airways and the alveoli (Weibel, 1973). These cells act as the lung’s first line of 
defense against the toxic effects of inhaled particles, as they play a major role in the 
protection of lung against these particles. The reaction of alveolar macrophages to the 
inhaled particles is complex. Upon contact with the particles, AMs release superoxide 
anion (Sweeney et al., 1981), which could be monitored by measurement of 
chemiluminescence (Miles et al, 1978; Castranova et al, 1980). Eventually, AMs engulf 
these foreign particles and attempt to digest them by releasing lysosomal enzymes into 
phagocytic vacuoles (Myrvik and Evan, 1967). 
4-Distribution and Localization of CYP1A1 and Other Isoforms in Pulmonary 
Alveoli of Different Animal Species 
4.A. Human 
In humans, CYP1A1 is constitutively expressed in very low level and the 
intensity of expression varies within different pulmonary cells (Antilla et al, 1991). By 
immunohistochemistry, CYP1A1 is mainly localized in the epithelium of the peripheral 
airways, the ciliated columnar epithelium of the bronchioles and the cuboidal and 
columnar cells of the terminal bronchioles (Antilla et al, 1991). Immunohistochemical 
staining was also observed in AT-II cells and in a few cases, within type I cells (Antilla et 
al, 1991). Pulmonary vascular endothelium infrequently showed CYP1A1 
immunopositive staining but the alveolar macrophages were always negative (Antilla et 
al, 1991).  Another important CYP isoform in humans is CYP1B1. CYP1B1 is regulated 
through the AhR and its mRNA was detected in liver, lymphocytes, cells of 
bronchoalveolar lavage and endometrium, but not in lung (Hakkola et al, 1997). 
However, by immunohistochemistry, CYP1B1 was localized only in a range of malignant 
tumors, such as tumors of the breast, colon, lung, esophagus, skin, lymph node, brain, and 
testis and there was no detectable immunostaining for CYP1B1 in normal tissues (Murray 
et al, 1997). Therefore, CYP1B1 seems to be constitutively expressed in tumors (tumor 
specific) but undetectable in most normal tissue although CYP1B1 mRNA is present 
(McFadyen et al, 2003). Other isoforms, such as CYP2B6, CYP2E1, CYP2J2, and 
CYP3A5 proteins are expressed in human lung (Hukkanen et al, 2002). 
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4.B. Rodents 
In rodents, the CYP activity of the lung has been demonstrated mostly in 
epithelial and endothelial cells (Pairon et al, 1994).  CYP protein expression and activity 
has been identified in three main types of cells: Clara (terminal non-ciliated) cells in the 
bronchiolar epithelium, AT-II cells in the alveolar spaces, and endothelial cells in the 
vascular compartment (Serabjit-Singh et al, 1980; 1988; Plopper et al, 1987; Lacy et al, 
1992; Jones et al, 1983; Kheith et al, 1987; Overby et al, 1992). Various materials of the 
lungs have been used to demonstrate the protein expression and activity of CYP isoforms 
in the lungs of rodents, such as the microsomes (Domin et al, 1986; Keith et al, 1987; 
Guengerich et al, 1982; Vanderslice et al, 1987; Tindberg and Ingelman-sundberg, 1989; 
Sesardic et al, 1990; Carlson and Day, 1992), isolated lung cell fractions of untreated or 
pretreated animals (Devereux et al, 1982; Lacy et al, 1992; Jones et al, 1983; Chichester 
et al, 1991), and tissue preparation for ultrastructural analysis (Serabjit-Singh et al, 1988; 
Overby et al, 1992; Aida et al, 1992). The predominant form of CYP in the uninduced rat 
lung is CYB2B1 (Guengerich et al, 1982), which is mainly localized in Clara cells and to 
a lesser extent in AT-II cells (Baron and Voigt, 1990; Kheith et al, 1987). In contrast to 
lung, the hepatic CYP2B1 is induced by Phenobarbital (Kim and Kemper 1997). Other 
CYP isoforms, such as 1A1 (Pairon et al, 1994), 2A3, 3A2, and 4B1, are also expressed 
in lung but in very small quantities (Foster et al, 1986; Voigt et al, 1990; Kimura et al, 
1989; Keith et al, 1987; Vanderslice et al, 1987). The CYP2E1 protein is another isoform 
expressed only in rat lungs after being induced by substrates such as acetone or ethanol 
(Tindberg and Ingelman-Sundberg, 1989; Carlson and Day, 1992). 
By immunohistochemistry and in situ hybridization techniques, 3-
methylchlolantherene (3MC) - induced rat CYP1A1 was localized primarily in Clara 
cells and AT-II cells, with some labeling observed in other alveolar wall cells. These cells 
could not be specifically identified microscopically and were believed to be either 
alveolar type I cells or capillary endothelial cells (Pairon et al, 1994). In humans, similar 
results have been demonstrated without detection of any activity in the endothelial cells 
(Marcus et al, 1990). 
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4.C. Rabbits 
In rabbits, the pulmonary CYP monooxygenase system includes three main 
isoforms of CYPs; 2B4, 4B1 and 1A1, which were previously classified as forms 2, 5 and 
6, respectively (Daniels and Massey, 1992). CYP1A1 was demonstrated by 
immunohistochemistry in rabbits induced by TCDD using a polyclonal goat anti-rabbit 
CYP1A1 antibody and was localized mainly in the endothelial cells of the interalveolar 
septa (Overby et al, 1992).  Within the endothelial cells, only the perinuclear area 
associated with endoplasmic reticulum was labeled with the antibody, and no labeling of 
the plasma membrane was detected (Overby et al, 1992).  Minimal CYP1A1 labeling was 
detected in alveolar type I and AT-II cells with absence of macrophage immune reactivity 
(Overby et al, 1992). A dense CYP1A1 staining has been observed in the terminal non-
ciliated bronchiolar epithelial (Clara) cells which are considered the primary pulmonary 
site of cytochrome P-450-dependent monooxygenase activity (Domin et al, 1986; 
Plopper et al, 1987; Serabjit-Singh et al, 1980).  This could be attributed to the 
enrichment of the Clara cells with large amount of agranular (smooth) endoplasmic 
reticulum to which the CYPs are associated (Plopper, 1983). Although the CYP1A1 was 
not detected in the alveolar macrophages of TCDD-induced rabbit by 
immunohistochemistry (Overby et al, 1992), it was detected in the microsomal fraction of 
alveolar macrophages from rabbits administered with TCDD (Domin et al, 1986). While 
the major constitutive isoform of CYPs in rabbit lung is CYP2B4, this isozyme is present 
in very low concentrations in the liver of this animal species (Williams et al, 1991). 
However, treatment of rabbits with phenobarbital induces CYP2B4 in liver but has no 
effect on the levels in lungs (Williams et al, 1991). In contrast to CYP2B4, CYP1A1 can 
be induced in rabbit lungs by beta-naphthoflavone) using a dose of 80 mg/kg by 
intraperitoneal injection (Daniels and Massey, 1992).  
4.D. Food Producing Animals 
In food-producing animals, such as sheep and cattle, CYP1A1 is rarely 
investigated and little information is available about its expression and localization in 
pulmonary tissue (van't Klooster et al, 1993a).  Knowledge about the CYP 
monooxygenase system in agricultural species is not only useful for describing the 
xenobiotic metabolism comparable to humans, but also extremely important for the risk 
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assessment of the applied veterinary pharmacotherapy and public health concern, 
particularly when these animals are considered as a main source of many foods (van't 
Klooster et al, 1993a; 1993b). This is particularly crucial because of the presence of drug 
residues and/or their metabolites in the foods of animal origin (van't Klooster et al, 
1993b; Juskevich, 1987). The induction of CYP1A has been observed in cattle treated 
with pentachlorophenol (PCP), particularly in the liver and lung microsomes of the new 
born calves which were more responsive to induction than adults (Shull et al, 1986). The 
first CYP isoform purified from sheep lungs was the CYP2B, which was the most 
abundant form constitutively expressed in sheep lungs (constituting 75 % of the total 
CYPs) (Williams et al, 1991). Moreover, CYP1A1 and CYP2B1 have been induced in 
sheep hepatic microsomes after a single dose of ivermectin, a common antiparasitic drug 
in Veterinary Medicine (Skalova et al, 2001).  In goats, the subcutaneous injection of 
beta-naphthoflavone (BNF) significantly induced CYP1A1 and CYP2B1 in liver 
microsomes as assessed by measurement of  7-ethoxyresorufin deethylase (EROD) and 
7-pentoxyresorufin deethylase (PROD), respectively (van't Klooster et al, 1993b). BNF 
induces CYP1A1 in cultured hepatocytes isolated from sheep, goat, and cattle (van't 
Klooster et al, 1993b). 
5-Pathological Alterations Associated with Respirable Particle Exposure  
 Lungs, being at the interface between the body and the environment, are major 
targets of many chemicals. They are exposed to xenobiotics carried by the inspiratory air 
and the blood (Pairon et al, 1994).  The response of different alveolar cells to respirable 
particles is a complex process. Exposure to coal dust, silica, and/or other related 
inorganic particulates can activate alveolar macrophages to secrete cytokines, such as 
TNF-α and interleukin-1 (Kelley, 1990), fibronectin (Davies and Erdogdu, 1989), and 
other soluble mediators that act in situ (Kelley, 1990)  producing acute cellular injury and 
initiating lung fibrosis (Davis, 1986).  TNF-α plays a key role in the cellular response to 
particulate inhalation as it enhances the synthesis of other chemokines, such as 
interleukin-8 (IL-8), macrophage inflammatory protein 2 (MIP-2), MIP-1, and monocyte 
chemotactic protein 1α (MCP-1α) by alveolar macrophages, epithelial cells, endothelial 
cells and fibroblasts. In addition, TNF-α stimulates the endothelial expression of the 
adhesion molecules, such as vascular cell adhesion molecule 1 (VCAM-1), intercellular 
                                                                            29
adhesion molecule 1 (ICAM-1), and E-selectin. The intravascular inflammatory cells are 
recruited into the lung interstitium and alveolar spaces by interaction with the endothelial 
adhesion molecules and chemotactic gradients (Driscoll, 1996) (Figure 7). 
 
Figure 7. Proposed mechanism of pulmonary inflammation following exposure to 
respirable particles (Adapted from Driscoll, 1996).  
Alveolar type I cells are more vulnerable to toxic and physical injury than AT-II 
cells (Lee et al, 1994). The damage of these cells usually leads to denudation of the 
subepithelial basement membrane (Evans et al, 1973; Adamson et al, 1974) with 
subsequent leakage of the plasma constituents, such as albumin, from the pulmonary 
vasculature to the alveolar spaces (Crouch, 1990). 
AT-II cells generally respond to exposures of respirable particles, such as silica 
and coal dust, by increasing their number (hyperplasia) and size (hypertrophy) (Panos et 
al, 1990). The mechanism of cellular proliferation in response to particle exposure is 
unclear. Interestingly, carbon black, which has a minimum cellular toxicity, has been 
shown to produce a persistent AT-II cellular hyperplasia and neutophilic inflammation in 
rats (Harkema et al, 2003). A possible role of the extracellular signal-regulated kinases 
(ERKs) was suggested by Albrecht et al (2001) when they found a chronic activation of 
phosphorylated ERKs in immunohistochemical examination of lung sections of coal dust-
exposed rats.  The release of alveolar macrophage-produced mitogenic factor by activated 
macrophages is another possible role that enhances the cell cycle proliferation and DNA 
synthesis in rabbit AT-II cells (Brandes and Finkelstein, 1989). However, other factors in 
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the bronchoalveolar lavage (BAL) of normal rats have been shown to stimulate the DNA 
synthesis in the primary culture of rat AT-II cells (Leslie et al, 1989). This discrepancy 
was solved by Panos et al (1990) by demonstrating a similar mitogenic effect of BAL 
fluid collected from normal and silica-treated rats suggesting that other factors may be 
involved in the silica-associated AT-II hyperplasia.  The AT-II hypertrophy associated 
with particle exposure could be attributed to cellular enlargement during cell division 
(Miller et al, 1986), an increase in cytoplasm during preparatory stage of differentiation 
and transition from AT-II to type I cells, or edema and degeneration associated with cell 
death (Miller et al, 1986; Baserga, 1985).  It is well known that the cell size is increased 
during DNA synthesis and mitosis (Baserga, 1985) and the cell component should be 
duplicated during each cell cycle to maintain a uniform cell size between generations 
(Fraser and Nurse, 1978; Killander and Zetterberg, 1965).  Furthermore, during lung 
injury and particle exposure, the AT-II cells can differentiate into type I cells, which have 
a volume of 2-5 fold greater than that of AT-II cells but are not considered hypertrophied 
AT-II cells (Crapo et al, 1983). 
6-Respirable Particles Affecting Lung 
6.A. Coal Dust Particles 
6.A.1. Origin and Composition  
Coal is produced by progressive coalification of swampy vegetation throughout 
the world. Although coal is composed mainly of carbon, coal mine dust also contains 
oxygen, hydrogen, nitrogen, trace elements and inorganic minerals and crystalline silica. 
Trace elements include copper, cadmium, boron, nickel, antimony, iron, lead, and zinc 
(Castranova and Ducatman, 1997). Some of these trace elements can be cytotoxic and 
carcinogenic in experimental models (Castranova and Vallyathan, 2000). The mineral 
contaminants may include kaolin, quartz, mica, calcite and pyrite. The rank of coal varies 
according to its carbon contents.  As rank increases, the ratio of carbon to other mineral 
and chemical contaminants increases.  Generally, higher rates of pneumoconiosis have 
been associated with anthracite coal mining than that found in bituminous miners. 
(Ortmeyer et al, 1973; Bunnet et al, 1979).  This was attributed to the higher surface free 
radicals in anthracite than bituminous coal (Dalal et al, 1990; 1991; and 1995).  
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Moreover, anthracite has higher crystalline silica than bituminous coal (Wallace et al, 
1994).  
6.A.2. Exposure Conditions 
There are two principal types of exposures in mining, surface and underground, 
that result in pulmonary exposure. Surface exposure usually occurs outdoors with 
inhalation of low levels of coal mine dust.  Underground exposure is more frequently 
associated with inhalation of a significant amount of coal dust and development of 
pneumoconiosis. (Castranova and Ducatman, 1997). Mixed exposures are common in 
underground coal mining. For example, the pulmonary exposure to silica in roof bolters 
occurs during drilling processes into the noncoal ceiling of mines. Moreover, diesel 
equipment in coal mines produces mixed exposures to coal dust and diesel particulates 
(Castranova and Ducatman, 1997). 
6.A.3. Pathological Reaction to Coal Mine Dust Exposure 
 Inhalation of coal mine dust is associated with several diseases in humans such as 
coal workers’ pneumoconiosis (CWP), bronchitis, emphysema, Caplan disease and 
silicosis (Kleinerman et al, 1979; Green and Vallyathan, 1998).  
6.A.4. Coal Workers’ Pneumoconiosis (CWP) 
6.A.4.i. Forms of CWP 
CWP is classified according to severity into simple and complicated CWP. 
Simple CWP is characterized by black dust macules which are usually concentrated in 
the upper lung lobes. Coal nodules consist of coal dust and dust-laden macrophages 
usually localized at the bifurcations of respiratory bronchioles. These nodules can be 
palpable and have a diameter of 2-5 mm. This syndrome can progress to complicated 
CWP. With increasing time and dust exposure complicated CWP develops, that is, 
progressive massive fibrosis (PMF). In PMF, the lesions are bigger (1 cm diameter), 
more numerous, and usually localized in upper and posterior portions of the lungs. These 
lesions mainly contain increased collagen, coal dust, and inflammatory cells. The Federal 
Coal Mine Health and Safety Act of 1969 legislatively defined "black lung disease" to 
include not only CWP but also other chronic pulmonary diseases affecting coal miners, 
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such as chronic bronchitis and other obstructive pulmonary diseases (Castranova and 
Ducatman, 1997).  
6.A..4.ii. Radiographic Picture of CWP 
 Simple pneumoconiosis is not always reflected in radiographic changes 
(Kleinerman et al, 1979).  The sensitivity of the chest radiograph is affected by many 
factors, such as the lesion size, background density, contrast effect and thickening of the 
chest wall (Parkes, 1982; Morgan, 1984).  When radiographic changes are present, 
radiographic opacities 0.001-l.0 cm in diameter may appear and are most frequently 
round opacities. With progression of CWP, the distribution of the opacities increases. As 
the PMF develops, there is an increase in the number of irregular opacities as well as an 
increase in nodular size to exceed 1.0 cm in diameter (Castranova and Ducatman, 1997; 
Rossiter et al, 1967). Chest radiographs are ranked by the size, shape, and profusion of 
the opacities. In simple CWP, rounded opacities are ranked by increasing size as p, q, and 
r. A scale of s, t, and u is used to rank irregular opacities. Distribution of lesions is 
designated as upper, middle, and/or lower lung zones. Profusion, which means increased 
density of opacities, has a rank of 0, 1, 2, or 3 (Vallyathan et al, 1996; Castranova and 
Ducatman, 1997).  It has been demonstrated that profusion category has a direct 
relationship to dust burden in the lungs.  PMF is categorized radiographically as A, B, or 
C as opacities progressively increased (Castranova and Ducatman, 1997).  
6.A.4.iii. Pathology of CWP 
 The pulmonary pathological changes of CWP range from simple dust 
accumulation to fibrosis of varying degrees (Green and Vallyathan, 1998). Early coal 
dust exposure is manifested by aggregation of particles within the cytoplasm of intra-
alveolar macrophages and is a marker of recent exposure. With time, the dust is localized 
around the walls of bronchi, lymphatics, and pulmonary vessels, and in the walls of 
respiratory bronchioles, without detectable fibrosis. The first distinctive lesion of CWP is 
the appearance of coal macules that are typically found in the walls of respiratory 
bronchioles, particularly at bifurcations.  The coal dust macule is defined as an 
aggregation of coal dust-laden alveolar macrophages, in a size that range from 0.5 to 6 
mm within the wall of respiratory bronchioles and adjacent alveoli (Vallyathan et al, 
1996).  Coal dust accumulation is accompanied by a variable degree of collagen 
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deposition. However, at this stage, the macule cannot be palpated (Castranova and 
Ducatman, 1997). With extended exposure, the fibrotic nodules can develop. As with 
macules, varying degrees of fibrosis and pigmentation can be found. When there is a 
central zone of concentric collagen fibers (rather than interlacing bundles of collagen), 
the nodules should be classified as silicotic nodules.  The nodules are defined as an area 
of fibrosis and are firm when palpated. The nodules are usually located in a background 
of coal dust macules, however they can be an isolated finding. Nodules can be found in 
subpleural and peribronchial connective tissues as well as respiratory bronchioles.  Focal 
emphysema is a specific form of emphysema seen in coal miners which is associated with 
distention and over expansion of alveolar spaces near fibrotic respiratory bronchioles 
(Castranova and Ducatman, 1997). 
6.A.4.iv. Epidemiology of CWP 
 Epidemiological data suggests a direct relationship between the mass of 
respirable coal dust and the incidence of CWP in miners (Walton et al, 1977). A 
sequence of events has been supported by the epidemiological data during initiation and 
progression of CWP, which includes the following steps (Castranova and Ducatman 
1997): 
i) Coal dust is inhaled and deposited at the bifurcations of the respiratory bronchioles; 
(ii) Localized inflammation begins and alveolar macrophages engulf coal dust particle to 
become dust laden. Aggregation of dust-laden macrophages forms a coal macule; 
(iii) Coal macules enlarge and congregate to form coal nodules with further dust 
deposition and inflammation; 
(iv) Pulmonary emphysema may follow when the lesions contract, tearing surrounding 
tissue; and 
(v) Progressive massive fibrosis is the result of subsequent collagen deposition at sites of 
coal deposition. 
6.A.4.v. Progressive Massive Fibrosis (PMF) 
PMF is defined as a zone of fibrosis that has a diameter of greater than 1 cm, and 
can appear as single or multiple lesions (Vallyathan et al, 1998). Grossly, PMF lesions 
appear as hard, black masses which may be round, oval, or irregular but generally with a 
fairly sharp demarcation from the surrounding parenchyma. PMF often demonstrates 
                                                                            34
central cavitation that could be detected during sectioning. Microscopically, PMF is 
recognized either as an amorphous zone of collagen or aggregation of multiple nodules, 
which commonly co-occur with silicosis. The lesions usually contain a large quantity of 
coal pigment, cholesterol crystals and debris. PMF is a destructive and progressive lesion 
that distorts and obliterates functional lung tissue (Castranova and Ducatman, 1997). The 
PMF-induced distortion of the lung parenchyma is usually accompanied by compensatory 
emphysema (Vallyathan et al, 1996). 
6.A.4.vi.  Relationship between Coal Dust Exposure and Lung Cancer 
 Exposure to coal mine dust and the development of CWP has not been associated 
with lung cancer (Rooke et al, 1979). On the contrary, an epidemiologic study of US coal 
miners suggests that they have a lower than normal risk of lung cancer (Costello et al, 
1974). Moreover, no relationship has been found between coal dust exposure and lung 
cancer type (Vallyathan et al, 1985). On the other hand, a higher than normal incidence 
of stomach cancer has been associated with coal dust exposure (Enterline, 1964). Ong et 
al, (1985) proposed a particular mechanism for developing stomach cancer associated 
with coal dust exposure. Initially, after the coal dust is swallowed and reaches the 
stomach, it intermixes with nitrite content of the food.  The coal-associated organic 
material then undergoes a nitrosation under the acidic condition in the stomach. This 
nitrosation product has been demonstrated to induce the neoplastic transformation of a 
mammalian cell line (Wu et al, 1990). 
6.A.4.vii. Mechanisms of Coal Dust-Induced Cellular Toxicity 
Four main mechanisms of toxicity were proposed for initiation and progression of 
CWP (Castranova 2000). The first is the direct cytotoxicity of coal dust resulting in cell 
damage with subsequent release of proteases and lipases. The second mechanism 
includes over-production of oxidants by alveolar phagocytes, such as macrophages with a 
rate overwhelming the antioxidant defenses resulting in protein nitrosation and tissue 
injury. The third mechanism involves the activation of cytokines (chemical mediators) 
from alveolar epithelium and alveolar macrophages. These mediators recruit excessive 
numbers of polymorphonuclear leukocytes (PMN) and macrophages into the alveolar 
spaces with production of more oxidant, enhancing the pulmonary oxidant stress.  The 
fourth mechanism is associated with fibroblast proliferation, enhancement of collagen 
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synthesis, and induction of pulmonary fibrosis upon stimulation by the growth and 
fibrogenic factors secreted from alveolar macrophages and alveolar epithelial cells in 
response to coal dust exposure 
6.A.4.vii.a. Direct Cytotoxicity: 
Coal dust has been shown by in vitro and animal studies to cause hemolysis (red 
blood cell lysis) and release of lactate dehydrogenase (LDH) from alveolar macrophages 
(Harrington 1972, and Amadis and Timilar, 1978).  The direct cytotoxic effect of coal 
dust is affected by its metal content, such as nickel (Christian and Nelson, 1978) and iron 
(Dalal et al, 1995). Moreover, coal dust fracturing has been associated with the 
generation of surface radicals that can injure the biological membranes. However, these 
radicals are less bioactive that those generated during fracturing of silica (Vallyathan et 
al, 1995). 
6.A.4.vii.b. Alveolar Macrophages-Stimulated Oxidant Production 
 A relationship has been established between the pathogenicity of the coal dust, 
pulmonary damage, and the ability to enhance oxidant production (Backford et al, 1997). 
Coal mine dust has been demonstrated to stimulate alveolar macrophages to increase the 
synthesis of reactive oxygen and nitrogen species such as superoxide, hydrogen peroxide, 
and nitric oxide (Castranova, 2000). These reactive oxygen species (ROS) induce cellular 
damage and injury (Weiss and Buglo, 1982). Moreover, coal dust may contain stable 
radicals that can produce ROS in the biological fluids resulting in direct oxidative 
damage in a non-cellular mechanism (Schins and Borm, 1999).  
6.A.4.vii.c. Stimulation of the Proinflammatory Mediators Release 
 Coal dust exposure in animals elicits pulmonary inflammation that is 
characterized as infiltration of alveolar macrophages (AM) and polymorphonuclear 
leucocytes (PMN) in the alveolar spaces (Castranova et al, 1985, Bowden and Adamson, 
1978). Once the phagocytic cells are recruited into the alveolar spaces, they stimulate the 
production of chemotactic cytokines and chemokines by AM and AT-II epithelial cells 
(Driscoll et al, 1993). The most common chemotaxins for PMNs are Leukotriene B4, 
platelet-activating factor (PAF), and interleukin (IL)-1 (Driscoll, 1997). Tumor necrosis 
factor alpha (TNF-α) may not have a direct chemoattractant effect. However, it is a 
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potent chemokine stimulant, with effects on macrophage inflammatory protein (MIP-1 or 
MIP-2) and cytokine-induced neutrophil chemoattractant (Driscoll et al, 1995).  
 When the PMN are recruited into the alveolar spaces, they are stimulated by 
several inflammatory cytokines, such as TNF-α, PAF, and IL-1, to increase oxidant 
production resulting in excessive oxidant burden in the lung. The accumulation of 
oxidant may overwhelm the antioxidant defenses resulting in lung injury, scarring and 
fibrosis (Castranova 2000). In oxidative stress, The NF-κB is activated (Shukla et al, 
2000), and upregulates the proinflammatory cytokines such as TNF- α (Kim et al, 2003) 
that aggravate the inflammatory process. Moreover, the released TNF- α activates the 
NF-κB by enhancing the phosphorylation and degradation of the inhibitor IκB as 
previously mentioned. Although there is little data on NF-κB in coal dust exposure, the 
NF-κB is activated by TNF- α in silicosis as shown by increasing of its DNA binding 
activity (Vallyathan et al, 1998).  
6.A.4.vii.d. Stimulation of Growth and Fibrogenic Factors Production by AM 
 The fibrogenic factors produced by the alveolar macrophages and pneumocytes 
under the effect of coal mine dust exposure were detected in the bronchoalveolar lavage 
(BAL) of miners affected with CWP (Castranova, 2000). The most important of these 
growth and fibrogenic mediators that promote the lung response to fibrosis was the TNF-
α, which has direct proliferative effects and enhances the secretion of platelet derived 
growth factor (PDGF) (Hajjar et al, 1987). Other mediators, such as transforming growth 
factor (TGF) α and β, and insulin-like growth factor (IGF) are released from AM and 
epithelial cells, and were found to stimulate the proliferation of mesenchymal cells 
(Bonner et al, 1991; Madtes et al, 1988; Moses et al, 1990; Rom et al, 1988). The 
glycoprotein, fibronectin, can stimulate fibroblast proliferation and greatly contribute to 
particle-associated pulmonary fibrosis (Rennard et al, 1981; Bitterman et al, 1983).  
6.B. Crystalline Silica Particles 
 Exposure to crystalline silica, the crystalline form of silicon dioxide causes severe 
occupational lung disease in coal miners called silicosis (Castranova and Ducatman, 
1997). Silicosis is a chronic inflammatory fibrotic lung disease (Miles et al, 1993) that is 
characterized by the development of silicotic nodules, chronic debilitation, and eventual 
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death in some cases (Driscoll and Guthrie, 1997). Crystalline silica has several 
polymorphs; those commonly investigated are the quartz, cristobalite, tridymite, coesite, 
and stishovite. The most toxic forms of crystalline silica are tridymite and cristobalite 
followed by quartz (Seaton, 1984). Chemically, silica is composed mainly of silicon 
dioxide (SiO2) and some other cations may occur in trace amounts, such as aluminium, 
iron, and titanium. The iron content of silica may be involved in the production of 
reactive oxygen radicals through a Fenton-type reaction (Goodglick and Kane, 1986; 
Mossman and March, 1989) (Fe 3+              Fe 2+ + e-) that may greatly contribute to silica 
cytotoxicity (Razzaboni and Bolsaitis, 1990).  
6.B.1. Mechanisms of Silica-Induced Cytotoxicity and Fibrosis 
 The cytotoxic effect of the silica is attributable to 4 major mechanisms. These 
mechanisms have been discussed in detail under the coal dust effect. However, in 
silicosis, the cytotoxic effect is more robust than coal dust for the following reasons: 
1- The silanol group (SiOH), which is uniquely present on the surface of silica 
particulate, acts as an H donor. Therefore, it interacts with the biological 
membranes by forming a hydrogen bond resulting in injuries of these membranes 
(Nash et al, 1966). This was suggested because the polyvinylpyrilidine-N-oxide 
was found to reduce the silica toxicity by acting as proton acceptor, consequently 
protecting the biological membranes from the surface SiOH group. 
2- The presence of the negative surface charge of the SiO- group is crucial for silica-
induced cytotoxicity (Nolan et al, 1999; Castranova and Vallyathan, 2000). This 
negative group could enhance the interaction of silica with the scavenger 
receptors on the surface of alveolar macrophages (Nolan et al, 1981; Kobzek, 
1985).  
3- Silica radicals, such as Si. and SiO., are usually produced at the fracture planes 
during fracturing of silica (Vallyathan et al, 1988). These radicals may participate 
in induction of oxidative stress, particularly when they come in contact with 
aqueous medium that results in the production of hydroxyl radicals (Vallyathan et 
al, 1988). It has been demonstrated that lipid peroxidation has a direct relationship 
with the hydroxyl radicals produced by silica in vitro (Vallyathan et al, 1988; 
Dalal et al, 1991) and in vivo (Castranova et al, 1996; Vallyathan, 1995). 
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4- The presence of surface iron in silica augments the production of hydroxyl 
radicals by silica exposure and enhances the cytotoxicity in vivo and in vitro 
(Vallyathan et al, 1988; Castranova et al, 1997). 
6.B.2. Pathological and Inflammatory Responses to Silica Exposure 
 Pulmonary cytotoxicity in silicosis has been demonstrated on a large scale in 
animals and humans (Holland, 1990; Saffioti and Stinson, 1988, Green and Vallyathan, 
1995). Different clinical types of silicosis have been identified based upon the intensity 
and the period of exposure or upon the chest radiographic picture (Driscoll and Guthrie, 
1997; Green and Vallyathan, 1995, Ziskind et al, 1986; Seaton, 1984).  
Radiologically, simple silicosis and progressive massive fibrosis can be identified. 
Simple silicosis is characterized by the presence of small opacities (silicotic nodules) 
(Ziskind et al., 1986; and Seaton, 1984) with a diameter of less than 10 mm (Weissman 
and Wagner, 2002) without respiratory impairment unless accompanied by tuberculosis 
(Snider, 1978 and Craighead et al., 1988). Simple silicosis may develop into progressive 
massive fibrosis (PMF) when congregation of these silicotic nodules occurs followed by 
destruction of lung tissue and a significant disturbance in lung function (Snider, 1978). 
Until now, 3 different types of silicosis are recognized: chronic, accelerated, and acute 
(Weissman and Wagner, 2002). The occurrence and development of these forms is 
determined by the amount of exposure and the total cumulative silica inhalation (Green 
and Vallyathan, 1995; Ziskind et al, 1986; Seaton, 1984). Chronic silicosis is 
characterized by the appearance of simple silicotic nodules 10-30 years post exposure 
(Weissman and Wagner, 2002) because it usually progresses very slowly. However, in 
some cases, nodules may congregate to form PMF (Weissman and Wagner, 2002). 
Accelerated silicosis, which develops in less than 10 years after exposure to silica 
(Weissman and Wagner, 2002), is accompanied by a rapid progression to PMF, severe 
lung dysfunction, and is life threatening (Ziskind, 1986; Seaton, 1984). Acute silicosis, 
on the other hand, is the form that develops very rapidly [(a few weeks to 5 years post 
exposure (Weissman and Wagner, 2002)] after exposure to high concentrations of silica 
(Banks et al, 19981; Suratt et al, 1977; Xipell, 1977) and is associated with severe 
alveolar and interstitial inflammation, alveolar proteinosis, and rapid respiratory failure 
(Driscoll and Guthrie, 1997). 
                                                                            39
7-Difference between CWP and Silicosis 
 CWP was originally thought to be a variant form of silicosis because of the 
similarity of chest radiographs of coal miners and silicotic people. A differentiation 
between CWP and silicosis was first proposed by Collis and Gilchrist (1928). They 
reported that Welsh stevedores who trimmed coal in the holds of ships developed nodules 
in the chest which were indistinguishable from those of underground coal miners. 
Histological examination of autopsied lungs from these coal trimmers showed lung 
lesions distinct from the characteristic whorled nodules of silicosis (Gouph, 1940). In 
1947, Heppleston demonstrated that the histological pulmonary lesions in coal trimmers 
were similar to those in underground coal miners. In 1954, he showed that, these 
pulmonary lesions, in contrast to silicosis, consisted of black stellate dust macules 
surrounded by dilated respiratory bronchioles. In general, silicosis is more progressive 
than CWP and may initiate, develop and progress more rapidly (Scarisbrick, 2002). 
8-Interaction  Between PAH, AhR and Apoptotic Pathways  
8.A. Role of AhR in Cellular Apoptosis 
Apoptosis, or programmed cell death is a genetically-controlled process that 
occurs as a response of the cell to environmental (such as radiation) and developmental 
(e.g. embryogenesis) stimuli ending by programmed death of the cells (Wylie, 1980; 
Orren et al, 1997). Therefore, apoptosis is a negative selection mechanism by which the 
organism gets rid of damaged or unneeded cells (Buckley, 1998). Apoptosis plays an 
important role in tissue remodeling (Stanley et al, 1992) and eliminating cells that are 
excessively developed, improperly developed, or genetically damaged (Thompson, 
1995). For example, the remodeling of certain epithelial cells, such as AT-II cells 
(Bardales et al, 1996) during the repair process following acute lung injury was attributed 
solely to the occurrence of apoptosis in these cells (Polunovsky et al, 1993). 
Cellular death by apoptosis has characteristic hallmarks that start with 
condensation of the cytoplasm, loss of the plasma membrane microvilli, and nuclear 
condensation followed by fragmentation (Buckley, 1998). Apoptosis can be differentiated 
from necrosis by the presence of activated endogenous proteases, disruption of the 
cytoskeleton, cell shrinkage and formation of membrane blebbing, condensation of the 
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nucleus with DNA fragmentation forming oligonucleosomes, and elimination of the 
damaged cells without any inflammatory response (Thompson, 1995).  
Apoptotic pathways initiate via different entry sites, such as death receptor 
(receptor pathway) or mitochondria (mitochondrial pathway) (Fulda, and Debtain, 2002).  
Both pathways result in the activation of effector caspases (cysteine aspartate proteases) 
(Kaufmann and Earshaw, 2000). The receptor pathway is associated  with stimulation of 
death receptors of the tumor necrosis factor (TNF) receptor (TNFR) superfamily such as 
CD95 (APO1/Fas) resulting in receptor aggregation and recruitment of the adaptor 
molecule Fas-associated death domain (FADD) and caspase-8 (Sprick et al, 2000). The 
end result is the activation of caspase-8 that initiates apoptosis by direct cleavage of 
downstream effector caspases (Peter and Krammer, 1989). In the mitochondrial pathway, 
apoptogenic factors such as apoptosis inducing factor (AIF), cytochrome c, and  caspase-
2 or caspase-9 are released from mitochondria into the cytoplasm to activate  caspase-3 
by the formation of apoptosome complex (cytochrome c/Apaf-1/caspase-9) (Kroemer and 
Reed, 2000). This is followed by a downstream mitochondrial activation of caspase-8 
resulting in further cleavage of effector caspases and apoptosis (Fulda, and Debtain, 
2002) (Figure 8). Bax is a member of Bcl-2 family that comprises different proteins 
involved in controlling apoptosis and induced by a variety of stimuli (Desagher et al, 
1999). Bax interacts with Bid, another preapoptotic protein belonging to Bcl-2 family 
resulting in conformational changes that drive Bax to translocate from cytosol to the 
mitochondria, increasing the release of cytochrome c and initiating apoptosis (Aiba-
Masago et al, 2002) (Figure 8). However, Bax may be expressed in many tissues without 
demonstration of any apoptotic features (Olive and Ferrer, 1999, Penault-Llorca et al, 
1998) suggesting that Bax has other cell functions (Aiba-Masago at al, 2002). Peptide 
caspase inhibitors Z-Asp-Chz-DCB and zVAD-fmk have been shown to inhibit apoptosis 
induced by overexpression of Bax in COS-7 cells suggesting that Bax induces apoptosis 
in a caspase-dependent mechanism (Kitanaka et al, 1997). 
The DNA fragmentation associated with apoptosis was demonstrated by agarose 
gel electrophoresis that showed a ladder appearance at 200 base-pair intervals (Compton, 
1992). More recently, Gavrieli et al, (1992) were able to localize the DNA fragmentation 
by visualization of apoptosis in situ using routine immunohistochemistry of paraffin 
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embedded tissue sections. This in situ apoptosis assay (ISAA) depends upon the binding 
of the terminal deoxynucleotide transferase to the 3/-OH end of the fragmented DNA and 
incorporating biotinylated deoxyuridine at the sites of DNA breaks. The localization of 
apoptosis was then visualized by binding of fluorescein- or peroxidase labeled avidine 
(Bardales, 1996; Gouchuico et al, 1997). The ISAA, which is also described as terminal 
deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) proved more 
sensitive than the laddering assay in detecting apoptosis in different cells (Hagimoto et al, 
1997). 
Exposure of female mice to PAHs enhanced the expression of Bax in the oocyte, 
which was accompanied by induction of apoptosis. This was confirmed by the prevention 
of PAHs-mediated ovarian damage by selectively antagonizing the AhR by α-
naphthoflavone (Shiromizu and Mattison, 1985; Mattison and Nightingale, 1980) or 
inactivation of Bax (Matikainen et al, 2001).  
Apoptosis is considered the main cellular mechanism through which oocyte 
depletion is induced under both physiological and pathological conditions (Morita and 
Tilly, 1999; Perez et al 1997; 1999; Morita et al 2000; Pru and Tilly, 2001). Computer-
based scanning of the promoter sequences of a number of  regulatory genes involved in 
apoptosis showed that mouse Bax promoter has two core AhR response elements 
(AhRE1 and AhRE2) (Matikainen et al, 2001). In addition,  increasing Bax mRNA levels 
and accumulation of its protein in quiescent (primordial) and early growing (primary) 
oocytes followed a single intraperitoneal injection of 9,10-dimethylbenz[a]anthracene 
(DMBA), a prototypical PAH (Matikainen et al, 2001). It is possible that Bax expression 
is directly regulated by the PAH-activated AhR which is indicated by the simultaneous 
expression of both AhR and Arnt in oocytes (Matikainen et al, 2001).  
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Figure 8. Diagram showing the apoptotic pathway through receptor dependent and 
mitochondrial dependent mechanisms (adapted from Fulda and Debtain, 2002; Spickle et 
al, 2000; Kroemer and Reed, 2000). 
Although apoptosis remained detectable in Hepa-1 cells after blocking the 
CYP1A1 activity by 1-aminobenzotriazole (Mann et al, 1999), the MCF-7 human breast 
cancer cells are resistant to the dimethylbenz(a)anthracene-induced apoptosis due to 
reduction of CYP1A1 expression (Ciolino et al, 2002). The role of CYP1A1 in induction 
of dimethylbenz(a)anthracene-induced apoptosis in MCF-7 was attributed to its 
metabolization of this compound into a genotoxic forms that are able to bind to DNA 
leading to apoptosis (Ciolino et al, 2002).  
8.B. Role of AhR in Cellular Proliferation 
 Interestingly, the AhR increases cellular proliferation (hyperplasia) by stimulating 
c-myc expression (Kim et al, 2000). The proposed mechanism involves the association of 
the AhR with the Rel A subunit of the NF-κB producing a complex that was able to 
cotransactivate the c-myc expression in non-malignant MCF-10F breast epithelial and 
malignant Hs578T breast cancer cells (Kim et al, 2000).  
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9-Role of AT-II Cell Apoptosis in Remodeling of Lung Parenchyma 
 Apoptosis or programmed cell death is known to play a role in tissue remodeling, 
as shown by remodeling of lung mesenchymal cells during the reparative phase of acute 
lung injury in humans (Polunovsky et al, 1993). Apoptosis is responsible for resolution of 
AT-II cell hyperplasia in patients with acute lung injury (Bardales et al, 1996).  AT-II 
cell proliferation can be induced in different animal models by exposure to oxygen, 
ozone, asbestos, LPS (Ulich et al, 1994) silica (Albrecht et al, 2001; Friemann et al, 
1999; Williams et al, 1993; Panos et al, 1990), coal dust (Friemann et al, 1999) and 
carbon black (Harkema et al, 2003). Recently, apoptosis has been demonstrated in the 
human epithelial cell line A459 and primary rat AT-II cells following exposure to 
ambient air particles of different sizes (Hetland et al, 2003). 
10- Modification of CYP1A1-Induced Carcinogenesis by Exposure to Particles 
 The effect of respirable particles, such as silica and coal dust, on CYP1A1 
induction has been studied to improve risk assessment for lung cancers in smoking coal 
miners. In one epidemiological study, the lung cancer risk in smoking miners was not 
significantly different or even less than other smoking populations (Costello et al, 1974). 
Recent epidemiologic studies have suggested that lung cancer in coal mine workers may 
not be detected because of the healthy worker-survivor effect (Albrecht et al, 2002). 
 The International Agency for Research in Cancer (IARC), has classified 
crystalline silica, in the form of quartz or cristobalite, as a carcinogen (IARC, 1997). Nine 
of the studies done by the IARC showed a higher risk of human lung cancer associated 
with silicosis (Castranova and Vallyathan, 2000). Previous findings were suspicious 
about the carcinogenicity of silica because of the limited evidence of carcinogenicity in 
humans, although there was sufficient evidence for carcinogenicity in animals (Holland, 
1990).  
 It has been demonstrated that intratracheal exposure to silica alone without 
exposure to CYP1A1 inducers enhances the CYP1A1-dependent enzymatic activity (7-
ethoxyresorufin-o-deethylase, EROD) in rat lung microsomal fraction (Miles et al, 1993). 
A recent case control study showed that occupational exposure to coal dust significantly 
enhanced the lung cancer risk in women (Rachtan, 2002). However, lung cancer was 
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mostly absent in people exposed concomitantly to silica and other lung carcinogens, such 
as PAH of cigarette smoke (Cocco et al, 2002). Based upon abundant epidemiological 
studies, Chechoway and Franzblau (2000) came up with the conclusion that risk 
assessment should interpret and manipulate silicosis and lung cancer as distinct entities 
whose cause/effect relationships are not necessarily associated. 
 The CYP1A1 induction is sometimes modified in mixed exposures relative to 
single exposures. For example, exposure to kerosene soot significantly increased the 
induction of CYP in rat lung; however, the co-exposure of the kerosene and chrysolite 
(asbestos) simultaneously significantly depleted the microsomal content of CYPs (Arif et 
al, 1994). Also, exposure to occupational crystalline silica dust decreased the activity of 
the CYP1A1-dependent enzymatic process, 7-ethoxyresorufin-O-dethylase (EROD), in 
rat lungs (Battelli et al, 1999) and rabbit lungs (Ghanem et al, 2003) exposed to a potent 
CYP1A1 inducer, beta-naphthoflavone. Furthermore, EROD activity was suppressed in a 
dose-dependent manner by intratracheal exposure to respirable, poorly soluble, coal dust 
particles in rats (Ghanem et al, 2003). 
11-Pattern of CYP1A1 Expression in Cellular Proliferation 
The CYP1A1-dependent enzymatic activity, EROD, was undetectable in 
proliferating cultures of mouse lung epithelial cells, but the level became detectable once 
cultures were confluent (Reiners et al, 1992). It was suggested that EROD expression 
was regulated as a function of the proliferative process of the cell culture. An inverse 
relationship between cellular proliferation and CYP expression was suggested by the 
observation that proliferative regeneration of hepatic cells following partial hepatectomy 
was associated with lower CYP protein levels and activities than normal liver (Hino et al, 
1974; Presta et al, 1980; Klinger and Karge, 1987; Ronis et al, 1992).  It seems that 
hepatic cells are allocated to replication, rather than transcription, with a main function of 
DNA being proliferate and regenerate the cells after hepatectomy (Liddle et al, 1989; 
Waxman, 1989; Morgan et al; 1985; Steer, 1995). Moreover, an inverse relationship 
exists between another form of CYP, CYP2B1 apoenzyme, and the proliferation level of 
AT-II cells, as previously concluded (Lag et al, 1996). The CY2B1 apoenzyme was 
lowest in AT-II cell culture during the most active proliferative stage, which coincided 
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with presence of largest number of cells in S-phase and highest proliferating cell nuclear 
antigen (PCNA) expression (Lag et al, 1996).    
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CHAPTER 3 
RESPIRABLE COAL DUST PARTICLES MODIFY CYTOCHROME P4501A1 
(CYP1A1) EXPRESSION IN RAT ALVEOLI  
ABSTRACT 
Cytochrome P450 1A1 (CYP1A1) plays a critical role in the metabolism of 
cigarette smoke-containing organic compounds, such as polycyclic aromatic 
hydrocarbons (PAHs), producing highly reactive intermediates that bind to cellular DNA 
and trigger lung tumors. Epidemiological studies report that coal miners, most of whom 
are smokers, have a lower risk of developing lung cancer than non-miner smokers 
(Costello et al, 1974). Therefore, we hypothesized that exposure to coal mine dust (CD) 
might be a modifying factor for development of pulmonary carcinogenesis by altering 
cell-specific CYP1A1 induction.   To investigate this hypothesis, we evaluated the ability 
of CD particles (less than 5 microns) to prevent induction and activity of pulmonary 
CYP1A1. For that purpose,   male, Sprague Dawley rats (220-270g) were intratracheally 
instilled with 0, 2.5, 10, 20, 40 mg coal dust/rat or vehicle (saline).   Eleven days later, 
the pulmonary CYP1A1 was induced in all rats by intraperitoneal (IP) injection of β-
naphthoflavone (BNF: 50mg/kg IP), as a well-known potent CYP1A1 inducer.  After 3 
days, rats were sacrificed and the metabolic activity of CYP1A1 was measured as 7-
ethoxyresorufin-O-deethylase (EROD) activity in fresh lung microsomes.  The amount of 
CYP1A1 protein in lung microsomes was quantified by Western blot using a polyclonal 
rabbit anti-rat CYP1A1 antibody. Cell-specific expression of CYP1A1 was quantified by 
dual immunofluorescent staining of CYP1A1 and cytokeratins 8/18, cytoskeletal proteins 
highly expressed in alveolar type II (AT-II) cells. Our data showed a dose-dependent 
suppression of EROD activity by CD exposure (r2= 0.399, p=0.0028).  Western blot 
CYP1A1 protein was significantly lower in rats exposed to the highest dose (40 mg/rat) 
of CD and BNF than rats treated with BNF alone (p=0.031). Immunoflourescent 
examination showed a significant reduction of CYP1A1 area colocalized in AT-II cells in 
rats exposed to CD 20 and 40 mg and BNF compared to rats treated with BNF alone.   
These findings suggest that CD exposure modifies BNF-mediated CYP1A1 induction by 
altering its cell specific localization in pulmonary alveoli and interferes with CYP1A1 
metabolic activity.  
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INTRODUCTION 
Studies of CYPs have recently received a great interest because these enzymes 
play critical roles in metabolism of drugs, carcinogens, dietary xenobiotics and steroid 
hormones (James and Whitlock 1999).  The CYP proteins are heme-containing proteins, 
which are members of a gene super-family that contains almost 1000 members in species 
ranging from bacteria to plants and animals (Hasler et al, 1999).  Cytochrome P4501A1 
(CYP1A1) has garnered particular interest because of its involvement in the conversion 
of organic compounds, like polycyclic aromatic hydrocarbons (PAH) in cigarette smoke, 
into carcinogenic intermediate species (Crespi et al, 1989; Shimada et al, 1989; Eaton et 
al, 1995) that can initiate lung cancer development.  Moreover, the expression of 
CYP1A1 can be induced at the transcriptional level by its substrates.  The transcriptional 
regulation of the CYP1A1 gene by polycyclic aromatic hydrocarbons (PAH) is mediated 
through ligand-dependent activation of the aryl hydrocarbon receptor (AhR), which 
translocates to the nucleus upon activation, dimerizes to the aryl hydrocarbon receptor 
nuclear translocator (Arnt) protein and binds to the xenobiotic responsive element (XRE) 
in the regulatory region of the CYP1A1 gene (Ma and Whitlock 1997; Tian et al, 1999,)    
Coal is a fossil fuel mined all over the world.  Coal mine dust generated during 
underground coal mining results in significant respiratory exposure to coal miners.   In 
addition to the carbon, which is the main component of coal, it also contains oxygen, 
nitrogen, hydrogen, and trace elements, including non-coal minerals.  The trace elements 
may include copper, nickel, cadmium, boron, antimony iron, lead, and zinc (Sorenson et 
al, 1974).  Some of these trace elements can be cytotoxic and carcinogenic in 
experimental models (Castranova 2000).  Mineral contaminants include quartz, kaolin, 
mica, pyrite and calcite (Parkes, 1994).  Coal dust inhalation is associated with 
development of a respiratory disease of coal miners called coal workers’ pneumoconiosis 
(CWP). CWP is categorized according to severity into simple and complicated CWP.  In 
the simple form, black dust macules appear and consist of dust-laden macrophages 
concentrated near respiratory bronchioles.  In complicated CWP, also described as 
progressive massive fibrosis (PMF), the nodules are larger (exceeding 1 cm diameter), 
and more numerous.  These nodules contain increased amount of collagen, coal dust, and 
inflammatory cells (Castranova, 2000).   
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Epidemiological studies demonstrated that lung cancer in coal miners occurs less 
frequently than in general population after adjustment for age and smoking (Meijers et al, 
1991; Kuempel, 1995).  Instead, coal dust exposure is associated with lung scarring 
(pulmonary fibrosis) and accumulation of particles in dust-laden alveolar macrophages 
(Castranova, 2000).  Most of the studies of lung cancer in coal miners are difficult to 
interpret because most of the miners are smokers.  This means that they are exposed to a 
mixed exposure of the coal dust particles and the carcinogenic compounds of cigarette 
smoke.  Recent studies from our laboratory suggest that exposure to another occupational 
dust, crystalline silica, decreases the activity of the CYP1A1-dependent enzymatic 
process, 7-ethoxyresorufin-O-dethylase (EROD), in rat lungs exposed to a potent 
CYP1A1 inducer, beta-naphthoflavone (Battelli et al, 1999).  Silicosis in rats is also 
associated with the appearance of new population of alveolar epithelial cells without 
detectable expression of CYP1A1 or CYP2B1, even after exposure to inducers of 
CYP1A1 (Battelli et al, 1999; Levy et al, 1997).  If other fibrogenic inhaled particulates, 
such as coal dust, also reduce the activity of carcinogen-activating CYP1A1-dependent 
enzymatic processes, the expected result would be a reduction in the lung cancer 
attributable to chemical carcinogens activated by CYP1A1, such as the PAH in cigarette 
smoke.  Therefore, we investigated the effect of coal dust inhalation on the metabolism of 
chemical carcinogens in lungs of rats.  These studies will help determine if the effect of 
silica on CYP1A1 is a unique feature of silica dust or is a characteristic of pulmonary 
exposure to other respirable particles, which cause alveolar epithelial cell hypertrophy 
and hyperplasia, such as coal dust.  For that purpose, we designed a dose response 
experiment in rats to investigate the dose-dependent effect of CD. We injected beta-
naphthoflavone (BNF) of the PAH family, as a potent and specific CYP1A1 inducer (Lee 
et al, 1998). The study utilized the immunofluorescent localization of critical proteins and 
morphometric analysis of immunofluorescent-stained tissue to investigate the effect of 
coal dust on the expression of CYP1A1 in the deep lung.  We also determined the 
CYP1A1-dependent enzymatic activity in lung microsomes.  Lungs from the same rats 
were microscopically examined to determine histopathological alterations associated with 
changes in cell specific protein expression.  The amount of CYP1A1 protein in the lung 
microsomes of control and exposed rats was determined by Western blot analysis using 
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polyclonal rabbit anti-rat CYP1A1 antibodies.  To our knowledge, we demonstrated for 
the first time that CD exposure inhibits the PAH-induced CYP1A1-dependent enzymatic 
activity in a dose responsive fashion. This suppression was also observed in pulmonary 
alveoli of CD exposed rats in immunofluorescent-stained section. In addition, the amount 
of CYP1A1 detected by western blot in lung microsomes was also diminished.  
MATERIALS AND METHODS 
Animals 
Male Sprague-Dawley rats (~220-270g) were purchased from Hilltop Labs 
(Scottsdale, PA).  Upon arrival, the rats were kept in an AAALAC-approved barrier 
animal facility at NIOSH.  Food and water were supplied ad libitum. Rats were housed in 
Shoebox cages on autoclaved hardwood and cellulose (Alpha-Dri) bedding in HEPA 
filtered laminar-flow, ventilated cage racks (Thoren). Rats were allowed to acclimatize in 
their cages for at least 7 days before the experiment. 
Experimental Design 
By using a research randomizer program (www.randomizer.org), rats were 
randomized into five groups, of 4 rats each. Each group was intratracheally (IT) instilled 
with 0, 2.5, 10, 20, or 40 mg CD /rat (~ 0, 1, 4, 8, and 16 mg/100 gm BW) suspended in 
sterile saline. Eleven days later, rats were intraperitoneally (IP) injected with the 
CYP1A1 inducer beta-naphthoflavone (BNF) (50 mg/kg BW) suspended in filtered corn 
oil. Three days after BNF injection, rats were euthanized and the right lung lobes were 
homogenized for collecting the lung microsomes whereas the left lungs were inflated 
with 10% neutral buffer formalin for histopathology.  
Coal Dust Particles:  
       The size of these particles was less than 5 microns with surface area 7.4 m2/g.  The 
particles contained 0.34 % total iron of which 0.119 % is surface iron.  The particles were 
weighed, placed in a scintillation vial, covered with foil and heat sterilized in an oven at 
160 ºC for 2 hours.  Coal dust suspensions were prepared from heat-sterilized samples 
using non-pyrogenic sterile saline (Abbott Laboratories, North Chicago).   
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Intratracheal Instillation 
 The coal dust particles were suspended in sterile saline at a concentration of 8.3, 
33.3, 66.6, and 133.3 mg/ml.  Rats received either 0.3 ml of this suspension (~2.5, 10, 20, 
and 40 mg/rat) or equivalent dose of saline (vehicle). The rats were anesthetized by 
intraperitoneal (IP) injection of sodium methohexital (Brevital, Eli Lilly Indianapolis, IN) 
and were intratracheally instilled using a 20-gauge, 4-inch ball-tipped animal feeding 
needle as previously described ( Porter et al, 2002) 
Beta-Naphthoflavone (BNF) Preparation 
       Solutions of 5 % BNF (Sigma, St. Louis, MO) in corn oil (50 mg/ml) were prepared 
one day before intraperitoneal (IP) injection.  Prior to use, the corn oil was filtered with 
non-pyrogenic Acrodisc 25 mm syringe filter (0.2 µm in diameter) (Pall Gelman 
sciences, Ann Arbor, MI) to assure sterility.   The solution suspension was vortexed until 
the particles were evenly suspended and then sonicated in Ultronics sonicator (Mahwa, 
NJ) for 15 minutes before injection.  BNF solutions were injected once, IP, at a dose of 
50 mg/kg 3 days before sacrifice. 
Euthanasia 
Euthanasia was induced by IP injection of 0.5 ml 26% sodium pentobarbital 
(Sleepaway®, Fort Dodge Animal Health, Fort Dodge, IA) 2 weeks after CD exposure. 
Necropsy 
The lungs and attached organs including tracheobronchial lymph node, thymus, 
heart, aorta, and esophagus were removed.  The right lung lobes were collected and 
weighed at necropsy for microsomal preparation while the left lung lobe was inflated 
with 3 cc of 10% neutral buffered formalin (NBF).  Tracheobronchial lymph nodes, liver, 
spleen, and right and left kidneys were also fixed in 10 % NBF.  Fixed tissues were 
trimmed the same day, routinely processed in a tissue processor and embedded in paraffin 
the following morning. Tissue sections of left lung were stained with Hemotoxylin and 
Eosin (H&E). Additional 5-micrometer sections were used for immunofluorescence. 
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Microsomal Preparation 
Lung microsomes were prepared for determination of EROD activity as an 
indicator of the CYP1A1-dependent enzymatic activity, 7-pentoxyresorufin-O-deethylase 
(PROD) activity as an indicator of the CYP2B1-dependent enzymatic activity, and for 
Western blot analysis of CYP1A1 and CYP2B1 proteins.  Microsomes were prepared as 
previously described (Flowers and Miles, 1991; Ma et al, 2002). At the necropsy, the 
right lung lobes were weighed and chopped 4 times with a Mc1Iwain tissue chopper 
(Mickle Engineering Co., Gomshall, Surrey, UK) set at slice thickness of 0.5 mm.  Then, 
the chopped lung tissues were suspended in ice-cold incubation medium (145 mM KCL, 
1.9 mM KH2PO4, 8.1 mM K2HPO4, 30 mM Tris-HCL, and 3 mM Mg Cl2; pH 7.4) at a 
ratio of 1gm lung to 4 ml incubation medium.  The suspended solution was homogenized 
using a Teflon-glass Potter-Elvejhem Homogenizer (Emerson, NJ) through 16 complete 
passes.  The cell nuclei and debris were removed by centrifugation of the homogenate at 
2500 rpm for 10 minutes in a Sorvall Model RC2-B refrigerated centrifuge (Ivan Sorvall 
Co., Northwalk, CT).  Mitochondria were slowly deposited by three sequential 
centrifugations for 20 minutes each at 5,000, 9,000, and 13,000 rpm to reduce the 
mitochondrial contamination of the microsomes.  The resulting supernatant was ultra-
centrifuged at 40,000 rpm for 75 minutes in a Beckman Model L5-50 Ultracentrifuge 
(Beckman Instruments, Palo Alto, CA) to get the microsomal fraction (Figure 1).  The 
pellet was re-suspended in the incubation medium in a ratio equal to the original lung 
weight (i.e. 1gm lung/ 1ml medium) and frozen at -80C until assayed. 
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Figure 1. Four main steps involved in the microsomal preparation of rat lungs. The 
process included (1) Collecting the right lung lobes, (2) Chopping the lungs, (3) 
Homogenizing lungs, and (4) Centrifugation of lung homogenate to remove the cellular 
and nuclear debris and to reduce the mitochondrial contamination of the microsomal 
fraction 
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Determination of the Total Lung Proteins  
The protein content of lung microsomes was measured by the bicinchoninic acid 
(BCA) method as previously described (Smith et al, 1985, Ma et al, 2002) using the BCA 
protein assay kit (Pierce, Rockford, IL) in a spectra Max 250 Spectrophotometer 
(Molecular Devices Corporation, Sunnyvale, California). Bovine serum albumin was 
used as the standard. 
Measurement of EROD and PROD activities 
  EROD and PROD activities were measured as previously described (Burke et al, 
1985 and Ma et al, 2002) using a luminescence spectrometer model LS-50 (Perkin-
Elmer, Norwalk, CT). A 10 µM concentration of 7-ethoxyresorufin (Sigma, St. Louis, 
MO) solution prepared from 2.35 µg 7-ethoxyresorufin in 1 ml DMSO was used for the 
standard curve following each run.  EROD and PROD activities were expressed as 
picomoles of the produced resorufin per minute per milligram microsomal protein 
(pmol/min/mg protein). 
Western Blot Analysis 
Western Blot analysis of lung microsomes was conducted as previously described 
(Ma et al, 2002). Each gel received 75 µg of microsomal protein for CYP1A1 and 20 µg 
for CYP2B1.  The nitrocellulose membrane was probed using a polyclonal rabbit anti-rat 
CYP1A1 antibody (Xenotech, Kansas city, KS) or a monoclonal mouse anti-rat CYP2B1 
antibody (Xenotech) at 4ºC overnight. Blocking of non-specific binding was made by 
incubating the membrane with a solution of 1% dry milk in tris-buffered saline/tween 
(TBS/T) for 1 hour at room temperature with rocking. The membranes were then 
incubated for 1 hour at room temperature with a goat anti-rabbit antibody (Santa Cruz 
Biotech. Inc., Santa Cruz, CA) for CYP1A1 or goat anti-mouse antibody (Santa Cruz 
Biotech. Inc., Santa Cruz, CA) for CYP2B1. For positive control, liver microsomes of 
BNF-treated rat (Xenotech) were used for CYP1A1 or liver microsomes of 
phenobarbital-treated rats (Amersham, Piscataway, NJ) for CYP2B1.  The CYP1A1 and 
CYP2B1 proteins were detected by enhanced chemiluminescence (ECL) reagent kit 
(Amersham).  The x-ray films (Fuji Film Corp., LTD., Tokyo, Japan) containing protein 
bands were scanned by the Eagle Eye II scanner (Stratagene, La Jolla, California 92037) 
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with Eagle Sight software. The scanned images were quantified by ImageQuant software 
version 5.1 (Molecular Dynamics, Sunnyvale, CA). The quantification of western blot by 
this software calculates the volume under the surface area created by a 3-D plot of the 
pixel locations and pixel intensities.  Each sample was quantified three times, and then 
the averages of the values were used to calculate the individual measurement. The data 
were expressed as a percentage of the CYP1A1 or CYP2B1 positive controls. 
Dual Immunofluorescence Technique  
Paraffin-embedded, formalin-fixed sections from the left lung lobe were used for 
immunofluorescent detection of CYP1A1 and cytokeratins 8/18, which are cytoskeletal 
proteins used as markers of AT-II cells (Kasper et al, 1993).  Briefly, 
immunofluorescence was a two-day procedure (Figure 2) where in the first day the slides 
were first heated in the oven at 60 ºC for 10 to 20 minutes. The slides were deparaffinized 
and rehydrated in xylene in 3 sequential 6 minute immersions, a 3 minute immersion in 
100 % alcohol, 3 minutes in 90 % alcohol, 3 minutes in 80 % alcohol, and 5 minutes in 
distilled water.  The antigenicity of hidden epitopes was retrieved using 0.01M disodium 
ethylenediamine tetraacetate (Fischer Scientific, Fair Lawn, New Jersey), pH 8 in a 
microwave heating procedure. Specifically, slides in the EDTA solution were heated for 
1 minute and 45 seconds in the microwave on high and then for 6 minutes on defrost.  
EDTA solution was then added to replenish the solution which had been evaporated and 
the slides were reheated for 6 additional minutes on defrost.  To avoid the non-specific 
binding of the primary antibodies, the slides were blocked with 5 % BSA in PBS (IgG 
free) (Sigma) for 10 minutes at room temperature (RT).  Then the slides were rinsed with 
distilled water and blocked with 5% pig serum in PBS (Biomeda Corporation, Foster city, 
CA) for 10 minutes at RT.  The slides were then rinsed with distilled water and primary 
antibodies were applied.  We used a polyclonal Guinea pig anti-cytokeratins 8/18 
antibody (RDI, Flanders, NJ) for staining of cytokeratins 8/18 at a 1:50 dilution in PBS.  
For CYP 1A1 staining, a polyclonal, affinity purified, highly cross-absorbed rabbit anti-
rat CYP1A1 antibody (Xenotech,) was used at a 1:5 dilution.  Both primary antibodies 
were applied by utilizing the capillarity generated between each pair of slides in a 
microprobe holder (Fischer Scientific).  The slides were kept at room temperature 
overnight during which the primary antibodies were allowed to bind to the antigen 
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(CYP1A1 and cytokeratins 8/18).  On the second day, the slides were incubated in the 
oven at 37 ºC for 2 hours after which they were thoroughly rinsed with distilled water and 
the secondary antibodies were dropped onto the slides.  A FITC-labeled, donkey anti-
Guinea pig IgG (Research Diagnostic Inc., Flanders, NJ) was used to detect cytokeratins 
8/18 at a 1:50 dilution with PBS.  For CYP1A1 detection, Alexa 594-conjugated goat 
anti-rabbit antibody (Molecular probes, Eugene, Oregon) was applied at a dilution of 1:20 
with PBS. The secondary antibodies were allowed to bind to the primary antibodies for 2 
hours in the dark. For the negative control, the primary antibodies were omitted and 
replaced by rabbit serum.  Slides were rinsed with distilled water, cover slips were 
applied using gel mount (Biomeda Corp., Foster City, CA), and the slides were allowed 
to dry for 2 hours. Ten images were captured using a digital camera (Quantix 
Photometrics, Roper Scientific Inc, Trenton, NJ ) fitted on an Olympus photomicroscope 
(OlympusAX70, Olympus American Inc., Lake Success, NY)  by a researcher blinded to 
the exposure status. For each slide, 5 images were captured from proximal alveolar 
regions (PAR) where most of the dust particles tend to accumulate (Nikula et al, 1997). 
Another 5 images were obtained from random alveolar (RA) regions, which were not 
located near visible alveolar ducts.  The aim of selecting those 2 areas is to assure 
sampling of the alveolar regions representative of the site of coal dust particle deposition. 
Five images were also captured from the terminal bronchiolar region to count the number 
of CYP1A1-positive bronchiolar epithelial cells. The digital camera settings for contrast, 
brightness, and gamma were held constant for all slides. The staining was described as 
being specific due to the absence of background staining, distinct cellular localization of 
CYP1A1 and cytokeratins 8/18, and absence of the staining in the negative control slides 
where rabbit serum was applied instead of the primary antibodies. 
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Figure 2. Immunofluorescent technique for staining tissue sections. The procedure 
included: 
1- Preparation of tissue section of 4 µm thickness from paraffin embedded tissue. 
2- Deparafinization and rehydration of tissue sections by emersion in xylene and 
alcohol. 
3- Retrieval of protein epitopes by using EDTA and microwave heating. 
4- Blocking the non-specific antibody binding by pig serum and bovine serum 
albumin. 
5- Addition of the primary antibody to allow binding to the antigen then labeling the 
primary antibody with fluorescent-conjugated secondary antibody. 
6- Examination of the fluorescent emission from the secondary antibody under 
fluorescent microscope at standard settings. 
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 Quantification of CYP1A1 and Cytokeratins 8/18 by Morphometric Analysis  
The lung area occupied by red fluorescence (representing CYP1A1 expression), 
green fluorescence [representing cytokeratins 8/18, which are cytoskeletal proteins highly 
expressed in primitive epithelia such as the cuboidal AT-II cells (Kasper et al, 1993)], 
and colocalized (concomitantly occurring) red and green fluorescence were quantified by 
using commercial morphometry software (Metamorph Universal Image Corp.). The area 
of CYP1A1 colocalized with cytokeratins 8/18 in AT-II cells was obtained by the 
following formula:  
                     C = R x T where; 
C stands for the area of CYP1A1 that co-expressed (colocalized) with 
cytokeratins 8/18 in AT-II cells, 
R stands for the percent of CYP1A1 expressed in AT-II cells measured by the 
Metamorph software, and 
T stands for the total CYP1A1 area expressed in the whole alveolar septum 
(including AT-II and alveolar non-type II cells) measured by the Metamorph software. 
Moreover, the proportional CYP1A1 expression in AT-II cells, which is the 
relative area of CYP1A1 to cytokeratins 8/18 expression, was calculated from the 
following formula:  
                                        P =   R x T where; 
                                                                G 
C, R, and T as defined above and,  
G is the total green area of cytokeratins 8/18 expressed in AT-II cells.  
P is the proportional CYP1A1 expression within areas occupied by the AT-II marker, and 
adjusts for increases associated with AT-II hyperplasia. 
By this method, we were able to analyze the expression pattern in AT-II cells. 
Moreover, the hyperplasia of AT-II cells was also determined by measuring the area 
containing the FITC expression (green area), which represents the expression of 
cytoskeletal proteins 8/18 by AT-II cells. The threshold ranges for red and green colors 
were held constant during morphometric analysis of all images.  
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Histopathology: 
Slides were interpreted by a board-certified veterinary pathologist blinded to the 
exposure status of the individual slides. Changes assessed in each slide included: AT-II 
cell hyperplasia and hypertrophy, alveolitis (inflammation), and hyperplasia of bronchus-
associated lymph tissue. Histopathologic changes were scored for severity and 
distribution from zero to five as previously described (Hubbs et al, 1997). Briefly, 
severity was scored as none (0), minimal (1), mild (2), moderate (3), marked (4), or 
severe (5). Distribution was scored as none (0), focal (1), locally extensive (2), multifocal 
(3), multifocal and coalescent (4), or severe (5). The pathology score is the sum of the 
severity and distribution score. 
Statistical Analyses 
The dose responsive effects of coal dust instillation on EROD, PROD, and 
Western blot for CYP1A1 and CYP2B1 were assessed using linear regression analysis. 
Pairwise comparisons of each dose to the control group were analyzed using one-way 
analysis of variance followed by Dunnett’s test. AT-II hyperplasia and hypertrophy based 
on immunofluorescence were analyzed using one-way analysis of variance followed by 
Dunnett’s test to compare each dose to the control group. Pathology scores were analyzed 
using the nonparametric Kruskal-Wallis test followed by the Wilcoxon Rank-sum test for 
pairwise comparisons. All differences were considered statistically significant at P<0.05. 
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RESULTS 
 
Effect of Coal Dust Exposure on EROD and PROD 
The IT instillation of coal dust suppressed the CYP1A1-dependent enzymatic 
activity (EROD) in a dose-dependent fashion (r2=0.399, p=0.0028) (Figure 3). Rats 
exposed to 40 mg/rat CD with BNF had a significant lower EROD activity than those 
exposed to control saline with BNF (p=0.036). Similarly, CYB2B1-dependent enzymatic 
activity (PROD), the major CYP isoform in rat lungs, showed a dose-dependent reduction 
by CD exposure using linear regression (r2= 0.458, P=0.001). PROD was significantly 
reduced in rats exposed to 20 and 40 mg/rat CD with BNF compared to control, saline 
with BNF (p 0.017) (Figure 4).  
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Figure 3. BNF-induced CYP1A1-dependent enzymatic activity (EROD) is suppressed in 
a dose dependent fashion by intratracheal exposure of rats to 0, 2.5, 10, 20, or 40 mg coal 
dust suspended in the vehicle (saline). EROD activity is significantly reduced at 40 
mg/rat CD exposure comparing to the control saline. Values are means and standard error 
of 4 rats /group. EROD was measured as pmol/min/mg microsomal protein. All rats 
received 50 mg/kg BNF IP 3 days before sacrifice. The linear regression best fit curve 
showing the reduction of EROD activity with increasing CD exposure. * Significantly 
different from control at p<0.05.  
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Figure 4. Lung microsomal CYP2B1-dependent enzymatic activity (PROD) is reduced in 
a dose-dependent manner by CD exposure.  Values are means and standard error of 4 rats 
/group. PROD was measured as pmol/min/mg microsomal protein. All rats also received 
IP BNF (50mg/kg) 3 days prior to sacrifice.  The linear regression best fit curve showing 
the reduction of PROD activity with increasing CD exposure. * Significantly different 
from control at p<0.05.  
 
Western Blot Analysis 
CYP1A1 
A representative Western blot of the pulmonary microsomal preparations is 
shown in Figure 5A. The results were expressed as the percentage of the CYP1A1 
positive control. The amount of CYP1A1 quantified by Western blot in CD and BNF-
exposed was less than in rats exposed to BNF without CD. Groups treated with the 
highest dose of CD (40mg/rat) showed a significant reduction of CYP1A1 protein 
compared to control (p=0.03) (Figure 5A and B). 
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Figure 5. In A, a sample of Western blot showing significant repression of CYP1A1 
protein in lung microsomes by coal dust exposure (p=0.029) at high dose of CD 
(40mg/rat) analyzed by linear regression.  Microsomal protein (75 µg) from a positive 
control (liver microsomes of BNF-treated rats) (lane 1), pulmonary microsomes from 
BNF-treated rats (lane 2 & 4) and CD and BNF-exposed rats (2.5mg CD lane 3, 10mg 
CD lane 5, 20mg CD lanes 6 &7, and 40 mg CD lane 8) were subjected to SDS gel 
electrophoresis using Tris-glycine SDS running buffer and blotted to nitrocellulose 
membranes.  The membranes were probed with rabbit anti-rat CYP1A1 antibody 
overnight at 4ºC then goat anti-rabbit antibody as described in the materials and methods.  
Lane 9 is the molecular weight standard. In B, the data from multiple Western blots is 
expressed as the percentage of CYP1A1 positive control from quantification of four 
different samples from each exposure group. The values represent means ± SE, n=4. 
*significantly different from control group at P < 0.05. 
 
CYP2B1 
The CYP2B1 protein, the major isoform of CYP subfamily in the rat lung, was 
measured in the lung microsomes.  CYB2B1 is not inducible by BNF in rat lungs but can 
be induced in liver by phenobarbitals. The amount of lung CYP2B1 detected by Western 
blot was numerically, but not significantly, less in CD-exposed rats than control rats (6A 
and B). The results were expressed as the percentage of CYP2B1 positive control. 
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Figure 6. The effect of coal dust on CYP2B1 in the lungs of BNF-exposed rats assessed 
by Western blot using linear regression analysis. Microsomal protein (20 µg) from 
control rats (saline and BNF) and exposed (CD and BNF) rats were subjected to SDS gel 
electrophoresis using Tris-glycine SDS running buffer and blotted against nitrocellulose 
membrane. The membranes were probed with mouse anti-rat CYP2B1 antibody 
overnight at 4ºC then goat anti-mouse antibody as described in the materials and 
methods. The amount of lung CYP2B1 detected by Western blot is decreased, although 
not significantly, by coal dust exposure. In A, the first lane (c) is the positive CYP2B1 
control (liver microsomes of Phenobarbital-treated rats), the last lane is the molecular 
weight standard, while all other treatments are indicated above the lanes. In B, 4 different 
samples for each treatment were quantified and the data expressed as a percentage of 
positive CYB2B1 control. Values are means ± SE, n=4. 
 
Effect of CD Exposure on Histopathological Changes of Lung Alveoli 
 AT-II cell hyperplasia (increased cell number) and hypertrophy (increased cell 
size), alveolitis (alveolar inflammation), and lymphoid hyperplasia of tracheobronchial 
lymph node were the major histopathological changes assessed in sections stained by H 
and E. Accumulation of dust-laden macrophages in the alveolar spaces was a noteworthy 
finding in coal dust exposed alveoli (Figure 7). Rats exposed to CD (2.5, 10, 20, and 
40mg/rat) showed significant hyperplasia and hypertrophy of AT-II cells compared to 
control (p<0.001 in all treatment doses); Figure 8. In addition, alveolitis (alveolar 
inflammation) was significantly increased in rats exposed to 2.5, 10, 20, and 40mg/rat 
CD (p=0.01, p=0.006, p=0.002, p=0.002, respectively) (Figure 8) 
%
 o
f p
os
iti
ve
 C
YP
2B
1 
co
nt
ro
l
0
20
40
60
80
100
Salin
e/BN
F
CD 1
0mg/
BNF
CD 2
.5mg
/BNF
CD 2
0mg/
BNF
CD 4
0mg/
BNF
                                                        
 
63
   
     
Figure 7. Microphotograph of tissue section stained with H & E showing AT-II cellular 
hyperplasia and hypertrophy. Dust-laden macrophages are also shown as dark spots in the 
alveolar spaces. These histopathological changes are absent in control (B). The bar is 20 
µm. 
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Figure 8: Histopathological changes in rat lungs after intratracheal exposure to coal dust. 
Changes were scored for severity and distribution of alveolitis and AT-II hyperplasia and 
hypertrophy as described in the material and methods. * indicates that alveolitis is 
significantly higher than control (saline/BNF) at p < 0.05. + indicates that AT-II 
hyperplasia and hypertrophy are significantly higher than control (saline/BNF) at p < 
0.05. Data were analyzed by the non-parametric Kruskal-Wallis test followed by 
Wilcoxon Rank-Sum test for pairwise comparisons. Values are means ± SE, n=4. 
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Results of dual Immunofluorescence: 
The result of immunofluorescent changes by CD exposure is summarized in Table 
1. 
I-Pattern of CYP1A1 Expression in Alveolar Region of the Lung 
A specific pattern of rat CYP1A1 expression was observed in the alveolar region 
of the lung by immunofluorescence examination.  In rats exposed to BNF alone (control 
rats), the CYP1A1 expression (red-labeled area in Figure 9) was mostly localized to the 
endothelium of the pulmonary vasculature and in cells of the alveolar septum.  
Statistically, areas of CYP1A1 expression were significantly smaller in AT-II cells than 
in other cells (NT-II cells) of the alveolar septum (p=0.003) (Figure 9B and C).   
II-Pattern of Cytokeratins 8/18 Expression in the Alveolar Region of the Lung 
 The green fluorescent Cytokeratins 8/18 were clearly expressed in the cytoplasm 
of cuboidal cells that were mainly localized on the corners of the alveolar septum (Figure 
9A). These cells have the plump morphology characteristic of AT-II cells of the alveolar 
septa. No green fluorescence was visualized in the other types of cells of the alveolar 
septum, which were then designated as alveolar NT-II cells (Figure 9A). 
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III-Effect of CD on AT-II Cell Proliferation by Immunofluorescent Examination 
 The area of expression of cytoskeletal proteins (cytokeratins 8/18), which are 
highly expressed in the cytoplasm of AT-II was quantified morphometrically and 
expressed as square micrometer. In the proximal alveolar (PA) regions, this area was 
significantly larger in rats exposed to 20 and 40 mg CD/rat and BNF than control (Figure 
10A), indicating hyperplasia and hypertrophy of AT-II cells ( p= 0.027 and p=0.02, 
respectively) (Figure 10 A and 11B). On the contrary, no significant change of AT-II 
hyperplasia and hypertrophy was detected in the random alveolar (RA) regions of CD-
exposed rats compared to control (Figure 10B and Figure 12B,). 
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Figure 10. Morphometric quantification of area of cytokeratins 8/18 expression in AT-II 
cells. In A, the area was quantified in the PA regions and showed a significant increase of 
cytokeratins 8/18 expression in rats exposed to 20 and 40 mg/rat coal dust and BNF 
compared to control. In B, no significant change was detected in cytokeratins 8/18 
expression of the RA regions of rats exposed to CD vs. control. Data were analyzed by 
one way analysis of variance followed by Dunnett’s test. * indicates significant 
difference from control at p<0.05. Values are means ± SE, n=4. 
 
IV-Effect of CD exposure on CYP1A1 Expression by Alveolar Non-Type II (NT-II) 
Cells  
1-CYP1A1 Expression by Alveolar NT-II Cells in Saline vs. Coal Dust Exposed Rats: 
A- In proximal Alveolar (PA) Regions  
The area of expression of CYP1A1 (measured in square micrometer) by alveolar 
NT-II cells (all cells in the alveolar septum except for AT-II cells) of PA regions (regions 
of coal dust accumulation) was significantly lowered in groups exposed to 20 mg and 40 
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mg/rat CD and BNF compared to BNF control group (p=0.007, p=0.008, respectively) 
(Figure 11A). This was indicated by the reduction of the red-labeled area that is not co-
expressed with green-labeled area (NT-II cells stained red only for CYP1A1) as shown in 
Figures 12A and B. 
B- In Random Alveolar (RA) Regions  
No significant change was detected in the area of CYP1A1 expression by alveolar 
NT-II cells of RA regions (regions of minimum particle aggregation) of groups exposed 
to CD and BNF compared to control group. This result was illustrated by morphometric 
quantification of CYP1A1 expression in alveolar NT-II cells where none of the 
cytokeratins 8/18 were localized with CYP1A1 (Figure 11B and Figure13A and B). 
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Figure 11. Morphometric quantification of immunofluorescent-stained sections for 
CYP1A1 and cytokeratins 8/18 of NT-II cells of the PA and RA regions of control and 
CD-exposed rats. In A, the CYP1A1 expression area in alveolar NT-II cells is 
significantly reduced in groups exposed to 20 and 40 mg/kg CD and BNF compared to 
that exposed to BNF alone. However in B, no significant changes in the area of CYP1A1 
expression in NT-II cells of the RA regions of CD-exposed rats compared to control. 
Values are means ± SE, n=4. * Significantly different from control at p<0.05.  
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2-CYP1A1 Expression by Alveolar NT-II Cells in PA Regions vs. RA Regions of CD-
Exposed Rats: 
 CYP1A1 expression by alveolar NT-II cells was compared in 2 different alveolar 
regions, the proximal versus random alveolar regions. The area of CYP1A1 expression 
measured in alveolar NT-II cells of PA regions was significantly reduced compared to the 
RA region in rats exposed to 20 and 40 mg/kg CD and BNF (p=0.048, p=0.022, 
respectively) (Figure14 ).  
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Figure 14. Morphometric quantification of CYP1A1 expression in NT-II cells of PA 
regions vs. RA regions. The area was measured in square micrometer. * indicates that 
CYP1A1 expression is significantly lower in NT-II cells of PA regions compared to RA 
regions in rats exposed to 20 mg/rat CD and BNF at p<0.05.    indicates that CYP1A1 
expression is significantly lower in NT-II cells of PA regions compared to RA regions in 
rats exposed to 40 mg/rat CD and BNF at p<0.05. Values are means ± SE, n=4.  
 
V-Effect of CD Exposure on CYP1A1 Expression by AT-II Cells 
1-CYP1A1 Expression by AT-II Cells in CD-Exposed Rats vs. Control in the PA 
Regions 
A- Relative Area (proportion) of CYP1A1 Expression in green AT-II Cells 
The relative area of red fluorescent CYP1A1 expression to the green fluorescent 
area of cytokeratins 8/18 expression was calculated by the formula described in the 
materials and methods section, and was designated as proportional CYP1A1 expression, 
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which determines the amount of CYP1A1 expression within AT-II cells with correction 
for changes in AT-II cell number.  The proportional CYP1A1 expression in AT-II cells of 
PA regions was significantly reduced in rats exposed to 20 mg (p=0.005) and 40 mg 
(p=0.003) CD and BNF compared to control (Figure 15A). 
B- Area of CYP1A1 Colocalized with Cytokeratins 8/18 in AT-II Cells 
The expression of CYP1A1 in AT-II cells is visualized as a yellow fluorescence 
due to concomitant expression of the red-fluorescent CYP1A1 and green-fluorescent 
cytokeratins 8/18 (Figure 9C).  The expression (co-localization) of CYP1A1 in AT- II 
cells of the PA regions measured in µm2 was significantly lowered in rats exposed to 20 
mg/rat (p=0.007) and 40 mg/rat (p=0.002) CD and BNF compared to control (Figure 
15B). This was indicated by the reduction of the red areas that colocalized (co-expressed) 
with green areas in rats receiving higher exposures of CD (Figure12B). 
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Figure 15. Morphometric quantification of proportional CYP1A1 expression (A) and 
colocalization area (B) in AT-II cells. In A, * indicates significant reduction of fractional 
CYP1A1 expression in AT-II cells in the PA regions of rats exposed to 20 and 40 mg/rat 
CD with BNF compared to the PA region of BNF-treated rats at p<0.05. in B, * indicates 
significant reduction of area of CYP1A1 expression in AT-II cells (colocalization area) in 
PA region exposed to 20 and 40 mg/rat CD with BNF compared to control at p<0.05. 
 
2-CYP1A1 Expression by AT-II cells in CD-Exposed Rats vs. Control in RA Regions 
The expression of CYP1A1 in AT-II cells (either the co-localization or the 
proportional expression) was not significantly affected by CD exposure in RA regions 
(data not shown). 
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3-CYP1A1 Expression by AT-II Cells in PA Regions vs. RA Regions of CD-Exposed 
Rats: 
 The area of CYP1A1 expression measured in AT-II cells showed no significant 
changes in PA regions when compared to RA regions in CD-exposed groups compared 
with BNF-exposed groups (data not shown) 
IV-Effect of CD Exposure on CYP1A1 Expression in the Whole Alveolar septum: 
The area of CYP1A1 expression was measured in the alveolar septum as a total 
red area, which represent the expression by all different types of cells at the septum.  A 
significant reduction was detected with 20 and 40 mg/rat CD in PA regions (Figure 16A). 
However, there was no change observed in RA regions (Figure 16B). In addition, in rats 
exposed to 20 and 40 mg of CD, CYP1A1 expression in RA regions was significantly 
less than in PA regions (Figure 17). 
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Figure 16. Morphometric analysis of area of CYP1A1 expression in the whole alveolar 
septal cells of the PA (A) and RA (B) regions. In A, the total CYP1A1 area localized in 
PA regions lung alveoli of rats exposed to 20 and 40 mg CD and BNF is significantly 
lower than BNF-exposed . In B, however, no significant change is observed Values 
represent means ± SE (n=4).  *Significantly different from control saline/BNF at P<0.05. 
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Figure 17: Quantitative analysis of the total alveolar area expressing CYP1A1 in PA 
regions vs. RA regions. The total CYP1A1 area expressed in all alveolar cells of PA 
regions is significantly decreased in rats exposed to 20 and 40 mg CD and BNF 
compared to that of the RA regions. The letter a above the bar indicates a significant 
difference from RA regions of rats exposed to 20 mg CD and BNF at p<0.05. the letter b 
above the bar indicates a significant difference from RA regions of rats exposed to 40 mg 
CD and BNF at p<0.05. Values represent means ± SE (n=4). 
 
IIV-Effect of CD on CYP1A1 Expression by the Non-Ciliated Bronchiolar Epithelial 
(Clara) Cells  
 The number of the CYP1A1-positive non-ciliated bronchiolar epithelial cells was 
counted per micrometer of the basement membrane. No significant change in the number 
of CYP1A1-positively stained cells was observed in BNF and CD-exposed rats compared 
to BNF-exposed rats (Figure 18 and 19). 
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Figure 18. Effect of CD exposure on CYP1A1 expression by terminal non-ciliated 
bronchiolar (Clara) cells. The number of Clara cells positive for the CYP1A1 
immunofluorescent signal per µm of basement membrane showing no significant 
difference between CD exposed rats and control. Values represent means ± SE (n=4).  
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Table 1. Summary of morphometric quantification of immunofluorescent-stained sections 
against CYP1A1 and cytokeratins 8/18 in rat lungs exposed to coal dust. 
 
 saline CD 2.5 mg CD 10 mg CD 20 mg CD 40 mg 
                Region  
parameter 
PA RA PA RA PA RA PA RA PA RA 
Cytokeratins 8/18 
expression 
471.1 
± 
152.6 
509.1 
± 
133.7 
236.7 
± 
152.6 
44.8 
± 
133.7 
907.2 
± 
152.6 
421.2 
± 
133.7 
829.5* 
± 152.6 
462.4 
± 
133.7 
1160* ± 
152.6 
512.8 
± 
133.7 
Area of CYP1A1 in 
AT-II cells (µm2) 
124.5 
±  
40.4 
79.2  
±  
54.5 
75.5 
±  
40.4 
67.7  
±  
54.5 
129.9 
±  
40.4 
57.3 
±  
54.5 
35.4  
±  
40.4 
87.8 
±  
54.5 
24.0  ±  
40.4 
181.9 
±  
54.5 
proportional CYP1A1 
expression in AT-II 
cells  
0.274 
± 
0.043 
0.260 0.319 
± 
0.043 
0.163 0.141 
± 
0.043 
0.175 0.039* 
± 0.043 
0.187 0018* ± 
0.043 
0.275 
Area of CYP1A1 in 
NT-II cells (µm2) 
540.9 
± 
76.86 
711.5 
±  
127 
471.2 
± 
76.86 
328.8 
±  
127 
372.1 
± 
76.86 
353.9 
±  
127 
136.1*☼ 
±  
76.86 
328.9 
±  
127 
144.2*☼ 
±  
76.86 
537.2 
±  
127 
Area of CYP1A1 in 
all alveolar cells 
(µm2) 
665.4  
± 
103.0 
575.0 
± 
173.6 
546.8 
± 
103.0 
396.4 
± 
173.6 
498.7 
± 
103.0 
411.3 
± 
173.6 
171.4 *☼ 
± 103.0 
416.8 
± 
173.6 
168.2*☼  
± 103.0 
719.2 
± 
173.6 
CYP1A1 positive 
Clara cells/µm  
0.0482 ± 
0.0062 
0.0446 ± 
0.00482 
0.0525 ± 
0.0018 
0.0513 ± 
0.00784 
0.0317 ± 
0.00785 
 
The values presented are means ± SE, n=4. * means significant difference from the 
control (saline) regarding the same region. ☼ indicates significant difference of PA 
regions from RA regions of the same treatment group. 
 
 
 
 
 
 
 
 
 
 
 
 
                                                        
 
76
DISCUSSION 
Some epidemiological studies report that coal miners, primarily smokers, have a 
lower risk of developing lung cancer compared with control non-miners (Costello et al, 
1974). Moreover, lung cancer risk in workers exposed to the more toxic particles, such as 
silica, was mostly absent when workers were concurrently exposed to other workplace 
lung carcinogens, such as polycyclic aromatic hydrocarbons (PAHs) (Cocco et al, 2001).  
Such data concerning lung cancer in miners are difficult to interpret because miners are 
exposed to a mixture of environmental pollutants; such as the coal dust particles and the 
PAH in cigarette smoke 
Using rats with induced CYP1A1, as it is in cigarette smokers, our EROD data 
showed that coal dust exposure suppressed induced CYP1A1 activity in a dose-dependent 
fashion (Figure 3). Previous studies in our laboratory showed that IT exposure of rat 
lungs to crystalline silica (20mg/rat) significantly suppressed induced EROD activity 
(Battelli et al, 1999). Although coal dust is less cytotoxic than silica (Castranova, 2000), 
it is able to inhibit the CYP1A1-dependent enzymatic activity (EROD) in a dose 
responsive manner suggesting that CD particles are among the toxic respirable 
compounds, that include silica, that interfere with CYP1A1 metabolic activity in rat 
lungs.  Western blot analysis was performed using a polyclonal rabbit anti-rat CYP1A1 
antibody to detect CYP1A1 protein expression in the lung microsomes. The amount of 
CYP1A1 protein in the gel was reduced at all doses of CD treatment, but was significant 
only in the highest dose (40 mg/rat) (Figure 5A and B).  This suggested that the reduction 
in the CYP1A1 activity upon exposure to CD is partly attributed to the reduction of 
CYP1A1 expression and protein synthesis by different pulmonary cells.  
The activity of CYP2B1, measured in lung microsomes as PROD activity, 
showed a dose-dependent reduction by exposure to coal dust (Figure 4).  CYP2B1 is the 
major constitutive isoform of cytochrome P450s in rat lungs (Martin et al, 1993; 
Guengerich et al, 1982).  CYP2B1 expression is not inducible in the rat lung (Guengerich 
et al, 1982).  BNF, a specific CYP1A1 inducer, significantly up-regulates CYP1A1 
expression in the lung parenchyma (Lee et al, 1998, Jones et al, 1983, and Sesardic et al, 
1990). Western blot analysis for CYP2B1 showed a reduction of the protein, albeit not 
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significant, in BNF and CD-exposed rats compared to rats receiving BNF alone. This 
suggested that CD exposure modified not only the CYP1A1 expression and activity but 
also the activity of CYP2B1 in the rat lung.  
Cell-specific expression and localization of CYP1A1 were studied by 
immunofluorescence followed by quantification using morphometric analysis. 
Immunofluorescence was employed in this study because preliminary studies indicated 
that it was more sensitive than enzymatic immunohistochemistry and useful for localizing 
the sites of pulmonary CYP1A1 through double labeling (Battelli et al, 2001).  
Morphometric analysis of immunofluorescent-stained sections for CYP1A1 demonstrated 
that within the alveolar septum, CYP1A1 expression area was generally localized to 
flattened cells morphologically suggestive of alveolar type I cells (Figure 9D). By using 
colocalization to sites of cytokeratins 8/18 expression to determine AT-II CYP1A1 
expression, it was demonstrated that most of the alveolar area expressing CYP1A1 is not 
occupied by AT-II cells.  This was not surprising because alveolar type I epithelial cells 
cover greater than 90% of the internal surface area of the lungs (Wang et al, 2002; 
Gonzalez and Dobbs, 1998) whereas type II epithelial cells account for less than 10% 
(Castranova et al, 1988). Moreover, it has been observed by in situ hybridization in the 
lungs of 3-methylcholanthere-induced rats that CYP1A1 labeling was visualized in other 
alveolar wall cells that could be either capillary endothelial cells or alveolar type I 
pneumocytes (Pairon et al, 1994).  An overall reduction of CYP1A1 expression within 
the alveolar septum was observed in BNF-induced rats exposed to 20 mg and 40 mg 
CD/rat compared to those exposed to BNF induction and saline. These results were 
consistent with EROD activity, suggesting that both CYP1A1 protein expression in the 
alveolus and its metabolic function throughout the lung are suppressed by CD exposure. 
Localization of CYP1A1 in terminal non-ciliated bronchiolar epithelial (Clara) cells was 
also investigated because Clara cells are considered the major area of CYP1A1 
expression in lungs since they are rich in agranular endoplasmic reticulum (Plopper, 
1983) where CYP1A1 is localized. The number of CYP1A1-positive cells was counted 
per micrometer of the basement membrane. This number did show a significant change in 
rats exposed to CD and BNF compared to the control. This result suggested that CD 
modified CYP1A1 expression at the alveolar rather than the bronchiolar level, 
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presumably because the CD particles tend to aggregate in alveolar regions adjacent to the 
alveolar duct.  
Previous morphometric studies demonstrated that the alveolar tissue represents 
87% of the total lung volume in rats where the volume of alveolar type I cells is more 
than twice that of alveolar type II cells (Carpo et al, 1983 and Perkinton, et al, 1982). 
Following lung injury at the alveolar level, the damage of type I pneumocytes is repaired 
by progenitor alveolar type II cells that can proliferate and regenerate the damaged 
alveolar surface and may differentiate into type I cells, thus reconstituting the alveolar 
architecture (Melloni et al, 1995; Wang et al, 2002). The hypertrophy and hyperplasia of 
AT-II cells were obvious in immunofluorescence (Figure 12B) and histopathology 
(Figure 7A). Despite the increasing numbers (hyperplasia) and size (hypertrophy) of AT-
II cells, AT-II cell-specific CYP1A1 expression decreased as many of these cells were 
devoid of detectable CYP1A1 (Figure 12B). This suggested that coal dust exposure was 
associated with the appearance of new populations of AT-II cells but that many of these 
cells did not contain detectable amounts of CYP1A1. A number of investigators have 
reported that CYP activities and the level of CYP apoproteins decreased after partial 
hepatectomy and regeneration of hepatic cells (Hino et al, 1974; Presta et al, 1980; 
Klinger and Karge, 1987; Ronis et al, 1992). The priority of hepatic cell function during 
regeneration is the key factor where the replication, but not the transcription, is the main 
function of DNA regenerating the cells (Liddle et al, 1989, Waxman, 1989, Morgan et al, 
1985, and Steer, 1995).  One possible explanation for our findings may be that like 
regenerating hepatocytes, AT-II cells during the hyperplasia and hypertrophy, are mainly 
devoted to proliferation and not to expressing CYP1A1. Consistent with that were the 
higher levels of CYP2B1 protein expression and mRNA in freshly isolated AT-II cells, 
but these levels diminished in the cell culture (Lag et al, 1996).  
 Histopathological changes assessed in stained sections showed that CD exposure 
enhanced the pulmonary inflammatory response (Figure 7B and 8). Lung inflammation 
was characterized by intra-alveolar and interstitial accumulation of macrophages and rare 
neutrophils. The dust-laden macrophages were enlarged and often aggregated in clumps 
of two or more cells. The alveolar inflammation was often centered around alveolar ducts 
where CD particles were deposited. These findings were consistent to those described by 
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Nikula et al, (1997). It has been demonstrated that the ability of the liver to metabolize 
drugs in rodents is impaired following inflammatory stimuli that are accompanied by a 
depletion of total hepatic CYP content and a declined microsomal metabolism of drug 
substrates (Ghezzi et al, 1986; Bissell and Hammaker, 1976). In other similar studies, the 
experimentally-induced inflammatory reactions resulted in a reduction of the microsomal 
CYP concentration and their metabolizing activity in the liver (Beck and whitehouse, 
1974; Mahu and Feldman 1984; Endo et al, 1981; Baer and Green, 1981). In addition, 
exposure of cultured hepatocytes to inflammatory stimuli decreased the total microsomal 
CYP, CYP-catalyzed enzyme activities, and levels of CYP proteins and mRNAs 
(Morgan, 1997). Although relatively little data describes the effect of inflammation on 
extrahepatic CYP expression and some evidence suggests that extrahepatic CYPs are 
likely to be differentially regulated by different inflammatory stimuli  (Morgan, 2001). 
The CD-induced pulmonary inflammation shown in our experiment was associated with 
suppression of pulmonary CYP1A1 induction and CYP2B1expression and activity in the 
rats. Studies of possible roles of pro-inflammatory mediators are underway. 
In conclusion, our data showed for the first time that CD exposure had a 
modifying effect on the BNF-induced CYP1A1 expression via altering its cell specific 
localization in rat lung. CD was able to suppress the activity and expression of CYP1A1 
as demonstrated by the dose-dependent reduction of EROD activity and diminution of 
CYP1A1 apoprotein measured by Western blot analysis. Not only was CYP1A1 
induction modified by CD exposure, but the activity of another CYP isoform, CYP2B1, 
was suppressed in a dose-dependent fashion. The overall results suggested that coal dust 
exposure was a complex modifier of the CYP1A1 induction in rat lungs and had the 
ability to trigger pulmonary inflammation and reduction of CYP1A1 induction and 
activity.  
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CHAPTER 4 
SUPPRESSION OF RABBIT PULMONARY CYP1A1 INDUCTION BY 
RESPIRABLE CRYSTALLINE SILICA 
ABSTRACT 
Silicosis is an inflammatory and fibrosing occupational lung disease which is also 
associated with increased risk of developing lung cancer. However, inflammation 
interferes with the biological activation of polycyclic aromatic hydrocarbon (PAH) 
procarcinogens to ultimate carcinogens by cytochrome P450 1A1 (CYP1A1). In addition, 
the carcinogenic effects of crystalline silica and cigarette smoke, which contains PAHs, 
are subadditive in some epidemiologic studies. Investigating the modifying effect of 
silicosis on PAH metabolism will facilitate interpretation of epidemiologic studies of 
mixed exposures to cigarette smoke and crystalline silica. We have, therefore, 
investigated the hypothesis that acute and chronic silicosis can modify PAH-induced 
pulmonary carcinogenesis by altering cell specific induction of pulmonary CYP1A1. 
Acute or chronic silicosis were induced in male New Zealand White rabbits by 
intratracheal instillation of 300 mg respirable crystalline silica 2 weeks or 1 year prior to 
sacrifice, respectively. Chronic silicosis was principally localized to one side of the lung 
to minimize the signs of respiratory diseases. Control rabbits received intratracheal 
instillation of saline. CYP1A1 was induced in all exposure groups by intraperitoneal 
injection of beta-naphthofalvone (BNF, 80mg/kg IP) 2 and 3 days prior to sacrifice. 
CYP1A1 function as assessed by 7-ethoxyresorufin-O-deethylase (EROD) activity was 
significantly lower in BNF-exposed rabbits with acute (p=0.01) or chronic (p=0.02) 
silicosis than in rabbits receiving BNF alone. By Western blot, CYP1A1 protein was 
significantly reduced in acute (p=0.02) but not chronic silicosis. Cell specific expression 
of CYP1A1 was assessed in sections of lung by immunofluorescent double labeling for 
CYP1A1 and cytokeratins 8/18, cytoskeletal proteins expressed in Alveolar type II (AT-
II) and airway epithelial cells. In the alveolus, total septal expression of CYP1A1 per unit 
area was decreased in both acute and chronic silicosis. In terminal bronchioles, both acute 
and chronic silicosis resulted in a decrease in the number of Clara cells expressing 
CYP1A1 per mm basement membrane. These results suggest that silicosis suppresses the 
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induction of CYP1A1 activity and alters the alveolar and bronchiolar cellular expression 
of CYP1A1 in rabbits. 
INTRODUCTION 
 CYP1A1 is the microsomal enzyme responsible for the bioactivation of pro-
carcinogenic compounds such as benzo[a]pyerene, producing biologically active 
intermediates that bind to the DNA to produce adducts and lung cancer (Gelboin, 1980; 
Crepsi et al, 1989; Shimada et al, 1989; Anttila et al, 1991; Eaton et al, 1995). CYP1A1 
is associated with the endoplasmic reticulum of many cells, particularly those of 
xenobiotic-metabolizing organs such as liver and lungs (Anttila et al, 1991). It is well 
known that CYP1A1 is induced via an aryl hydrocarbon receptor (AhR)-ligand binding 
mechanism. The binding of a ligand, such as a PAH, causes dissociation of a 90-KDa 
heat-shock protein (Hsp90) and other cytoplasmic factors such as the AhR-interacting 
protein (AIP) (Ma and Whitlock, 1997) from the AhR in the cytoplasm, which leads to 
translocation of the AhR to the nucleus where it dimerizes with another structurally 
related protein, AhR nuclear translocator (Arnt). This heterodimer binds to the xenobiotic 
responsive element (XRE) in the regulatory region of the CYP1A1 gene initiating its 
expression and induction (Takahashi et al, 1996; Abbot et al, 1999; Ke et al, 2001; 
Hayashi et a., 1994).  The promoter region of CYP1A1 assumes a particular nucleosomal 
configuration in un-induced cells that could explain its barely detectable constitutive 
expression (Morgan and Whitlock, 1992; Whitlock, 1999). Upon induction, the CYP1A1 
promoter undergoes a change in chromatin structure and loss of the nucleosomal 
configuration that facilitates the attachment of promoter-binding proteins (Wu and 
Whitlock, 1992).  The changes in the chromatin structure and configuration at the 
CYP1A1 promoter area are AhR-dependent and Arnt-dependent processes (Whitlock, 
1999).          
 Silicosis is an occupational lung disease resulting from exposure to the crystalline 
form of the mineral silicon dioxide or silica (Driscoll and Guthrie, 1997). Silicosis is 
characterized by inflammation and fibrosis in the lower respiratory tract. Because silica is 
one of the most abundant minerals in the earth’s crust, there are significant opportunities 
for exposure particularly in occupations or activities involving cutting, shaping, or 
polishing of rock. The increase in silicosis during the past years is mainly attributed to the 
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development of tools and processes that generate high concentrations of fine particles 
(<10µm in diameter), which are able to penetrate into the deep lung tissues, and elicit 
their toxic effects (Craighead et al, 1998; Castranova et al, 1996; Peters 1986). 
Crystalline silica is toxic to a wide range of animal species including humans (Holland, 
1990; Saffiotti and Stinson, 1988; Green and Vallyathan, 1995). In humans, there are 
different forms of silica-induced lung disease differentiated according to the nature and 
progression of the lung pathology (Driscoll and Guthrie, 1997).  Radiologically, simple 
and progressive massive fibrosis can be identified. Simple silicosis is characterized by the 
presence of small opacities (silicotic nodules) (Ziskind et al, 1986; Seaton, 1984) with a 
diameter of less than 10 mm (Weissman and Wagner, 2001) without respiratory 
impairment unless accompanied by tuberculosis (Snider, 1978; Craighead et al, 1988). 
Simple silicosis may develop into progressive massive fibrosis (PMF) when congregation 
of these silicotic nodules occurs followed by destruction of lung tissue and a significant 
disturbance in lung function (Snider, 1978). Different types of silicosis are recognized; 
chronic, accelerated, and acute silicosis (Weissman and Wagner, 2002). The occurrence 
and development of these forms is determined by the amount of exposure and the total 
cumulative silica inhalation (Green and Vallyathan, 1995; Ziskind et al, 1986; Seaton, 
1984). Chronic silicosis is characterized by the appearance of simple silicotic nodules 10-
30 years post exposure (Weissman and Wagner, 2002) because it usually progresses very 
slowly. However, in some cases, nodules may congregate to form PMF (Weissman and 
Wagner, 2001). Accelerated silicosis, which develops in less than 10 years after exposure 
to silica (Weissman and Wagner, 2002), is accompanied by a rapid progression to PMF, 
severe lung dysfunction, and is life threatening (Ziskind, 1986; Seaton, 1984). Acute 
silicosis, on the other hand, is the form that develops very rapidly [a few weeks to 5 years 
post exposure (Weissman and Wagner, 2002)] after exposure to high concentrations of 
silica and is associated with severe alveolar and interstitial inflammation, alveolar 
proteinosis, and rapid respiratory failure (Driscoll and Guthrie, 1997).  
 In a recent study by Cocco and co-workers, (Cocco et al, 2001) who worked with 
modifications of silica-associated lung cancer by other workplace lung carcinogens, lung 
cancer risk in miners exposed to respirable silica alone was higher than those exposed to 
silica and PAH. The effect of crystalline silica exposure on the CYP1A1- mediated 
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metabolism of pulmonary chemical carcinogens, such as those in cigarette smoke is 
unclear.  Addressing this effect is biologically important because many chemical 
carcinogens, such as PAHs in cigarette smoke are metabolized in the lung by CYP1A1 
enzyme systems to produce more active carcinogens (Crepsi et al, 1989; Shimada et al, 
1989; Eaton et al, 1995) that may result in an increased risk of developing lung cancer.  
Recent studies from our laboratory suggest that silicosis decreases the activity of 
CYP1A1-dependent enzymatic activity, 7-ethoxyresorufin-O-deethylase (EROD), in the 
lungs of rats exposed to a potent CYP1A1 inducer, beta-naphthoflavone (Battelli et al., 
1999). Cell specific studies on CYP1A1 expression and localization showed that silicosis 
led to the appearance of a new population of hypertrophied and hyperplastic alveolar 
epithelial cells without immunohistochemically detectable CYP1A1 or CYP2B1 (Levy et 
al, 1995; Battelli et al, 1999).  
 However, a debate concerning the species differences between rats and humans 
regarding their response to inhaled particles has emerged (Mauderly, 1997). Moreover, 
the pattern of particle retention as well as the lung tissue response to respirable particles 
in rats may not be predictive of those of primates who are exposed to poorly soluble 
particles particularly at high occupational exposures (Nikula et al, 1997). Such debates 
necessitate the need for investigating the effect of respirable crystalline silica on the 
induction of the carcinogen-activating system, CYP1A1, in the lung by conducting a 
study on a non-rodent model. Rabbits were used to investigate our hypothesis because a 
model of rabbit silicosis has been previously established (Dale, 1973a; 1973b; Wallace et 
al, 2002). Moreover, a high degree of homology between rabbits and human has been 
reported regarding the critical proteins involved in CYP1A1 induction process, such as 
the AhR and Arnt. (Takahashi et al, 1996).  Based upon the homology studies of AhR 
and Arnt between rabbit and human, and the existence of a rabbit model of silicosis, the 
rabbits were a suitable non-rodent model to illustrate the effect of silicosis on the 
carcinogen-metabolizing enzymatic activity of CYP1A1.                                                                                  
In this study, we have investigated the hypothesis that acute and chronic silicosis 
can alter cell-specific induction of CYP1A1 in the lung, thus modifying the metabolism 
of carcinogenic polycyclic aromatic hydrocarbons in the lung. To avoid concerns about 
differences between human and rodent pulmonary responses to respirable particles, we 
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have investigated this hypothesis using a well-established rabbit model of silicosis 
Wallace et al, 2002). In this model, silicosis progresses with time to produce a fibrosing 
lung disease which occasionally includes silicotic nodules which are remarkably similar 
to the human silicotic nodules, the pathognomonic lesion of silicosis in man. By using a 
partially localized model of chronic silicosis, clinical disease was prevented which 
permitted maintenance of these rabbits for a year. A more generalized model of silicosis 
was used to model acute silicosis and was directly comparable to our previous rat 
studies. Because constitutive CYP1A1 expression is extremely low in both animals and 
man and because CYP1A1 activity is induced in people who smoke, CYP1A1 activity 
was induced in all rabbits in the study using the model polycyclic aromatic hydrocarbon, 
BNF. We have used antibodies to cytokeratins 8/18, proteins which are highly expressed 
in airway epithelium and AT-II cells to help localize sites of expression of CYPIA1 
within the deep lung by immunofluorescence and have found that alveolar expression of 
CYP1A1 is principally localized in cells that are not AT-II cells, that the area of cells 
expressing CYP1Al in the alveolus is reduced in both acute and chronic silicosis and 
that the number of CYP1A1 expressing Clara cells per mm basement membrane is 
reduced in both acute and chronic silicosis. Acute, but not chronic, silicosis caused 
statistically significant reductions in the amount of induced CYPIA1 as determined by 
Western blot. However, CYP1A1-dependent EROD activity induction was reduced by 
both acute and chronic silicosis. Our findings support the hypothesis that acute and 
chronic silicosis decrease CYP1Al induction and modify the cell-specific expression of 
CYP1A1 in the rabbit lung. 
MATERIALS AND METHODS 
Rabbit Treatment and Experimental Procedure 
Male New Zealand White rabbits (3-5 kg) were housed in the AAALAC-
approved Laboratory animal facility of Health Sciences Center of West Virginia 
University. They were fed commercial rabbit pellets and provided water ad libitum. All 
procedures were approved by WVU-ACUC under protocol number 9911-06. Ten of these 
rabbits were designated for chronic exposure and were exposed to a single dose of silica 
or saline using a predominantly unilateral model with lesser distribution to additional 
lobes according to a previously published procedure (Wallace et al, 2002). A year later, 7 
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additional rabbits were randomized into 2 groups, which were intratracheally exposed to 
silica or saline and kept for 2 weeks as a model of acute exposure (i.e. in the chronic 
model, rabbits were exposed once and kept for 380 days, while in the acute model, they 
were kept for only 2 weeks). In the acute model, both lung lobes (right and left) were 
diffusely exposed to silica to be comparable to previous rat studies.   All rabbits, in both 
acute and chronic models, were exposed to a single dose of crystalline silica suspension 
(300 mg/rabbit in saline). CYP1A1 was induced in all rabbits by intraperitoneal (IP) 
administration of 2 doses of BNF of 80mg/kg each suspended in sterile filtered corn oil 3 
and 2 days before sacrificing. 
Preparation of Silica for IT Instillation 
Silica particles (< 5 microns) were weighed into scintillation vials, autoclaved at 
23 PSI, 250 ºF, for 30 minutes on the dry cycle. Rabbits exposed to silica received 300 
milligrams of heat-sterilized silica particles suspended in 3.0 ml non-pyrogenic saline 
(0.9% sodium chloride, Abbott Laboratories, North Chicago, IL) and vortexed to achieve 
a uniformly distributed suspension before IT instillation. The silica suspension used in 
the study was endotoxin-free as shown by endotoxin analysis using the Limulus 
Amebocyte Lysate assay (BioWhittaker; Walkersville, MD) as previously described 
(Olenchock and Stephen, 1990; Porter et al, 1999). 
Intratracheal Instillation (IT) in Rabbits 
Rabbits were first weighed and anesthesized by intramuscular (IM) administration 
of ketamine hydrochloride (Ketaset, Fort Dodge, IA) 5 mg/kg and xylazine hydrochloride 
(Rompun, Bayer Pharma, West Haven, CT) 100 mg/kg. After induction of anesthesia, 
which was marked by absence of palpebral reflex, an endotracheal tube of 3.0 mm 
external diameter was placed into the trachea under the guidance of a laryngoscope 
(Anesthesia Medical Specialties, Inc., Santa Fe Spring, CA) that was inserted through the 
mouth until the arytenoid cartilages were visualized. The presence of the endotracheal 
tube in the trachea was verified by feeling the expiratory air expelled out of its proximal 
tip.  A long polyethylene cannula with a 1.44 mm outer diameter (Becton Dickinson and 
Company, Sparks, MD) was passed through the lumen of the endotracheal tube into the 
trachea. A syringe containing saline or silica suspension was attached to the cannula and 
the plunger was slowly pressed down. For acute silicosis, the cannula was inserted to the 
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level of trachea and the rabbit was kept upright on the sternum. In chronic silicosis, the 
model was predominantly unilateral where the intubated rabbit was placed on its right 
side, the cannula was blindly inserted until it lodged in a bronchus, and then exposed 
(Wallace et al, 2002). The acute exposure method was directly comparable to rat 
intratracheal instillation. The chronic exposure method exposed both sides of the lung 
(Wallace et al, 2002), but because severe lesions were limited to one side of the lung, 
long-term humane maintenance of these rabbits was possible.  Because the technique for 
chronic exposure involves the blind passage of a cannula, the most affected lobes will not 
always be in the same site.  The advantage over bronchoscopy is less trauma, more rapid 
recovery from anesthesia, and involvement of many lobes in mild disease with the more 
severe lesions localized so that the rabbits remain healthy throughout the study but the 
disadvantage is that the localization of the more severe silicotic lesions varies. 
Necropsy 
Rabbits were humanely killed by intravenous injection of pentobarbital 
(Pentobarbital Sodium, Med-Pharmex, Inc., Pomona, CA) 1.5 ml/rabbit, followed 
exsanguination via the abdominal aorta.  The lungs and attached organs including 
tracheobronchial lymph nodes, thymus, heart, aorta, and esophagus were removed.  At 
necropsy, the right lung lobes were tied off, removed, and placed on ice for microsome 
preparation. The left lung lobes were inflated with 30 ml of 10% neutral buffer formalin 
(NBF) to prepare formalin fixed tissues for histopathology and immunofluorescence.  
The fixed tissues were trimmed later the same day, and processed on a Hypercenter XP 
tissue processor (Thermo Shandon, Pittsburgh, PA) over night.  The processed tissues 
were embedded in paraffin the following morning. Sections were routinely stained with 
hematoxylin and eosin (H&E) and with trichrome stain. In addition, five-micrometer-
thick sections were placed on Probe On PlusTm slides (Fischer Scientific, Pittsburgh, PA) 
for immunofluorescent double-labeling. In all rabbits, sampling for histopathology 
involves areas with obvious gross lesions. Due to the presence of silicotic nodules in the 
right lung lobes of two rabbits from the chronic silica-exposed group, the right lung lobes 
from these two rabbits containing the gross morphologic changes of silicosis were used 
for histopathologic examination, while the left lung lobes were used for microsome 
preparation. 
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Microsome Isolation 
All steps of microsomal preparation were carried out at -4ºC to avoid possible loss 
of microsomal activity.  Microsomes were prepared as previously described (Ma et al, 
2001; Flowers and Miles, 1991). Briefly, after necropsy, the right lung lobes (except for 
the 2 rabbits in the chronic exposure group where the left lung lobes were used) were 
weighed and chopped 4 times with a MacIlwain tissue chopper (Mickle Engineering Co., 
Gomshall, Surrey, UK) set at slice thickness of 0.5 mm.  The minced lung tissues were 
suspended in 4 times the lung weight of ice-cold incubation medium(1.9 mM 
KH2PO4,145 mM KCL, 30 mM Tris-HCL, 8.1 mM K2HPO4, and 3 mM Mg Cl2; pH 7.4) 
and homogenized by using a Teflon-glass Potter-Elvejhem homogenizer (Emerson, NJ) 
through 16 complete passes.  Differential centrifugation of the homogenate was used to 
obtain the microsomal pellets. First, the cell nuclei and debris were sedimented by 
centrifugation at 2500 rpm for 10 minutes in a Sorvall Model RC2-B refrigerated 
centrifuge (Ivan Sorvall Co., Northwalk, CT).  To reduce the mitochondrial 
contamination of the microsomes, Mitochondria were slowly sedimented by three 
sequential centrifugations at 5,000, 9,000, and 13,000 rpm for 20 minutes each.  To 
collect the microsomal pellets, the supernatant was ultra-centrifuged for 75 minutes at 
40,000 rpm in a Beckman Model L5-50 Ultracentrifuge (Beckman Instruments, Palo 
Alto, CA). The microsomal pellets were re-suspended in the incubation medium at a ratio 
equal to the original lung weight (1gm lung/ 1ml medium) and frozen at -80 ºC until use. 
Determination of the Total Lung Proteins 
The BCA (bicinchoninic acid) method was used to determine the protein content 
of lung microsomes as previously described (Ma et al, 2002; Smith et al, 1985) using the 
BCA protein assay kit (Pierce, Rockford, IL) and a spectra Max 250 Spectrophotometer 
(Molecular Devices Corporation, Sunnyvale, California). Bovine serum albumin 
was used as the standard. 
Western Blot Analysis 
The CYP1A1 protein in lung microsomes was determined by Western blot 
analysis as previously described (Ma et al, 2002). Briefly, 60 µg of the lung microsomal 
proteins, as measured by BCA method, were subjected to polyacrylamide gel 
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electrophoresis followed by electroblotting of the gel to a nitrocellulose membrane based 
on the manufacturer’s instruction (Invitrogen Corporation, Carlsbad, CA). The protein 
transferred to the nitrocellulose membrane was detected by overnight incubation with a 
polyclonal goat anti-rabbit CYP1A1 antibody (Oxford, Oxford, MI) at 4 ºC.  The 
membrane was then incubated with a donkey anti-goat IgG-HRP (horse radish 
peroxidase) conjugated secondary antibody (Santa Cruz Biotech. Inc., Santa Cruz, CA) 
for 1 hour at room temperature. Liver microsomes of a BNF-treated rat (Xenotech, 
Kansas city, KS) were used for a CYP1A1 positive control.  The ECL MW (molecular 
weight) marker (Invitrogen Life Technology, Carlsbad, CA) was used to determine the 
size of the CYP1A1 band. CYP1A1 protein bound to the membrane was detected by the 
enhanced chemiluminescence (ECL) method using the ECL detection reagent kit 
(Amersham, Piscataway, NJ). Super RX Fuji Medical X-ray film (Fuji Film Corp., LTD., 
Tokyo, Japan) was then exposed at room temperature to the membrane. The intensity of 
the bands on the X ray film was measured by the Strategen Eagle Eye II scanner (La 
Jolla, California) with Eagle Sight software. The density on the scanned images was 
measured using ImageQuant software version 5.1 (Molecular Dynamics, Sunnyvale, 
CA). Each sample was quantified three times to get the averages of the individual 
measurement, then the averages were used for statistical analyses. The Western blot 
results were expressed as a percentage of the CYP1A1 positive control. 
Measurement of the CYP1A1- and CYP2B4-Dependent Enzymatic Activities (EROD 
and PROD) 
Measurement of EROD and 7-pentoxyresorufin-O-deethylase (PROD) activities 
were conducted as previously described, using 150 and 300 µl of microsomal suspension 
(Ma, et al, 2002; Burke et al, 1985), respectively (suspension was prepared by adding an 
amount of buffer equal to original lung weight). PROD is a measure of CYP2B4 activity 
(Cawley et al, 2001). The CYP2B4 in rabbits is analogous to rat CYP2B1 (Oesch-
Bartlomowicz and Oesch, 2003). It is the major constitutively expressed CYP in rabbit 
lung but is present in very minute quantities in liver (Serabjit-Singh et al, 1979; 
Parandoosh et al, 1987).  A standard curve was made after each assay by using a standard 
solution of 2.35 µg of 7-ethoxyresorufin dissolved in 1 ml DMSO to get a 10 mM 
concentration. EROD and PROD activities were measured by a luminescence 
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spectrometer model LS-50 (Perkin-Elmer, Norwalk, CT) that measures the formation of 
fluorescent resorufin catalyzed by CYP1A1 or CYP2B4 activities. EROD and PROD 
activities were expressed as picomoles of the produced resorufin per minute per 
milligram microsomal protein (pmol/min/mg protein).   
Dual Immunofluorescence Technique for CYP1A1 and Cytokeratins 8/18 
The formalin-fixed paraffin-embedded sections of left lung lobe were used for 
double-label immunofluorescence.  Immunofluorescence was conducted to localize the 
CYP1A1 protein within alveolar and terminal non-ciliated bronchiolar cells (Clara). In 
addition, immunofluorescence identified alveolar type II (AT-II) cells by localizing the 
cytokeratins 8/18, which are cytoskeletal proteins expressed mainly in primitive epithelial 
cells such as AT-II  cells and airway epithelium.  The double-label Immunofluorescence 
was a two-day procedure. During the first day, the slides were heated and routinely 
deparaffinized in xylene and rehydrated in alcohol as previously described (Dey et al, 
1999). To maximize the antibody binding, the antigen was retrieved by using 0.01M 
disodium ethylenediamine tetraacetate (EDTA) (Fischer Scientific, Fair Lawn, New 
Jersey), pH 8.0.  Slides immersed in EDTA solution were heated for one minute and 45 
seconds on high in a microwave followed by 2 defrosting cycles of 6 minutes each.  
Tissue slides were blocked with a filtered [(Acrodisc syringe filter with 0.2 µm pore 
diameter (Pall Corporation, Ann Arbor, MI)], freshly prepared solution of 5 %  BSA (IgG 
free) (Sigma, St Louis, MO) in PBS (Ca++ and Mg++ free) (Sigma, St Louis, MO)  for 10 
minutes at room temperature (RT) to minimize the non-specific binding of the primary 
antibodies. Additional blocking was applied by dropping of 5% fresh pig serum 
(Biomeda Corporation, Foster City, CA) in PBS on slides for 10 minutes at RT.  The 
slides were then rinsed and incubated with a primary antibody mixture with a final 
dilution of 1:50 of the polyclonal Guinea pig anti-cytokeratins 8/18 antibody (Research 
Diagnostic Inc., Flanders, NJ) and the polyclonal goat anti-rabbit CYP1A1 antibody 
(Oxford biomedical Research, Inc., Oxford, MI).  The primary antibody mixture was 
applied by holding the slides in pairs in a microprobe holder (Fischer Scientific, Fair 
Lawn, NJ) and allowing the capillary action between each pair to pull the mixture onto 
the slides. The microprobe holder carrying slides was placed in a humidity chamber and 
incubated overnight at room temperature to allow binding of the primary antibodies to the 
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antigen (CYP1A1 and Cytokeratins 8/18).  On the second day, the humidity chamber 
containing the microprobe holder was incubated in the oven at 37 ºC for 2 hours. The 
excess and unconjugated primary antibodies were washed off by thorough rinsing with 
distilled water. Then, a mixture of the secondary antibodies was applied by dropping on 
the slides. The mixture was produced by equal volumes of  a polyclonal FITC-conjugated 
donkey anti-Guinea pig antibody (Research Diagnostic Inc.) at a dilution of 1:50 with 
PBS, and Alexa 594-conjugated rabbit anti-goat antibody (Molecular probes, Eugene, 
OR) for CYP1A1, diluted 1:20 with PBS. Before application, the mixture was 
centrifuged for 5 minutes at 2000 rpm and the supernatant dropped onto the slides, and 
the slides were incubated for 2 hours at RT in the dark.  After rinsing the slides, cover 
slips were applied using gel mount (Biomeda Corp., Foster City, CA) and slides were 
allowed to dry for 2 hours. For the negative control, the same procedure was applied 
except that the primary antibodies were replaced by rabbit serum (BioGenex, San Ramon, 
CA). 
Slides were examined using a fluorescent photomicroscope (OlympusAX70, 
Olympus American Inc., Lake Success, NY) and images were captured using the 40x 
objective and a Quantix cooled digital camera (Photometrics, Tucson, AZ) with QED 
camera plugin software (QED Imaging, Inc., Pittsburgh, PA). Fifteen images were 
captured per slide; five of which were taken from proximal alveolar (PA) regions located 
adjacent to the alveolar duct where most of the silica particles tend to accumulate 
(Warheit, 1989). The purpose of these samples was to assure that images were captured 
from representative alveolar regions with silica deposition. Another five images were 
obtained from random alveolar (RA) regions where no visible alveolar ducts are located. 
An additional five images were obtained from the terminal bronchioles which are lined 
by non-ciliated bronchiolar epithelial (Clara) cells. Since normal alveolar structure 
granulomas and nodular fibrosis, areas showing granulomas and nodular fibrosis were 
avoided during capture of images. The exposure settings of the digital camera were held 
constant for during capture of images from all slides.  For green fluorescence, a FITC 
filter cube with an excitation wave length of 460-500nm was used. For red fluorescence, 
a Texas Red filter cube with an  excitation wave length of 432.5-487.5nm was used. 
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Morphometric Analysis 
A specific software program (MetaMorph Universal Imaging Corp., 
Downingtown, PA) was employed to quantify and measure the area in µm2 of the red 
fluorescence that represents CYP1A1 protein and the green fluorescence that represents 
cytokeratins 8/18. Morphometric analysis was conducted on digital images captured 
using a 40x objective producing a microscopic field with an area of 34466.1 µm2.  The 
threshold range for positive red or green fluorescence was constant throughout the 
analysis process of all images.  These thresholds were selected to measure the area 
occupied by cells expressing green fluorescence in the cytoplasm (which in the alveolus 
indicates AT-II cells), the area of cells demonstrating red fluorescent labeling of 
CYP1A1 in the alveolar septum, and the co-localization of these proteins.  The 
morphometric analysis quantified the following: 
A-Quantification of CYP1A1 Expression in Alveolar Cells that are not AT-II Cells: 
We have designated the alveolar cells without cytokeratins 8/18 expression as 
alveolar non-type II (NT-II) cells. These cells are identified by their low affinity for 
cytokeratins 8/18 staining, which is specific for primitive epithelial cells such as airway 
epithelium and AT-II cells (Kasper, 1993). In the double labeled sections, cells 
expressing CYP1A1 fluoresce red. By morphometric analysis, the percent of CYP1A1 
that is not concomitantly stained with cytokeratins 8/18; that is the percent of area of 
CYP1A1 expression in NT-II cells was estimated. To calculate the area of CYP1A1 
expressed within NT-II cells, we multiplied this percent by the total red (CYP1A1) area 
within alveolar septum.  The resulting area was expressed in µm2. 
B-Quantification of CYP1A1 Expression in AT-II: 
By the aid of morphometric analysis, the CYP1A1 co-expression (co-localization) 
in AT-II was quantified. Colocalization means concomitant expression of CYP1A1 and 
cytokeratins 8/18 in AT-II. Two estimates were obtained to express this co-localization in 
AT-II cells: 
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1-The Area of CYP1A1 Colocalized to Cytokeratins 8/18:   
This area was estimated, in a similar way as in alveolar non-type (NT-II) cells, by 
multiplying the percentage of CYP1A1 that concurrently stained with cytokeratins 8/18 
by the total septal expression of CYP1A1. This area was expressed in µm2. 
2- The Proportional CYP1A1 Expression in AT-II Cells 
Proportional CYP1A1 expression is a ratio of the area of CYP1A1 expressed in 
AT-II to the total area of AT-II cells. This calculation was necessary because respirable 
particles often cause AT-II cell hyperplasia in the lung. Thus the proportional CYP1A1 
expression in AT-II cells corrects for increases in CYP1A1 in AT-II cells resulting from 
simple increase in the number and area of lung occupied by AT-II cells. This fraction was 
calculated from the following formula: 
                                           F = P x R  where; 
                                                     G  
F= proportional CYP1A1 expression in AT-II 
P= percentage of CYP1A1 colocalized to cytokeratins 8/18 (estimated by morphometry) 
R= red area (total) of CYP1A1 in alveolar septum (measured by morphometry) 
G= green area (total) of AT-II in alveolar septum (quantified by morphometry) 
C-Determination of AT-II Cell Hypertrophy and Hyperplasia: 
AT-II cell hypertrophy and hyperplasia were quantified by measuring the total 
area of green fluorescence in the alveolar septum expressed in each 40x field (34466.1 
µm2).  
D-Determination of CYP1A1 Pattern of Expression in Clara Cells 
The non-ciliated terminal bronchiolar (Clara) cells that stained positively for 
CYP1A1 (red) were counted per micrometer of the basement membrane. Morphometric 
settings helped standardize detection of positive cells consistently to avoid false positive 
or false negative results.  Therefore, this morphometric analysis provided a direct way to 
determine the effect of silica particle exposure on the expression pattern of CYP1A1 in 
AT-II cells, non-AT-II, and Clara cells. 
 Immunofluorescence analysis was used to compare the cell-specific localization 
of CYP1A1 in silica and BNF-exposed groups versus the control (BNF only) group.  
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Within the alveolus, cell-specific CYP1A1 has been compared in the PA regions (which 
are exposed to more silica) and the RA regions (which are random alveolar samples, and 
thus receive variable and lower silica exposure).  
Histopathology: 
Tissue sections from control and silica-exposed lungs were routinely stained with 
hemotoxylin and eosin (H&E) for histopathology. The stained slides were examined and 
interpreted by a board-certified veterinary pathologist while blinded to the exposure 
status of the individual rabbit. The changes of interest to be evaluated were: alveolitis 
(inflammation), AT-II cells hyperplasia and hypertrophy, and hyperplasia of bronchus 
associated lymph tissue. The histopathologic changes were converted to quantitative 
scores based upon the severity and distribution of the morphologic changes as previously 
described (Hubbs et al, 1997). The pathology score for each slide is the sum of the 
severity and distribution scores and the pathology score for each lung is the mean 
pathology score for each slide from that lung (Table 1). 
Table 1. Scoring system for histopathological changes caused by exposure of rabbit lungs 
to silica. 
Score Severity Distribution 
0 None None 
1 Minimal Focal 
2 Mild Locally extensive 
3 Moderate Multifocal 
4 Marked Multifocal and coalescent 
5 Severe Severe 
 
Statistical Analyses 
All analyses were performed with SAS version 8.2 and using Proc Mixed.  
Comparisons between saline treated and silica treated rabbits were performed using one-
way analyses of variance.  Comparisons of CYP1A1 immunostaining between cell types, 
and comparisons between compartments within the alveoli were performed using a 2 
factor repeated measures analysis of variance (treatment by cell type and treatment by 
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compartment).  All pairwise comparisons were performed with Fisher’s LSD.  All results 
were considered statistically significant at p<0.05. 
RESULTS 
 Activities of CYP1A1 and CYP2B4 
EROD (indicator of CYP1A1-dependent enzymatic activity) measured as 
pmol/min/mg of microsomal proteins was significantly reduced in rabbits with acute 
(p=0.011) and chronic silicosis (p=0.0453) exposed to BNF compared to rabbits exposed 
to BNF alone (Figure 1A and B, respectively). Acute exposure to silica particulates 
significantly lowered (p=0.0099) the PROD activity (Figure1C) while chronic exposure 
failed to induce any effect on the CYP2B4-dependent enzymatic activity (Figure 1D). 
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Figure 1. Effect of silicosis on EROD and PROD activities. EROD and PROD activities 
are expressed as pmol/min/mg protein. Acute silicosis significantly suppresses the BNF-
induced-EROD (A) and PROD (C) activity. Chronic silicosis inhibits EROD activity (B) 
and does not have any effect on PROD activity (D). * indicates significant difference 
from control (rabbits received BNF alone) at p<0.05. 
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Western Blot Analysis 
Western blot analysis demonstrated a reduction, albeit not significant, in CYP1A1 
protein in the lungs of BNF-treated rabbits with acute silicosis when compared to the 
lungs of rabbits exposed to BNF alone (Figure 2A and B). In chronic silicosis, no change 
was observed (Figure 3A and B). 
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Figure 2. Western blot analysis of CYP1A1 in lung microsomes of rabbits with acute 
silicosis. 60 µg of microsomal protein were subjected to SDS gel electrophoresis using 
Tris-glycine SDS running buffer and blotted to nitrocellulose membrane.  The 
membranes were probed with goat anti-rabbit CYP1A1 antibody overnight at 4 ºC. then 
donkey anti-goat IgG-HRP was used to visualize the bands. In A, Lane 1 is a positive 
control, while lane 12 is the molecular weight standard. Lanes 3, 4, and 5 are controls 
(acute saline/BNF), whereas lanes 7, 8, 9 and 10 are acute silica/BNF. Lanes 2 and 6 are 
empty. In B, the data expressed as the percentage of positive CYP1A1 control resulted 
from quantifying of western blot of control and silica treated rabbits.  
A                               B                                       
                                                                                      
 
Figure 3. Western blot analysis of CYP1A1 in lung microsomes of rabbits exposed to 
chronic silicosis.  Lane 1 is a positive control, while lane 14 is the molecular weight 
(MW) standard. Lanes 3, 4, 5, 6, 7 are control (chronic saline/BNF), while lanes 9, 10, 
11, 12, and 13 are chronic silica/BNF. Lanes 2 and 8 are empty. In B, the Western 
analysis data were quantified and expressed as the percentage of positive CYP1A1 
control. No significant change of CYP1A1 protein expression was observed in chronic 
silicosis (silica/BNF) exposure versus control (saline/BNF). 
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Dual Immunofluorescence for CYP1A1 and Cytokeratins 8/18 
A- General Distribution of CYP1A1 in the Rabbit Alveolus 
 AT-II (AT-II) cells were identified as green fluorescent (due to the markers, 
cytokeratins 8/18) plump cells localized at the corners of the alveoli, whereas NT-II cells 
were visualized as flattened cells without green fluorescence occupying the majority of 
alveolar septum using immunofluorescence visualization and a narrow beam FITC filter 
cube for excitation. Cells expressing CYP1A1 fluoresced red using a Texas Red filter 
cube for excitation. Superimposition of the red and green fluorescent images permitted 
determination of where CYP1A1 was expressed in the same sites as cytokeratins 8/18 
(Figure 4).  
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Quantification of CYP1A1 by morphometric analysis of proximal alveolar (PA) 
regions revealed its cell specific expression and localization within the alveolus. The area 
of CYP1A1 expression within AT-II cells was significantly lower than that of NT-II cells 
in all groups (acute saline/BNF, acute silica/BNF, chronic saline/BNF, and chronic 
silica/BNF groups) with p values 0.0001, <0.0001, 0.0006, and 0.0171, respectively 
(Figure 5A and C and Figure 6A and C, respectively). A similar pattern of expression has 
been found in random alveolar (RA) regions  where area of AT-II cells expressing 
CYP1A1 is significantly lower than NT-II cells in all groups with p values 0.0097, < 
0.0001, 0.0045, and <0.0001, respectively (Figure 5B and D and Figure 6A and D).  
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Figure 5. Morphometric quantification analysis of CYP1A1 immunofluorecence in AT-II 
cells versus NT-II cells of PA and RA regions BNF-treated rabbits acutely exposed to 
saline or silica. The area of CYP1A1 expression within these cells is expressed in square 
micrometer. * indicates significant difference from area of CYP1A1 expression in NT-II 
cells at P<0.05. 
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Figure 6. Morphometric quantification analysis of CYP1A1 immunofluorescence in AT-
II cells versus NT-II cells of PA and RA regions BNF-treated rabbits chronically exposed 
to saline or silica. The area of CYP1A1 expression within these cells is expressed in 
square micrometer. * indicates significant difference from area of CYP1A1 expression in 
NT-II cells at P<0.05. 
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B- Effect of Acute and Chronic Silicosis on CYP1A1 Expression by NT-II Cells in PA 
and RA Regions.  
In immunofluorescent-stained slides, the area of CYP1A1 expression quantified 
by morphometric analysis within NT-II cells of the PA regions was significantly reduced 
in rabbits acutely exposed to silica and BNF when compared to the control saline/BNF 
(p=0.0005). The area of CYP1A1 expression within NT-II cells of RA regions of rabbits 
acutely exposed to silica and BNF did not show a significant change compared to the 
control saline/BNF (Figure 7A).  A comparison of CYP1A1 expression within NT-II 
cells in the PA versus the RA regions indicated a significant reduction in the PA regions 
of  rabbits acutely exposed to silica and BNF compared to the RA regions (p=0.0006) 
(Figure 7A). 
In rabbits with chronic silicosis and BNF, the area of CYP1A1 expression 
quantified by morphometric analysis within NT-II cells of the PA regions was 
significantly reduced when compared to control saline/BNF (p=0.0066) (Figure 7B). 
However, the area of CYP1A1 expression within NT-II cells of RA regions of rabbits 
chronically exposed to silica and BNF did not show a significant change compared to the 
control saline/BNF. A comparison of CYP1A1 expression within NT-II cells in the PA 
versus the RA regions indicated a significant reduction in the PA regions of rabbits 
chronically exposed to silica and BNF compared to RA regions (p=0.0243) (Figure 7B). 
Results of CYP1A1 expression in NT-II cells are summarized in Table 2. 
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Figure 7. Morphometric quantification analysis of area of CYP1A1 expression measured 
in µm2 within NT-II cells of the PA regions and RA regions in acute and chronic 
silicosis. In A, the area of CYP1A1 expression within NT-II cells of the PA regions is 
significantly lower in rabbits acutely exposed to silica and BNF than the control 
saline/BNF (indicated by a above the bar). Also, the area of CYP1A1 expression within 
NT-II cells of the PA regions is significantly lower than the RA regions in rabbits acutely 
exposed to silica and BNF (indicated by b above the bar).  In B, the area of CYP1A1 
expression within NT-II cells of the PA regions is significantly lower in rabbits 
chronically exposed to silica and BNF than the control saline/BNF (indicated by c above 
the bar). Also, the area of CYP1A1 expression within NT-II cells of the PA regions is 
significantly lower than the RA regions in rabbits chronically exposed to silica and BNF 
(indicated by d above the bar). In RA regions, no significant change is observed between 
acute and chronic silica with BNF compared to the control (saline/BNF). The letters a, b, 
c, and d indicate significant difference at <0.05. 
 
Table 2. Effect of silica exposure on CYP1A1 expression in NT-II cells of rabbit 
alveoli.  
 
Exposure    PA regions (µm2) RA regions (µm2) 
Acute saline with BNF 327.068 ± 42.257  359.223 ± 110.968 
Acute silica with BNF 44.417   ± 5.212a,b 454.661 ± 45.39 
Chronic saline with BNF 528.445 ± 121.904 261.624 ± 76.238 
Chronic silica with BNF 74.385   ± 26.452c,d 382.002 ± 61.984 
 
Values represent means ± SE, (n=3-5).  
Superscript a indicates significant difference from acute saline with BNF of PA regions at 
p<0.05. 
Superscript b indicates significant difference from acute silica with BNF of RA regions at 
p<0.05. 
Superscript c indicates significant difference from chronic saline with BNF of PA regions 
at p<0.05. 
Superscript d indicates significant difference from chronic silica with BNF of RA regions 
at p<0.05. 
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C- Effect of Silica Exposure on CYP1A1 Expression in AT-II  
1- Proportional CYP1A1 Expression in AT-II Cells 
The proportional expression of CYP1A1 in AT-II cells was calculated by a 
formula described in the Materials and Methods and measures expression of CYP1A1 in 
AT-II cells corrected for increases in AT-II area. In acute silicosis with BNF, the 
proportional CYP1A1 expression in AT-II cells of PA regions was significantly lower 
(p=0.0293) than control saline with BNF (Figure 9A). Although, in rabbits exposed to 
acute silica and BNF, the proportional CYP1A1 expression in AT-II cells of PA regions 
was lower than that of RA regions (Figure 9A, Table 3), this reduction was not 
statistically significant.   
 In chronic silicosis (chronic silica/BNF), by contrast, the proportional CYP1A1 
expression in AT-II cells of the PA regions was not statistically distinguishable from 
expression in the PA regions of the control saline/BNF but significantly lower than 
expression in the RA regions of chronic silicosis/BNF (Figures 9B, Table 3). 
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Figure 9. Morphometric analysis of proportional CYP1A1 expression in AT-II cells in 
immunofluorescent-stained sections of rabbit lungs with acute and chronic silicosis. In A, 
the proportional CYP1A1 expression within AT-II cells of PA regions is significantly 
reduced in acute silicosis/BNF compared to control saline/BNF (as designated by the 
letter a above the bar). In B, the proportional CYP1A1 expression within AT-II cells of 
PA regions of chronic silicosis/BNF is significantly reduced compared to RA regions (as 
designated by the letter b above the bar), but no significant change is observed when 
compared to control saline/BNF. Values are means ± SE. The letters a and b indicate 
significant difference at <0.05. 
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Table 3. Effect of acute and chronic silicosis on proportional CYP1A1 expression in 
AT-II cells of rabbit alveoli. 
 
Exposure    PA regions RA regions 
Acute saline with BNF 0.0295±  0.0100 0.0148   ± 0.00622 
Acute silica with BNF 0.00399 ±  0.000888a 0.0583   ± 0.0292 
Chronic saline with BNF 0.208     ±  0.19 0.0392   ± 0.0241 
Chronic silica with BNF 0.00618 ±  0.00285b 0.0524   ± 0.0193 
 
Values are presented as means and SE 
a indicates significant difference from acute saline with BNF in PA regions at p<0.05. 
b indicates significant difference from chronic silicosis with BNF in the RA regions at 
p<0.05 
 
2- Area of CYP1A1 Colocalized (Co-Expressed) to Cytokeratins 8/18 
The area of CYP1A1 concomitantly expressed (colocalized) with cytokeratins 
8/18 per unit area of AT-II cells of PA regions was decreased and bordered ion statistical 
significance (p=0.0507) in rabbits acutely exposed to silica and BNF compared to control 
rabbits (acute saline/BNF exposure) (Figures 10A and 11, Table 4). This area was 
significantly reduced when compared to RA regions of rabbits exposed to acute silica and 
BNF (p=0.0475) (Figure 10A, Table 4). In chronic silicosis with BNF, the area of 
CYP1A1 expression colocalized in AT-II cells was significantly decreased in the PA 
region and compared to the RA regions and was reduced, albeit not significantly 
compared to the control saline/BNF (Figure 10B, Table 4). In areas where granulomatous 
inflammation and silicotic nodules were localized, the positive CYP1A1 cells were 
completely absent (Figure 11C). These regions were not included in the morphometric 
quantification. 
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Figure 10. Morphometric quantification of area of CYP1A1 expression colocalized to 
cytokeratins 8/18 in BNF-induced rabbits affected with acute and chronic silicosis. In A, 
the letter a above the bar indicates that acute silicosis/BNF significantly reduced 
CYP1A1 co-localization area in the PA regions compared to that in the RA regions. In B, 
the letter b above the bar designates a significant reduction of CYP1A1 co-localization 
area in PA regions compared to RA regions in rabbit alveoli with chronic silicosis/BNF.  
a, b, and c indicate significant difference at p<0.05. 
 
Table 4. Effect of silicosis on CYP1A1 colocalization in AT-II cells. 
  
Exposure    PA regions (µm2) RA regions (µm2) 
Acute saline with BNF 9.8515± 3.5771 5.362   ±  4.558 
Acute silica with BNF 1.7618 ± 0.4897a 15.091 ± 5.002 
Chronic saline with BNF 7.578 ± 3.264 9.83     ± 4.569 
Chronic silica with BNF 3.776 ± 2.066b 18.733 ±  6.995 
 
Values represent means ± SE, (n=3-5).  
a indicates significant difference from acute silica with BNF of RA regions at p<0.05. 
b indicates significant difference from chronic silica with BNF of RA regions at p<0.05. 
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D-Effect of Silicosis on Total CYP1A1 Expression in the Alveolar Septum 
The total red-labeled area of CYP1A1 expression in the alveolar septum (both 
AT-II and NT-II cells) of PA regions showed a significant reduction in both acute and 
chronic silicosis compared to the control saline (p=0.0007; 0.0069, respectively) and that 
of the RA regions (p=0.0006; p=0.0219, respectively) (Figure 12A and B, Table 4).  
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Figure 12. Morphometric assessment of the total area of CYP1A1 expressed in all cells of 
the alveolar septum. In A, the letter a above the bar indicates that the area of CYP1A1 
expression in the alveolar septum of PA regions in acute silicosis/BNF is significantly 
lower than control (acute) saline/BNF. A b above the bar indicates that the area of 
CYP1A1 expression in the alveolar septum of PA regions in acute silicosis/BNF is 
significantly lower than that of RA regions. In B, the letter c above the bar indicates that 
the area of CYP1A1 expression in the alveolar septum of PA regions in chronic 
silicosis/BNF is significantly lower than control (chronic saline/BNF). A d above the bar 
indicates that the area of CYP1A1 expression in the alveolar septum of PA regions in 
chronic silicosis/BNF is significantly lower than that of RA regions. Values are means ± 
SE and significance level was set at p<0.05. 
 
Table 5. Effect of acute and chronic silicosis on total CYP1A1 expression in alveolar 
septal cells 
 
Exposure    PA regions ( Random alveolar regions 
Acute saline with BNF 336.92 ± 45.818 364.584 ± 111.134 
Acute silica with BNF 46.353 ± 5.466a,b 469.752 ± 49.67 
Chronic saline with BNF 536.023 ± 123.951 271.453 ± 80.366 
Chronic silica with BNF 78.161 ± 27.931c,d 400.735 ± 64.027 
 
Values are the means of expression area (µm2) ± SE (n=3-5) 
a indicates significant difference from PA regions of acute saline with BNF of at p<0.05. 
b indicate significant difference from RA regions of acute silica with BNF at p<0.05. 
c indicates significant difference from PA regions of chronic saline with BNF at p<0.05. 
d indicates significant difference from RA regions of chronic silica with BNF at p<0.05. 
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E- Silica Exposure Produced AT-II Cell Hypertrophy and Hyperplasia 
 Rabbit silicosis caused AT-II cell hyperplasia and hypertrophy, which was 
significant in chronic silicosis/BNF compared to control saline/BNF (p=0.046) (Figure 
13A and B). Since cytokeratins 8/18 was indicated by green immunofluorescence, AT-II 
hypertrophy and hyperplasia was indirectly calculated from the measurement of the total 
green fluorescent areas in the alveolar septum (Figure 11).  
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Figure 13. Morphometric analysis of immunofluorescent-stained sections showing the 
effect of rabbit silicosis on hypertrophy and hyperplasia of AT-II cells. The area of 
cytokeratins 8/18 is measured in square micrometer as indicator of type AT-II cell 
hyperplasia and hypertrophy. Values are means ± SE. * significantly different from 
chronic saline/BNF at p<0.05. 
 
F-Acute and Chronic Silicosis Significantly Decreased CYP1A1 Expression in the 
Terminal Non-Ciliated Bronchiolar (Clara) Cells: 
The number of CYP1A1 immunoreactive Clara cells exceeding the red 
fluorescent threshold for 1A1 expression was counted and standardized per micrometer 
of the basement membrane. Clara cells were identified as a group of adjacent columnar 
non-ciliated airway epithelial cells resting on the basement membrane of the terminal 
bronchioles which stain green with cytokeratins 8/18 (Figure 14). They were 
differentiated from the cuboidal AT-II cells, which are usually found in the alveolar 
septa, by their morphology and location. Both acute and chronic exposure of rabbits to 
silica resulted in a highly significant reduction of CYP1A1 positive Clara cells per µm 
basement membrane compared to control (p=0.0005, p=0.00057, respectively) (Figures 
14, 15).  
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Figure 14: Effect of silicosis on CYP1A1 expression in rabbit non-ciliated terminal 
bronchiolar (Clara) cells. In A, ** indicates a highly significant reduction of the number 
of CYP1A1-positive Clara cells in acute silicosis and BNF than the control saline and 
BNF (p<0.001). In B, ** indicates a highly significant reduction of the number of 
CYP1A1-positive Clara cells in chronic silicosis and BNF compared to the control saline 
and BNF (p<0.001). Values presented as mean ± SE. the significance level is set at 
p<0.001 
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Histopathological Changes  
 Tissue sections from control and silica-exposed rabbits were stained with 
hematoxylin and eosin (H & E) and the histopathological changes were assessed and 
scored (Figure 16). Histopathological changes include AT-II hyperplasia and 
hypertrophy, pulmonary inflammation which was mostly histiocytic and suppurative to 
necrogranulomatous bronchointerstitial pneumonia with thickening of the alveolar wall 
(Figure 17). Alveolar lipoproteinosis was one of the common findings in silica-exposed 
rabbit alveoli. In some rabbit lungs with silicosis, silicotic nodules appear as centrically 
arranged collagen fibers surrounding necrotic foci (Figure 17B). These histopathological 
changes were absent in the control rabbits (Figure 17 C). 
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Figure 16: Alveolitis and AT-II cell hyperplasia and hypertrophy scored in H & E-stained 
tissue sections. Both alveolitis and AT-II changes were significantly higher in rabbit 
alveoli acutely and chronically exposed to silica particulate compared to control. * and _           
indicate that in rabbits exposed to acute silicosis and BNF, alveolitis and AT-II changes 
are significantly different  from control (acute saline/BNF), respectively. a and b indicate 
that in rabbits exposed to chronic silicosis and BNF, alveolitis and AT-II changes are 
significantly different  from control (chronic saline/BNF), respectively. Results represent 
mean ± SE. All results are statistically significant at p<0.05.  
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A B
C Figure 17: Photomicrograph showing the 
histopathological changes in rabbit 
silicosis. In A, AT-II cell hyperplasia and 
thickening of the alveolar septum is 
significant compared to the control (C). 
In B, the silicotic nodule contains
concentrically arranged hyalinized 
collagen (black arrows) around an area of 
necrosis.  A and C are sections stained 
with hematoxylin and eosin (H & E). In 
B, sections are stained by trichrome stain.
Alveolar  
Macrophages 
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DISCUSSION 
This study investigates the modifying effect of silicosis on the polycyclic 
aromatic hydrocarbon-associated induction and cell-specific localization of CYP1A1 in 
the rabbit lung by exposure to silica.  The use of the rabbit as a non-rodent model for this 
particular study has several advantages.  First, rabbit and human AhR and Arnt, which 
are the 2 main proteins involved in CYP1A1 induction and gene expression, are highly 
conserved between these two species (Takahashi et al, 1996). Moreover, a recent study 
suggests that rabbit, as well as mouse,  are among the species with CYP1A1 that is 
comparable to human as determined by the inhibition of EROD activity in the lung 
microsomes of these species by the antiserum to human CYP1A (Bogaards, et al, 2000).  
Therefore, this suggests that the results of rabbit studies, particularly those investigating 
the modification and alteration of CYP1A1 expression by exposure to environmental 
toxicants could be comparable to the human response to these compounds. Second, the 
rabbit as a non-rodent model helps resolve the debate concerning the use of the rat, to 
investigate genetic and histopathological changes associated with particle exposures in 
human lungs.  Third, CYP1A1 is one of the major isoforms of CYP present in the lungs 
of rabbit (Daniels and Massey, 1992). Fourth, CYP1A1 occurs in an amount of 1 to 3% 
of total CYP in pulmonary microsomes prepared from untreated rabbits. However, 
intraperitoneal injection of BNF produces a several fold induction of the CYP1A1 with 
associated induction of EROD activity in rabbits (Serabjit-Sinh et al, 1983; Philpot et al, 
1985). For all these reasons, rabbits were selected to fulfill the objectives of our study. In 
our experiment, CYP1A1 was induced in rabbits by intraperitoneal (IP) injection of a 
representative polycyclic aromatic hydrocarbon, BNF, (80 mg/kg) in corn oil as 
previously determined (Mathews et al, 1985; Daniels and Massey 1992).  BNF induces 
CYP1A1 through a mechanism identical to the benzo(a)pyrene in cigarette smoke by 
binding the aryl hydrocarbon receptors (AhR) (Ma and Whitlock, 1997) resulting several 
fold increase in CYP1A1 content and EROD activity (Serabijt-Singh et al 1983; Philpot 
et al, 1985). 
Exposure to silica alone, without exposure to CYP1A1 inducers (such as BNF) 
has been associated with increased CYP1A1-metabolic activity, EROD, in rats (Miles et 
al, 1993, 1994). However, the effect of mixed exposure was not investigated in the 
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previous study. At least one epidemiological study of mixed exposure to silica and PAH 
concluded that lung cancer risk was higher among people exposed to silica than those 
exposed to silica and other lung carcinogens, such as PAH (Cocco et al, 2001).  This 
suggests that silicosis may modify PAH-associated carcinogenesis. Because, CYP1A1 
activity is associated with an increased risk of lung cancer in smokers (Anttila et al, 
2001) and because smokers have induced CYP1A1 (Alexandrov et al, 2002; Willey et al, 
1997), the effect of silicosis on CYP1A1 induction is important.  EROD is a reaction 
catalyzed in rabbits by CYP1A1 (Serabjit-Singh et al, 1979; Devereux et al, 1989).  Our 
data showed that CYP1A1-dependent EROD activity induction by BNF was significantly 
suppressed by acute and chronic silicosis (Figure 1A and B). 
To further investigate the effect of silica on BNF-induced CYP1A1 apoprotein 
induction in rabbit lungs, Western blot analysis of lung microsomes was conducted using 
goat anti-rabbit CYP1A1 antibody. We found a reduction of CYP1A1 protein in acute 
silicosis compared to control (Figure 2A and B). This result supports downregulation of 
the protein as well as activity by exposure to silica. In chronic silicosis, Western blot did 
not show any change in the CYP1A1 protein compared to control (Figure 3A and B) 
although the EROD activity was significantly reduced (Figure 1B). This observation 
suggests that silica exposure in rabbits downregulates the induced pulmonary CYP1A1 in 
a posttranscriptional process in which the enzyme protein is expressed, as shown in the 
Western blot, but not active as shown in the suppressed EROD activity. A similar result 
was obtained by Paton and Renton (1998) when they had a significant reduction of 
EROD activity of Hepa 1 cells upon addition of tumor necrosis factor alpha directly to 
the cell, while the Western blot CYP1A1 protein showed no change. It is also possible 
that EROD activity is more sensitive indicator of changes of changes in CYP1A1 than 
western blot. It is noteworthy to mention that chronic silicosis models was induced in 
rabbits by a more localized exposure procedure to prevent respiratory impairment, and 
accordingly, the acute and chronic models can not be compared to each other but each 
one can be compared to its control. However, taken together, these results suggest that 
exposure of rabbits to crystalline silica suppresses BNF-induced CYP1A1 activity. 
PROD activity was also measured as an indicator of CYP2B4 activity in the 
lungs. PROD is a specific indicator of the CYP2B4 activity (Cawley et al, 2001). The 
 
 
 
115
CYP2B4 in rabbits is the analog of rat CYP2B1 (Oesch-Bartlomowicz and Oesch, 2003) 
which is the major isoform of CYP in rodents (Martin et al, 1993). Similar to rat 
CYP2B1, rabbit CY2B4 is constitutively expressed in lung tissue in high levels and 
considered the major CYP isoform in rabbit lung, but present in very minute quantity in 
liver (Serabjit-Singh et al, 1979; Parandoosh et al, 1987). Statistically, PROD was 
significantly lowered in rabbits with acute silicosis and BNF compared to the control 
(Figure 1C). However, no significant change in PROD activity was observed in lung 
microsomes from chronic silicotic rabbits (Figure 1D) compared to control. The 
significant reduction of PROD activity in acute silicosis suggests that downregulation of 
CYP activity in acute silicosis involves multiple isoforms. 
In order to determine the pattern of CYP1A1 expression by different alveolar cells 
upon acute and chronic exposure to crystalline silica, cell-specific localization of 
CYP1A1 protein has been analyzed by double-labeling immunofluorescence.  The dual 
immunofluorescence includes a double staining of the CYP1A1 protein and cytokeratins 
8/18 proteins, which are cytoskeletal proteins expressed in primitive epithelial cells of the 
lungs, such as alveolar AT-II cells and used as markers for these cells (Kasper et al, 
1993). A characteristic pattern of CYP1A1 expression has been detected by 
morphometric analysis of immunofluorescence in rabbit alveoli. Apparently, the NT-II 
cells (all alveolar cells except type II) in PA regions and RA regions, which were 
identified as cytokeratins 8/18 negative alveolar cells, significantly express CYP1A1 
protein more than AT-II cells, which were identified by their plump shape, and protrusion 
into alveolar lumen and positive immunofluorescence for cytokeratins 8/18 (Figure 
4A&B, 5, and 6). That observation suggests that alveolar AT-II cells are not the major 
cell types involved in CYP1A1 expression in rabbit alveolus; other alveolar septal cells 
are responsible for more area of CYP1A1 protein expression. Our findings are consistent 
with those of Domin et al, 1986 who demonstrated that the majority of pulmonary 
CYP1A1 (isoform 6) in rabbit lungs is localized in cells other than AT-II cells, Clara 
cells, or the alveolar macrophage. In rabbits exposed to 2,3,7,8- tetrachlorodibenzo-p-
dioxin (TCDD), an inducer of CYP1A1, the immunopositive areas of CYP1A1 
expression in the interalveolar septa were the capillary endothelium, with a minimum 
labeling of type I and AT-II cells (Overby et al, 1992). On the contrary, rat CYP2B1 
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isoform has been localized and concentrated mainly within alveolar type I cells because 
the selective destruction of these cells by trialkylphosphothiolates resulted in a marked 
loss of the enzyme (Dinsdale and Verschoyle, 2001). 
Hyperplasia and hypertrophy of AT-II cells were evident in acute and chronic 
exposures, compared to control as shown by the increase in the area of green 
fluorescence for cytokeratins 8/18 per alveolar microscopic field in AT-II cells of the 
alveolar septum (Figure 13) and by the histopathological examination. These findings are 
in agreement with those of Miller et al (1990), who demonstrated approximately two fold 
increase in the number of AT-II cells following silica exposure. The increased number 
(hyperplasia) and size (hypertrophy) of alveolar AT-II cells were not associated with a 
parallel increase of CYP1A1 expression in these cells. Indeed, per unit area of alveolar 
AT-II cells, CYP1A1 expression (proportional CYP1A1 expression) was significantly 
decreased in acute silicosis compared to control saline (Figure 9).  This observation 
suggests that many of the hyperplastic and hypertrophic alveolar AT-II cells appearing in 
rabbit lungs following exposure to silica do not express detectable levels of CYP1A1. 
This result is consistent with a previous rat study in our laboratory, which demonstrated 
that intrapulmonary exposure to silica lead to appearance of new population of AT-II 
cells without a detectable amount of CYP1A1 protein expression (Battelli et al, 1999). 
The response of alveolar AT-II cells to silica exposure has been extensively studied 
because these cells perform many vital functions in the lungs and increase in response to 
dust exposure (Miles et al, 1993). AT-II cells play an important role in synthesis and 
secretion of surfactant (Castranova, 1988) which increases surface tension (Pattle, 1955; 
Clements, 1957) and protects lungs from potentially toxic respirable particles 
(Castranova et al, 1988, Wallace et al, 1985) while contributory to the pathogenicity of 
acute silicosis (Lesur et al, 1995). AT-II cells are also involved in repairing alveolar 
epithelium by their differentiation into alveolar type I cells (Miller et al, 1990; 
Castranova et al, 1988). The alveolar AT-II cell population of the lung has been found to 
be very sensitive to the deposition of toxicants in the distal lung, and respond in two 
major ways upon exposure. Damage to the type I alveolar epithelial cells stimulates AT-
II cell proliferation, which subsequently differentiate to repopulate the injured type I cells 
and reconstitute the alveolar architecture (Miller and Hook, 1990; Melloni et al, 1995; 
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Wang et al, 2002; Sutherland et al, 2001). The second portion of the AT-II cell 
population may become enlarged in size (hypertrophic) (Miller and Hook, 1990).  
Moreover, AT-II cells, being rich in endoplasmic reticulum (Baron and Kawabata, 1983) 
and CYP monooxygenase system, are generally believed to be involved in metabolism of 
foreign compounds (xenobiotics) (Devereux et al, 1979; Jones et al, 1983; Baron and 
Kawabata, 1983; Rabovsky et al, 1986). However in our study, we found that the major 
area of the alveolus containing induced CYP1A1 was not the AT-II cells. In our study, 
we found that these hypertrophied and hyperplastic AT-II cells are frequently devoid of 
detectable CYP1A1. In addition, in acute silicosis the proportional expression of 
CYP1A1 in AT-II cells is reduced.  
The mechanisms involved in the reduction of CYP1A1 expression in AT-II cells 
following silica-induced proliferation are incompletely investigated. However, the 
inverse relationship between AT-II cell hyperplasia and CYP expression that we have 
observed in vivo is consistent with in vitro findings from previous studies.  Lag et al 
(1996) concluded that an inverse relationship could exist between CYP2B1 apoenzyme 
expression and the proliferation level of AT-II cells. That conclusion was based upon the 
observation that CYP2B1 apoenzyme was lowest in alveolar AT-II cell cultures during 
the most active proliferative stage, which coincided with presence of largest proportions 
of cells in S-phase and highest proliferating cell nuclear antigen (PCNA) expression. 
Similarly, the CYP1A1-dependent enzymatic activity, EROD, was undetectable in 
proliferating cultures of mouse lung epithelial cells, but the level became detectable once 
cultures were confluent (Reiners et al, 1992). It was suggested that EROD expression 
was regulated as a function of the proliferative process of the cell culture. An inverse 
relationship between cellular proliferation and CYP expression was also suggested by the 
observation that proliferative regeneration of hepatic cells following partial hepatectomy 
was associated with lower P450s protein levels and activities than normal liver (Hino et 
al, 1974; Presta et al, 1980; Klinger and Karge, 1987; and Ronis et al, 1992).  It seems 
that hepatic cells are allocated to replication, rather than transcription, as a main function 
of DNA to proliferate and regenerate the cells after hepatectomy (Liddle et al, 1989, 
Waxman, 1989; Morgan et al, 1985; Steer, T.C. (1995). Similarly, alveolar AT-II cells 
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may repair the damaged alveolar epithelium by proliferating and regenerating the injured 
alveolar wall instead of expressing CYP1A1. 
A more detailed cell-specific localization and morphometric quantification 
demonstrated that the area of alveolar NT-II cells expressing CYP1A1 was significantly 
decreased in both acute and chronic silicosis compared to control and compared to the 
internal control regions (RA regions) where few silica particles deposited (Figure 7, 
Table 2). This finding suggested that silica exposure not only altered the induction of 
CYP1A1 expression in AT-II cells, but also affected the alveolar NT-II cells. The overall 
effect for the alveolus was significant reduction of the alveolar area expressing CYP1A1 
in the whole alveolar septum in acute and chronic silicosis in PA regions compared to 
control and to RA regions (Figure 12, Table 4).  
Clara cells are considered the predominant nonciliated cell type at the terminal 
bronchiolar epithelium (Widdicombe and Pack, 1982; Plopper, 1983). They serve as an 
important site for xenobiotic metabolism in the distal lung (Boyd, 1977; Boyd et al, 1978; 
Boyd et al, 1980).  For this reason, we counted the number of CYP1A1 positive staining 
cells and standardized that number per micrometer of the basement membrane. Rabbit 
silicosis, either acute or chronic, in BNF-treated rabbits significantly reduced the number 
of CYP1A1 immunoreactive Clara cells in the terminal bronchiolar regions compared to 
BNF treatment alone (Figure 14 and 15). This may contribute to the reduction in EROD 
activity in silicosis. 
The inflammatory effects of silica on rabbit alveoli have been demonstrated by 
assessing the histopathological changes. Both acute and chronic silicosis produced a 
significant pulmonary inflammation and AT-II hyperplasia and hypertrophy as shown in 
Figure 16. Previous studies on rat showed that the pulmonary reaction to the inhalation of 
crystalline silica resulted in lung damage, inflammation, and hypertrophy and hyperplasia 
of AT-II cells (Miller et al, 1986; Miller et al, 1990; Castranova et al, 2002). In our study, 
the positive CYP1A1 immunoreactive cells completely disappeared in areas with 
granulomatous inflammation associated with rabbit silicosis (Figure 11C). Although 
these regions were not quantified morphometrically because of the absence of normal 
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alveolar cell populations, they may also contribute to the total reduction of the CYP1A1 
activity measured by EROD assay by replacing normal parenchyma.  
A number of investigators studying the effect of the inflammatory response on 
hepatic CYP metabolic activity concluded that the acute inflammatory reaction caused by 
subcutaneous injection of turpentine (Kobusch et al, 1986), bacterial lipopolysaccharide 
(LPS) (Morgan, 1989) and viral and bacterial infection (El-Kadi and Du Souich, 1998) 
depressed the constitutive hepatic CYP. It was also suggested that the inhibition in the 
metabolism was attributed to the inflammation itself (or to its consequences) and not to 
the inflammatory agents (Parent et al, 1992). Previous studies by Ke and co-investigators 
(Ke et al, 2001) have demonstrated that the proinflammatory mediators, such as tumor 
necrosis factor-α (TNF-α) that were released in response to lipopolysaccharide exposure 
downregulated the CYP1A1 in vitro. Their results showed that TNF-α inhibited the 
ligand-induced acetylation of histone H4 at the promoter region of CYP1A1 gene and 
consequently prevented CYP1A1 induction in Hepa1c1c7 cells. In addition, they 
demonstrated that nuclear factor kappa B (NF-κB) interacted with AhR and thus interfere 
with AhR-mediated CYP1A1 induction.  The effect of the mixed exposure to crystalline 
silica and CYP1A1-inducers, such as BNF on CYP1A1 expression and activity has been 
investigated only in our laboratory (Battelli et al, 1999). Our previous findings in rats 
indicated that silica produced a significant reduction of the induced CYP1A1 enzymatic 
activity (EROD).  The current study indicated that such findings were not unique to the 
rat. In rabbit with acute and chronic silicosis, the induction of CYP1A1 activity by BNF 
was inhibited. Our study suggested that AT-II cells and Clara cells in silicotic rabbits 
expressed CYP1A1 less frequently than did controls. Thus, one mechanism of modifying 
CYP1A1 induction in silicosis, appeared to be decreased CYP1A1 expression in both 
cells of the terminal bronchiolar and alveolar septum.  
 In conclusion, our data strongly suggests that rabbit silicosis is a modifying factor 
for CYP1A1 induction in rabbits. Factors associated with downregulation of CYP1A1 
induction in vivo include altering the cell specific localization of the apoprotein in the 
alveolus and terminal bronchioles. Silicosis, both acute and chronic, inhibited the 
induced-CYP1A1 enzymatic activity (EROD). This inhibitory effect on cytochrome P450 
isoforms is not limited to CYP1A1 induction. PROD activity which is associated with 
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CYP2B4, is also decreased with silica exposure. Suppression of CYP1A1 induction is 
associated with reduction of protein expressed in Clara cells, AT-II cells, and other cells 
of the alveolar septum, as assessed by quantitative immunofluorescence microscopy. 
CYP1A1 was not the only CYP isoform modified by exposure to crystalline silica, but at 
least one other CYP isoform, CYP2B4, also underwent suppression.  
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CHAPTER 5 
SUPPRESSION OF SHEEP PULMONARY CYP1A1 INDUCTION BY 
INTRATRACHEAL EXPOSURE TO RESPIRABLE COAL DUST PARTICLES 
ABSTRACT 
A non-rodent model was used to investigate the effect of coal dust (CD) exposure 
on CYP1A1 induction and localization in the lung. Since pulmonary effects of silica are 
similar in sheep and humans (Larivee et al, 1990), lambs were used in this study. 
Therefore, we investigated the hypothesis that CD exposure in sheep modifies CYP1A1 
metabolic activity and localization in pulmonary cells. To investigate this hypothesis, the 
right apical lobes of 9 Katahdin crossbred lambs were instilled with 500 mg coal dust (<5 
microns) using a flexible fiberoptic bronchoscope. Lambs were sacrificed 8 weeks after 
exposure. All lambs received 50mg/kg of the CYP1A1 inducer, BNF, suspended in corn 
oil or corn oil by intraperitoneal injection, 2 and 3 days prior to sacrifice. 
Bronchoalveolar lavage (BAL) fluid, microsomes and formalin-fixed lung tissue were 
collected from the instilled right tracheal bronchial lobes and the uninstalled left apical 
lobes. CYP1A1-dependent EROD activity and CYP2B-dependent PROD activity were 
significantly reduced in the microsomes of CD-exposed tracheal bronchial lobes relative 
to the uninstalled left lobes or the right tracheal bronchial lobes of sheep receiving BNF 
alone.  In addition, the cellular expression of CYP1A1 in alveolar type II cells, non-type 
II cells, and whole alveolar septum was significantly reduced in sheep exposed to CD and 
BNF compared to those receiving BNF alone. These results further support our 
hypothesis that CD exposure modifies the induction and cellular localization of CYP1A1 
protein. 
INTRODUCTION 
In the previous 2 chapters, we have demonstrated suppression of CYP1A1 
induction and its dependent enzymatic activity (EROD) by pulmonary exposures to 
respirable coal dust (in rats) and crystalline silica (in rabbits).  In addition, coal dust and 
silica particles respectively suppressed the enzymatic activity (PROD) of the CYP2B 
isoforms in rat and rabbit lungs. However, there is a scientific debate concerning the 
comparability of rat and human pulmonary responses to respirable particles of low 
toxicity, such as coal dust (International Life Science Institute (ILSI) Risk Science 
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Institute Workshop Participants, 2000). In this study, we used the lamb as a non-rodent 
model to establish the relationship between pneumoconiosis, caused by coal dust 
deposition in sheep lungs, and alteration in xenobiotic metabolism. Specifically, we have 
examined the activity, quantity, and localization of CYP1A1, the CYP isoform which 
activates some polycyclic aromatic hydrocarbons, such as those in cigarette smoke. In 
addition, we have studied the activity of CYP2B. CYP2B is the major constitutively 
expressed CYP member in sheep lung, which is analogous to CYP2B1 and CYP2B4 in 
rats and rabbits, respectively (Williams et al, 1991). Sheep were selected as a model 
because their pulmonary response to respirable crystalline silica, another cause of 
pneumoconiosis, is similar to that observed in humans (Begin et al, 1989, Larivee et al, 
1990). Sheep lungs are larger, which permits directed exposure and the use of internal 
control lobes, an important advantages in an outbred species.  
A literature search dealing with the effect of environmental toxicants, such as 
PAHs, on sheep CYP1A1 did not reveal any studies. However, some studies have 
investigated the effect of commonly used veterinary pharmaceuticals, such as ivermectin, 
on CYP1A1, 1A2, 2B and 3A because of the role of these isoforms in drug metabolism in 
farm and cloven-hoofed animals (Skalova et al, 2001). The sheep cDNA coding region of 
CYP1A1 has an 85 % homology to human CYP1A1 (Hazinski et al, 1995). Therefore, 
sheep appear to be an appropriate model to studying the effect of xenobiotics, such as 
PAHs, on CYP1A1-associated carcinogenic pathways. Our results showed a reduction of 
the CYP1A1-dependent (EROD) and CYP2B-dependent (PROD) enzymatic activities in 
lung microsomes of sheep exposed to a CD particle suspension and BNF (CYP1A1 
inducer). These results were further supported by Western blot analysis for CYP1A1 
protein and immunofluorescence examination of tissue sections stained for CYP1A1 and 
cytokeratins 8/18 (AT-II markers). 
MATERIALS AND METHODS 
Sheep 
Eleven Katahdin crossbred castrated male lambs weighing 17-30 kg at the start of 
the study were used. The lambs were housed in the Food Animal Research Facility 
(FARF) of West Virginia University. Lambs were fed Alfagreen Supreme Dehydrated 
alfalfa pellets (containing 17% crude  protein, 1.5% crude fat and 30% crude fibers), with  
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ad libitum supply of water. The lambs were kept in pens for 3 weeks prior to exposure for 
acclimatization. During this period, they were examined physically for pulse and 
respiratory rates. In addition, the body temperature and capillary refill time were 
examined and all parameters were within normal range.  To assure parasite-free lambs, 
ivermectin was injected subcutaneously 3 weeks before instillation. Lungs were 
examined by auscultation to assure normal lung sounds before coal dust instillations. 
Complete blood counts were taken from each lamb and were within normal limits. 
Experimental Design: 
Lambs were randomized into a coal-dust exposed and a control group using a 
randomizing program (www.randomized.com). The right apical lobe of each lung was 
instilled with CD or saline and the left apical lobes served as internal controls. The lambs 
were exposed in groups of two to three each day over an eight day period. The lambs 
were sacrificed eight weeks after exposure based upon the results of a preliminary coal 
dust instillation experiment. All lambs were subcutaneously injected with 10 mg/kg 
Tilmicosin antibiotic (Mycotil, Eli Lilly, Indianapolis, IN) one day after instillation of the 
final lamb as a prophylaxis against pulmonary infections. Three and two days before 
sacrifice, lambs were intraperitoneally (IP) injected with 50 mg/kg beta-naphthoflavone 
(BNF), to induce pulmonary CYP1A1.  
Preparation of Particle Suspension 
 Coal dust particles (< 5 micrometer in diameter, 500 mg/lamb) were heat 
sterilized for 2 h at 160 ºC. The particles used in this study contained 0.34 % total iron of 
which 0.119 % was surface iron. The coal dust suspension was prepared by addition of 
15 ml sterilized saline to 500 mg coal dust and vortexed. The suspension was drawn into 
a sterile syringe attached to a 1 mm diameter polyethylene tube and inserted into an 
endoscope (Jorgensen Laboratories Inc., Loveland, CO).  The whole amount was instilled 
in the right tracheal bronchial lobe. In the control group, only 15 ml of the sterile saline 
was instilled into the same lobe under the guidance of the fiberoptic bronchoscope. 
Intratracheal Instillation of Particles Using Flexible Fiberoptic Bronchoscope 
 Lambs were anesthetized by intramuscular injection of a combination of ketamine 
hydrochloride (Keta-ject, Phoenix Laboratories Inc., St. Joseph, MO 64503) 11 - 15 
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mg/kg and xylazine hydrochloride (Xyla-ject. Phoenix Laboratories Inc., St. Joseph, MO) 
0.22 mg/kg. When the lambs were in surgical plane anesthesia (manifested by absence of 
the palpebral reflex), they were placed in a dorsal recumbency with the head extended 
down the surgical table to facilitate the passage of the bronchoscope tube into the trachea. 
A mouth speculum (Ideal Instruments, Detroit, IL) was modified by cutting into 2 halves 
and one half was inserted and fixed in situ by a piece of gauze to avoid damage to the 
bronchoscope tube. Cetacaine spray (Cetylite Industries, Inc., Pennsauken, NJ) was 
spayed in the pharynx to minimize pain and the swallowing reflex.  An alcohol-sterilized 
flexible fiberoptic bronchoscope (Jorgensen Laboratories Inc., Loveland, CO) with a 5-
mm external diameter was inserted though the speculum into the trachea by passage into 
the laryngeal orifice. Positioning was confirmed by visualization of the tracheal rings and 
a cough reflex. Once the bronchoscope was in the trachea, the lambs were turned into 
sternal recumbency followed by further insertion of the endoscopic tube until the orifice 
of the right tracheal bronchus appeared (just before the major bifurcation). At this point, 
the distal tip of the endoscope was tilted toward the orifice, and a 1-mm diameter 
polyethylene cannula (Becton Dickinson and Company, Sparks, MD) was inserted 
through the working channel of the endoscope directly into the right tracheal bronchus 
orifice through which the coal dust suspension was instilled into the lumen of the 
mainstem bronchus of the right apical lobe. After the coal dust suspension instillation, 5-
10 cc of air was instilled into the mainstem bronchus. Importantly, in sheep, the right 
apical lobe is divided into 2 segments, the cranial segment and the caudal segment, each 
one receives a separate bronchus from the mainstem right tracheal bronchus (Getty, 
1975). In our instillation procedure, the CD was instilled in the mainstem tracheal 
bronchus so that both segments were exposed.  Post instillation, lambs were kept on the 
right side to allow settling of particle suspension within the instilled lobe. To facilitate 
anesthetic recovery, yohimbine hydrochloride (Yobine, LLOYD Laboratories, 
Shenandoah, OH) was injected IV (0.2-0.4 mg/kg) after the lambs were placed in the 
recovery stall.  
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Figure 1: The flexible fiberoptic bronchoscope (JorVet 569) used in the study attached to 
the light source (Jorgensen Laboratories Inc., Loveland, CO) 
Lamb Necropsy  
Lambs were euthanized by intravenous injection of Sodium pentobarbital 
(Sleepaway®, Fort Dodge Animal Health, Fort Dodge, Iowa) 26 mg/lb. Under deep 
surgical plane anesthesia, the abdomen was incised along the midline and the abdominal 
aorta was transected to assure exsanguination. The entire lung was weighed and the right 
tracheal bronchial lobe and the left apical lobe were separately weighed. Both lobes were 
lavaged with PBS solution to collect the bronchoalveolar lavage fluid (BALF) as 
described later. Following lavage, 10 % of each lobe, by weight was excised for 
microsome preparation and the other 90 % was fixed by airway perfusion with a volume 
of 3 ml/gm of 10 % neutral buffered formalin (NBF). The amount of NBF used was 
calculated form the following formula: 
Wt of lavaged lobe portion for histopathology x wt of the unlavaged lobe x 3 = mls of NBF 
Wt of the total lavaged lobe 
 
The formalin fixed tissues were trimmed later that day to prepare 4µm-thick 
tissue sections for histopathology and immunofluorescence.  
Certain criteria were set to include a lamb in the study. Any lamb that did not 
meet any one of these criteria was excluded. These criteria were: 
1- Absence of pulmonary infections.  
2- Presence of coal dust particles in the instilled lobe. 
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3- Absence of technical difficulties that may result in partial instillation of the 
designated amount of CD 
Two lambs were intended to be in the study but, due to failure to meet with the 
previous inclusion criteria, they were excluded. One of the lambs instilled with saline 
showed a bacterial pneumonia associated with translocation of bacteria and plant material 
from the esophagus/pharynx to the right apical lobe. Another lamb (supposed to be 
instilled with coal dust) was excluded because it showed no coal dust deposition by gross 
examination of lung tissue, inspection of tissue sediments during microsomal preparation, 
and microscopic examination of BAL and had minimal deposition noted histologically. 
That lamb had coughed powerfully during instillation, dislodging the bronchoscope. 
Therefore, that lamb was excluded.  All the lambs were castrated males but a single 
testicle was identified in one lamb that was determined histologically to be immature, as 
it contained no spermatogonia. The lamb with the single immature testicle was included 
in the experiment due to the internal control incorporated in the design. 
Preparation of Sheep Lung Microsomes  
 The microsomal fraction of lung homogenate was obtained by differential 
centrifugation method as previously described (Flowers and Miles, 1991; Ma et al, 2002). 
These microsomes were used for measuring the CYP1A1 and CYP2B1-dependent 
enzymatic activities (EROD and PROD, respectively). In addition, lung microsomes were 
subjected to electrophoresis to determine the CYP1A1 protein by western blot analysis. 
Determination of the Total Lung Proteins  
The total amount of protein content of lungs was measured in the microsomal 
suspension spectrophotometrically using the bicinchoninic acid (BCA) method as 
previously described (Smith et al, 1985; Ma et al, 2002) according to the direction of the 
BCA protein assay kit (Pierce, Rockford, IL) in a spectra Max 250 Spectrophotometer 
(Molecular Devices Corporation, Sunnyvale, California). Bovine serum albumin was 
used for the standard curve. Protein was measured as mg/ml. 
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Determination of CYP1A1- and CYP2B-Dependent Enzymatic Activities (EROD and 
PROD) 
  Spectrophotometric assays for measuring EROD and PROD metabolic activities 
were performed as previously described (Burke et al, 1985 and Ma et al, 2002) using a 
luminescence spectrometer model LS-50 (Perkin-Elmer, Norwalk, CT) and 7-
ethoxyresorufin (7-ER) (Sigma, St. Louis, MO)  as the standard. The 7-ER was used at a 
concentration of 10 µM that was prepared by dissolving 2.35 µg 7-ER in 1 ml DMSO.  
EROD and PROD activities were expressed as picomoles of the produced resorufin per 
minute per milligram microsomal protein (pmol/min/mg protein) as previously described 
(Ma et al, 2002).  
Immunofluorescence Double Labeling 
The tissue sections were stained to identify CYP1A1 and cytokeratins 8/18. The 
technique was basically the same as in rats (chapter 2). However, the tissue sections were 
incubated with the primary antibodies for 48 h instead of overnight in rat 
immunofluorescence. The primary antibodies were a polyclonal rabbit anti-rat CYP1A1 
(Xenotech) diluted 1:5 with PBS and a polyclonal Guinea pig anti-cytokeratins 8/18 
(RDI) diluted 1:50 with PBS. Rabbit serum was applied as a negative control, and the 
primary antibodies were omitted. After 48 h incubation at room temperature, the slides 
were incubated for additional 2 h at 37 ºC. The slides were then thoroughly washed to 
remove un-conjugated primary antibodies and then the secondary antibodies were 
dropped onto the slides. The secondary antibodies were a mixture of a FITC-labeled, 
donkey anti-Guinea pig IgG (Research Diagnostic Inc., Flanders, NJ) diluted 1:50 with 
PBS and Alexa 594-conjugated goat anti-rabbit antibody (Molecular probes, Eugene, 
Oregon) diluted 1:20 with PBS. The slides were incubated with the secondary antibodies 
for two h in the dark at room temperature. The slides were visualized using a fluorescent 
photomicroscope (OlympusAX70, Olympus American Inc., Lake Success, NY) and 
images were captured using the 40x objective and a Quantix cooled digital camera 
(Photometrics, Tucson, AZ) with QED camera plugin software (QED Imaging, Inc., 
Pittsburgh, PA). Five images were captured per slide from the proximal alveolar (PA) 
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regions, where most of the CD particle tend to localize near the terminal bronchioles and 
alveolar ducts.  
Mophometry 
Immunofluorescence morphometric analysis using Metamorph software 
(MetaMorph, Universal Imaging Corp., Downingtown, PA) was conducted on images 
captured from the proximal alveolar (PA) regions where CD accumulation was observed 
and from the same areas in control sheep.  A representative slide from each lobe, where 
most of CD was grossly observed, was stained for immunofluorescence.  Five images 
were captured per slide from completely perfused areas of the lung, where the alveoli 
were fully distended. The digital images were captured using a 40x objective producing a 
microscopic field with an area of 34466.1 µm2.  The captured images were quantified as 
previously described in chapters 3 and 4 to assess the localization of CYP1A1 in different 
alveolar epithelial cells. Briefly, the area of CYP1A1 expression was quantified in AT-II 
cells, NT-II cells, and the entire alveolar septum. The proportional CYP1A1 expression 
in AT-II cells was calculated as previously described in chapter 3.  AT-II cell hyperplasia 
and hypertrophy were assessed by measuring the area of cytokeratins 8/18 expression. 
Western Blot Analysis  
The amount of CYP1A1 apoprotein in lung microsomes was determined by 
Western blot as previously described (Ma et al, 2002) with minor adaptation. A Novex 
Tris glycine gel with 15 small wells, (Invitrogen Corporation, Carlsbad, CA), and 30 µg 
of microsomal proteins were subjected to SDS gel electrophoresis for 90 min at 120 volts 
followed by transfer to a nitrocellulose membrane (blotting) for another 90 minutes at 25 
volts. Liver microsomes of BNF-treated rat (Xenotech, Kansas city, KS) were used as a 
positive control. The membranes containing protein bands were identified by using a 
primary polyclonal rabbit anti- rat CYP1A1 antibody (Xenotech, Kansas city, KS) for 
overnight incubation at 4 ºC. Then, the membranes were washed and blocked for 1 h at 
room temperature with rocking with a 5% solution of dry milk in tris-buffered 
saline/tween (TBS/tween).  After blocking, the membranes were washed and incubated 
for 1 h with a HRP (horse radish peroxidase)-conjugated goat anti-rabbit IgG (Santa Cruz 
Biotech. Inc., Santa Cruz, CA) at room temperature. Super RX Fuji Medical X-ray film 
was then exposed to the membranes at room temperature. Band intensity developed on 
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the X ray film was measured by the Eagle Eye II scanner with Eagle Sight software 
(Strategene, La Jolla, California).  The density on the scanned images was measured 
using ImageQuant software version 5.1 (Molecular Dynamics, Sunnyvale, CA). Each 
image was quantified three times, the average of which was used for statistical analysis. 
After quantification, the data were presented as a percentage of the CYP1A1 positive 
control. 
Bronchoalveolar Lavage Fluid (BALF) Analysis 
 Both the right apical (exposed) and left apical (internal control) lobes were 
lavaged using ice-cold PBS (Ca++ and Mg++ free). Three consecutive lung lavages were 
performed in which the first lavage was collected by using 2 ml/gm lung while the 
subsequent 2 lavages were conducted by using 2.7 ml/gm lung weight. In the last 2 
lavages, the PBS fluid was flushed in and out of the lobes through a cannula and a 60-ml 
plastic syringe. The lobes were excised from the rest of lung and the incision site was 
clamped off by digital pressure during BAL collection process. Nevertheless, some of the 
lavage fluid was lost due to incision of the lung tissue which reduced the recovery of the 
fluid. Therefore, the BAL differential is considered more accurate that the total BAL cell 
yield. 
The BALF analysis was conducted as previously described (Porter et al, 1999). 
Briefly, the first BAL fluid was kept separate from the subsequent lavages and 
centrifuged at 500 x g for 10 min at 4 ºC to collect the BAL cells. The acellular 
supernatant was decanted and used for analysis as BAL fluid (BALF). Cells of the 
subsequent BAL were collected by centrifugation and the acellular supernatant lavages 
were decanted and discarded. BAL cells from the first and second lavages were 
combined, re-suspended in HEPES buffer (145 mM KCL, 1.0 mM CaCl2, 5.5 mM D-
glucose, 10 mM N-2-hydroxyethylepiperazine-N-2-ethanesulfonic acid:  pH 7.4), 
centrifuged at 500 x g for 10 min at 4 ºC, and the supernatant was discarded. The cell 
pellet was resuspended in HEPES buffer and kept in ice.  
BAL Cell Count and Differential Count 
 To assess pulmonary inflammation associated with coal dust instillation, the 
alveolar macrophages (AM) and the polymorphonuclear leucocytes (PMN) were counted 
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by using a coulter multisizer II and AccuComp software (coulter Electronics, Hialeah, Fl) 
as previously described (Castranova et al, 1990). Cytospin preparations of BAL cells of 1 
x 105 total phagocytes (AM and PMN) suspended in 200 µl HEPES-buffered solution 
were prepared by using a Shandon Elliot cytocentrifuge (800 rpm for 5 minutes). The 
cytospin preparations were stained with modified Wright-Giemsa stain as previously 
described, and cell differentials were determined by light microscopy (Porter et al, 
2002a). To calculate the differential cell counts, the total cell count (PM-PMN) obtained 
from Coulter Counter was multiplied by the cell percentage differentials from the 
cytospin preparations. In addition, the percentage of alveolar macrophages containing 
phagocytized coal dust particles was determined for each lamb.  
BALF Albumin Concentration 
 The albumin concentrations in the BALF reflect the integrity of the blood-
pulmonary epithelial cell barrier. The BALF albumin was measured as previously 
described (Porter et al, 2002a) by using a Cobas Fara II analyzer (Roche Diagnostic 
systems, Montclair, NJ). The albumin was determined colorimetrically, based upon its 
binding to bromocresol green (Doumas et al, 1971), at 658 nm using a commercial assay 
kit (albumin BCG diagnostic kit, Sigma Chemical Company, St Louis, MO). 
BALF Lactate Dehyrogenase (LDH) 
Lactate dehydrogenase activity was measured in the BALF as an indicator of 
cytotoxicity, by detection of the reduction of NAD+ associated with LDH catalyzed 
oxidation of lactate to pyruvate at 340 nm (Gay et al, 1969) using a commercial assay kit 
(Roche Diagnostics Systems, Montclair, NJ) as previously described (Porter et al, 
2002a).  
Alveolar Macrophage (AM) Chemiluminescence (CL) 
 AM chemiluminescence (AM CL) is a marker of increased production of reactive 
oxygen and nitrogen species by AM. In this assay, the use of unopsonized zymosan 
permits the measurement of chemiluminescence emitted from stimulated AM only 
(Castranova, 1987) and not PMN chemiluminescence (Hill, 1977; Allen, 1977). The 
assay was conducted in a total volume of 0.25 ml of HEPES-buffered medium as 
previously described (Porter et al, 2002a). 
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Nitric Oxide Dependent AM CL 
To determine the NO-dependent chemiluminesecence released from AM in 
response to particle exposure, the zymosan-stimulated chemiluminescence from cells 
preincubated with 1 mM nitro-L-arginine methyl ester (L-NAME, a nonselective NOS 
inhibitor (Vaughan et al, 2003)) was subtracted from zymozan-stimulated 
chemiluminescence from cells without nitro-L-arginine methyl ester as previously 
described (Porter et al, 2002b). 
Differential Blood Count 
 Blood samples were collected from all sheep to monitor the changes in blood 
status before and after CD instillation until sacrifice. Blood collection was conducted 
once after sheep arrival at the pens, 1 day before instillation, and  1, 3, 5, 7, 14, 28, 42, 
and 56 days after instillation.  Differential blood count was performed using a Cell-
DYN® 3500 R (Abbot Diagnostics, Santa Clara, California). Hematocrit values were 
measured by using microhematocrit tubes and microhematocrit centrifuge. 
Statistical Analyses 
 All analyses were performed with SAS version 8.2 and using Proc Mixed. In the 
comparison between CYP1A1 localization between AT-II cells and NT-II cells, in sheep 
exposed to BNF only, the model was the two factor repeated measures analysis of 
variance. In all other cases, where data of right exposed lobe were compared to the 
control and to the left unexposed lobes, the model was single factor repeated measures 
analysis of variance. All pairwise comparisons were performed using a pooled variance 
estimate and Fisher’s LSD (Least Significant Difference). All results were considered 
statistically significant at p<0.05. 
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RESULTS 
 The coal dust deposition was observed in the right apical lobe as black spots 
(Figure 2A) indicating a successful instillation.  
A                                                                             B 
  
Figure 2: Photographs of sheep lung showing (A) the deposition of coal dust particles in 
the caudal segment of the right apical lobe and the cranial segment of the left apical lobe 
as an internal control. In B, the orifice of the tracheal bronchus where the endoscope was 
inserted is shown. 
1- 7-Ethoxyyresorufin-O-Deethylase (EROD) Activity  
 The CYP1A1-dependent enzymatic activity (EROD), measured per mg 
microsomal protein was significantly reduced (p=0.0166) in lambs exposed to CD and 
BNF compared to those exposed to BNF alone. Moreover, EROD was significantly 
reduced (p=0.0265) in microsomes prepared from the CD-instilled lobe (right lobe) 
compared to the un-instilled lobe (left lobe) (Figure 3B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
133
A                  B 
ER
O
D
 (p
m
ol
/m
in
/m
g 
pr
ot
ei
n)
0
10
20
30
40
*
Saline/BNF
(right lobe)
CD/BNF
(right lobe)
Right exposed lobes
                                    
ER
O
D
 (p
m
ol
/m
in
/m
g 
pr
ot
ei
n)
0
10
20
30
40
50
(left un-exposed lobe) (right exposed lobe)
*
Left vs right lobes of CD-exposed sheep
 
Figure 3. Effect of CD exposure on pulmonary EROD activity in lambs. In A, EROD is 
significantly reduced in lambs exposed to CD and BNF compared to lambs with BNF 
alone. In B, EROD activity is significantly reduced in CD-exposed lobes compared to the 
control unexposed lobes. * Significantly different at p<0.05.  
 
2- 7-Pentoxyresorufin-O-Deethylase (PROD) Activity  
 The CYP2B-dependent enzymatic activity (PROD) was significantly lowered 
(p=0.042) in CD-exposed lambs with BNF compared to control (Figure 4A). Compared 
to the non-instilled lobe, PROD activity was reduced to less than 50 % in the CD-exposed 
lobe (Figure 4B) but did not reach a statistically significant difference. 
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Figure 3. Effect of CD exposure on pulmonary PROD activity in lambs. In A, PROD is 
significantly reduced in lambs exposed to CD and BNF compared to lambs with BNF 
alone. In B, PROD activity is reduced 50 % in CD-exposed lobes compared to the control 
unexposed lobes. * Significantly different at p<0.05.  
 
3-Western Blot Analysis 
CYP1A1 protein bands of right exposed lobes (Figure 5A) and left unexposed 
lobes (Figure 5B) were quantified and expressed as percentage of positive CYP1A1 
control. The CYP1A1 apoprotein measured in lung microsomes by Western blot was not 
significantly reduced in lambs exposed to CD and BNF compared to control (p=0.2) 
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(Figure 5C) and in the CD-exposed lobes compared to the control unexposed lobes 
(p=0.5) (Figure 5D). 
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Figure 5.  Effect of CD exposure on CYP1A1 protein measured by Western blot. 30 µg 
microsomal proteins were subjected to SDS-PAGE and electroblotted to a nitrocellulose 
membrane. The membrane was primed by a polyclonal rabbit CYP1A1 as described in 
the materials and methods. The results are expressed as a percentage of CYP1A1 positive 
control. CYP1A1 protein is lower in lambs exposed to CD and BNF than control (C). The 
CD-exposed lobes have a lower amount of CYP1A1 protein compared to the unexposed 
lobes (D). In A, lanes 1-5 are for right lobes of control (exposed to saline) and lanes 6-10 
are for right lobes of CD-exposed lambs. In B, lanes 1-5 are for left unexposed lobes of 
the control and 6-10 are for the left unexposed lobes of the CD group. C is the positive 
CYP1A1 control and MW is the molecular weight standard. 
 
4-Immunofluorescence Double Labeling for CYP1A1 and Cytokeratins 8/18 
A- Distribution of CYP1A1 in BNF-Induced Sheep. 
 Sheep CYP1A1 was visualized as red fluorescence in alveolar type II cells, non-
type II cells, and endothelial cells of the alveolar septum (Figure 7). However, the area of 
CYP1A1 quantified in alveolar non-type II (NT-II) cells is significantly greater than that 
in alveolar type II (AT-II) cells of the left (p=0.009) (Figure 6A) and right (p<0.001) 
(Figure 6B) apical lobes of the BNF-induced sheep. 
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Figure 6. Morphometric analysis showing the distribution of CYP1A1 in sheep lung. In 
A, the area of CYP1A1 expression in non-type II cells is significantly larger compared to 
CYP1A1 area in type II cells of the alveolus of left lung lobes. In B, the area of CYP1A1 
expression in non-type II cells is significantly larger, compared to CYP1A1 area in type 
II cells of the alveolus of left lung lobes. * Significantly different at p<0.05. Data are 
means ± SE, n=5 in the saline exposed group and 4 in the CD-exposed group. 
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B- CYP1A1 Induction is Suppressed in the Alveolus of CD-Instilled Sheep 
 Morphometric quantification of the CYP1A1 area of expression in lamb alveolus 
has been conducted in the CD-exposed and control sheep to assess the effect of CD 
instillation on the CYP1A1 induction. CYP1A1 area was quantified in alveolar type II 
cells, non-type II cells, and the entire alveolar septum.  
a- In Alveolar Type II (AT-II) Cells 
 The proportional CYP1A1 expression in AT-II cells, which adjusted for the 
increased area of AT-II cell, showed a highly significant reduction (p<0.001) in sheep 
exposed to CD and BNF compared to those receiving BNF alone (Figure 8A).  When 
compared to the left unexposed (internal control) lobes, the right lobes exposed to CD 
also showed a significant diminution (p=0.01) of proportional CYP1A1 expression in 
AT-II cells (Figure 8B). In addition, the area of CYP1A1 co-localized (co-expressed) 
with cytokeratins 8/18 marker in AT-II cells was smaller, albeit not significantly, in 
sheep exposed to CD and BNF than BNF alone (Figure 8C). Furthermore, the area of 
CYP1A1 that co-localized with cytokeratins 8/18 was also smaller in the CD-exposed 
right lobes compared to the unexposed left lobes (Figure 8D), but these differences were 
also not significantly different. 
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Figure 8. Morphometric quantification of CYP1A1 expression in AT- II cells. In A, there 
is a highly significant reduction of the proportional CYP1A1 expression in AT-II cells of 
CD-exposed lambs with BNF compared BNF alone. In B, the proportional CYP1A1 
expression in AT-II cells of the CD-exposed lobes is highly significantly decreased 
compared to the left unexposed lobes. In C the proportional CYP1A1 expression is 
reduced in CD-exposed sheep with BNF compared to BNF alone. In D, the proportional 
CYP1A1 expression is reduced in CD-exposed lobes compared the left unexposed lobes. 
** significantly different at p<0.001.  
 
b- Alveolar Non-Type II (NT-II) Cells 
 Cells in the alveolar septum that do not express cytokeratins 8/18 (AT-II makers) 
are not type II cells and are designated here as alveolar non-type II (NT-II) cells. These 
cells are usually thin, elongated and often contain immunofluorescence CYP1A1. The 
area of CYP1A1 expression in these cells is significantly diminished in alveolar septum 
of sheep exposed to CD and BNF compared to BNF alone (p=0.0015) (Figure 9A). In 
addition, the area of CYP1A1 expression in NT-II cells is significantly reduced in 
alveolar septum right lobes exposed to CD compared to the left unexposed lobes of the 
CD-exposed sheep (p<0.0299) (Figure 9B). 
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Figure 9. Morphometric quantification of the area of CYP1A1 expression in NT-II cells. 
In A, the area of CYP1A1 expression, measure in µm2 is significantly reduced in CD-
exposed sheep with BNF compared to BNF alone. In B, the area of CYP1A1 expression 
in NT-II cells of the CD and BNF-exposed right lobes is significantly lower than the left 
unexposed lobes exposed to BNF alone.* significantly different at p<0.05.  
 
c- Total CYP1A1 Expression in the Whole Alveolar Septum of Sheep 
 The total area of CYP1A1 expression in alveolar septum includes expression in 
AT-II cells and NT-II cells. This area showed significant reduction in sheep exposed to 
CD and BNF compared to sheep that received BNF alone (p=0.006) (Figures 10A and 
11). Moreover, in BNF-treated sheep, the area of CYP1A1 expression in the alveolar 
septal cells of the right lobes exposed to CD is reduced by 65.3 % compared to the left 
unexposed lobes of the CD-exposed sheep (Figure 10B). 
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Figure 10. Morphometric quantification of the total CYP1A1 expression in alveolar 
septum. In A, the total area of CYP1A1 expression in the alveolus, expressed as µm2 of 
CD-exposed sheep with BNF is significantly lower than BNF alone. In B, the area of 
CYP1A1 expression in the alveolus of right CD-exposed lobes is reduced by 65.3 % 
compared to the left unexposed lobes of CD-exposed sheep. * significantly different at 
p<0.05. 
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C-Effect of CD Exposure on Alveolar Type II (AT-II) Cell Hyperplasia in Sheep 
 The area of AT-II cells, as indicated by lung area with green fluorescence due to 
cytokeratins 8/18 expression, was quantified morphometrically. The area of AT-II cells 
was increased in the alveolus of sheep exposed to CD and BNF compared to BNF alone, 
albeit not significantly. The area of cytokeratins 8/18 expression in the alveolus of the 
right CD-exposed lobe was also numerically, but not significantly, increased relative to 
the left unexposed lobe (Figure 12). AT-II cell hyperplasia and hypertrophy were 
visualized in fluorescent-stained sections of CD exposed sheep (Figure 12). 
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Figure 12. Morphometric quantification of the cytokeratins 8/18 expression in alveoli of 
CD exposed and control sheep. In A, the area of cytokeratins 8/18 expression is 
numerically higher in CD-exposed sheep with BNF compared to control. In B, the area of 
cytokeratins 8/18 expression is numerically, but not significantly increased in CD 
exposed right lobes compared to the left unexposed lobes. Results represent means ± SE, 
n=5 in the saline exposed group and 4 in the CD-exposed group. 
 
4-Results of BAL Fluid Analysis 
A- BAL Cell Differentials 
a- Alveolar Macrophages (AM) 
 The number of BAL AMs was not significantly increased in the CD-instilled right 
lobe compared to the left lobes instilled with saline (Figure 13A) or the uninstalled left 
lobes (Figure 13C).  Cell differentials of cytospin preparation showed a significant 
increase in the percentage of AM in CD-exposed right lobes compared to the right lobes 
instilled with saline (p= 0.0008) (Figure 13B) or the unexposed left lobes (p=0.0318) 
(Figure 13D).  While no CD-laden AM was observed in saline exposed groups or the left 
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unexposed lobes, an average of 44.5% of the AM counted in the BAL of CD-exposed 
sheep contained coal dust particles (range 23 to 73 %). 
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Figure 13. Differential count of BAL cells. The AM yield is higher in CD-exposed right 
apical lobe than saline-exposed lobe (A) or left uninstilled (unexposed lobes) (C). The 
percentage of AM is significantly higher in CD-exposed right apical lobe than saline-
exposed lobe (B) or left uninstilled (unexposed lobes) (D). Results represent means ± SE, 
n=5 in the saline exposed group and 4 in the CD-exposed group. 
 
b- Polymorphonuclear Leucocytes (PMN) 
 The PMN yield in CD-exposed right lobes was not significantly higher than the 
right lobes exposed to saline (Figure 14A) or the uninstilled left lobes (Figure 14C).  Cell 
differentials of cytospin preparation exhibited a significant increase in the percentage of 
AM in CD-exposed right lobes compared to the right lobes instilled with saline (p=0.047) 
(Figure 14B) or the uninstalled left lobes (p=0.04) (Figure 14D).  These results suggest 
that the CD-exposed lobes exhibit higher phagocytic cell percentage. 
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Figure 14. Differential cell count of the BAL. The PMN yield is non-significantly higher 
in CD-exposed tracheal bronchial lobe than saline-exposed lobe (A) and left uninstilled 
(unexposed lobes) (C). The percentage of PMN is significantly higher in CD-exposed 
tracheal bronchial lobe than saline-exposed lobe (B) or left uninstilled (unexposed lobes) 
(D). Results represent means ± SE, n=5 in the saline exposed group and 4 in the CD-
exposed group. 
 
B- BAL Fluid Albumin 
 The albumin measured in the BAL fluid was not significantly increased in CD-
exposed right lobes compared to the saline-exposed right lobes (Figure 15A) and to the 
left uninstilled lobes (Figure 15B). 
  
 
 
 
 
 
 
 
 
          Right apical lobes 
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Figure 15. Albumin levels in BAL of CD-exposed lobes are not significantly increased 
compared to saline exposed (A) or left unexposed lobes (B).  Results are means ± SE, n= 
5 in the saline exposed group and 4 in the CD-exposed group. 
 
C- LDH in BAL Fluid 
 The LDH concentration in BAL of CD-exposed tracheal bronchial lobes was not 
significantly higher than saline-exposed lobes (Figure 16A) or left uninstilled lobes 
(Figure 16B). 
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Figure 16. BAL fluid LDH levels are not significantly increased in right tracheal 
bronchial lobes exposed to CD compared to the right lobes exposed to saline (A) or left 
unexposed lobes (B). Data shown are means ± SE, n= 5 in the saline exposed group and 4 
in the CD-exposed group. 
 
D-AM-Dependent (CL) and NO-Dependent AM (CL) 
 No change was seen in AM-dependent CL and NO-dependent AM CL in BAL 
samples of CD-exposed lambs compared to the controls (data not shown). 
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5- Differential Blood Count (Total Leucocytic Count) 
 The neutrophil, monocyte, and total leucocyte counts for both CD-exposed and 
control sheep were temporarily increased the day after the instillation and then gradually 
decreased the following days to reach almost the resting stage on the day of sacrifice 
(Figure 17A, B, and C, respectively). In addition, the hematocrit values do not show 
significant difference between CD-exposed sheep and controls (data not shown) at any 
time period (data not shown). 
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Figure 17. The total leucocyte count (A), neutrophil count (B), or monocyte count (C) 
exhibits a brief increase one day after instillation then reduced gradually to resting levels 
at the time of sacrifice for both CD-exposed and control group. Data shown are means ± 
SE, n= 5 in the saline exposed group and 4 in the CD-exposed group. 
 
6- Histopathological Changes 
 Histopathological changes of CD-exposed lung lobes included bronchointerstitial 
pneumonia with accumulation of dust-laden alveolar macrophages, mainly in the 
interstitial tissue with only occasional foci of alveolar histiocytosis, a finding expected in 
a lavaged lung. These changes were irregularly distributed but consistently present in the 
instilled right apical lobes. Thus, bronchointerstitial pneumonia with particle-laden 
interstitial macrophages was observed in the right apical lobe of all instilled lambs but 
was not present in all sections of this lobe in the instilled lambs. Bronchointerstitial 
pneumonia was not seen in the control lambs (Figure 18 C and D). AT-II cell hyperplasia 
and hypertrophy was also observed in CD-exposed lobes (Figure 18A and B). 
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DISCUSSION 
In this study, we investigated the modifying effect of respirable coal dust particles 
on CYP1A1 induction in BNF-exposed sheep. The response of sheep lung to CD 
particles, in regard to CYP1A1 expression, was similar to that of the other 2 species, rats 
and rabbits that have been investigated in the previous chapters. The model of CWP in 
sheep was based upon a previous model of sheep silicosis (Begin et al, 1989). However, 
the CD suspension was instilled only one time and the sheep were kept for eight weeks 
before sacrifice. The response of sheep lung to respirable particles, such as quartz, is 
similar to the human response, particularly in cellular cytotoxicity (Larivee et al, 1990).  
The results indicated that the intratracheal instillation of CD significantly 
inhibited the CYP1A1-dependent metabolic activity (EROD) lung microsomes (Figure 
1). This effect was localized only in the lobes that were instilled with CD (right lobes). 
However, in the left lobes, which were not exposed to CD particle suspension, there was 
no change in the activity, suggesting that the CD exposure inhibited the CYP1A1 
metabolic activity locally and the effect did not extend to include the neighboring lung 
lobes. Along with CYP1A1 activity, another CYP isoform, CYP2B, was measured. 
CYP2B is the major constitutive isoform of CYP family in sheep lungs (Williams et al, 
1991). The CYP2B-dependent enzymatic activity (PROD) showed a significant 
diminution in lung microsomes prepared from lung of sheep exposed to CD and BNF 
compared to BNF alone (Figure 2). This result suggested that, CD not only inhibited the 
activity of BNF-induced CYP1A1 in sheep lung, but the inhibitory effect also included 
another CYP isoform, constitutively expressed in sheep lungs. 
To assess the effect of CD exposure on CYP1A1 induction, the CYP1A1 protein 
was measured by Western blot. The amount of CYP1A1 protein measured by Western 
blot was reduced, albeit not significantly, in the CD-exposed lobes compared to 
unexposed lobes (Figure 3). Although the reduction was not significant, the general trend 
seemed to be suppressive as shown in Figure B.  
The suppressive effect of the CD on CYP1A1 induction in sheep lungs was 
further demonstrated by immunofluorescence double labeling. By using this technique, 
the CYP1A1 expression in different pulmonary epithelial cells was investigated. We used 
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cytokeratins 8/18, which are cytoskeletal proteins highly expressed in primitive epithelial 
cells, to recognize the AT-II cells (Kasper et al, 1993) in the lung alveolus. Accordingly, 
the cellular components of the stained lung tissue section were divided into 2 distinct 
populations using indirect immunofluorescence with a primary anti-cytokeratins 8/18 
antibody and a green FITC-labeled secondary antibody. One population stained 
distinctively green and those were AT-II cells (Figure 5A). The others did not stain green 
and were designated as NT-II cells. The CYP1A1 has been visualized in alveolar type II 
cells and NT-II cells. However, by morphometry, the area of CYP1A1 expression 
measured in NT-II cells, where no green fluorescence was visualized, was significantly 
higher than that area in AT-II cells. This result suggests that in the alveolus, AT-II cells 
are not the major sites of CYP1A1 induction and NT- II cells are important sites of 
CYP1A1 induction. In addition, there is a general deficit in the literature regarding the 
localization of inducible CYP1A1 in ruminant lungs. The majority of literature in 
ruminant CYPs concentrates on the inducibility of CYP1A1 in the liver of goat (van’t 
Klooster et al, 1993), or cattle (Shull et al, 1986) and this study is the first, to our 
knowledge to report the distribution pattern of CYP1A1 in sheep lungs. 
The CD instillation in sheep significantly reduced the area of CYP1A1 expression 
in AT-II cells (Figure 6), NT-II cells (Figure 7) and the entire alveolar septum (Figure 9). 
Therefore, one mechanism of suppression of BNF-induced CYP1A1 by CD exposure 
appears to be inhibition of CYP1A1 expression in different alveolar septal cells. These 
results are not surprising and are comparable to those seen in rats exposed to coal dust 
and rabbits exposed to silica. While increased size (hypertrophy) and number 
(hyperplasia) of AT-II cells were not significant in this study, they were increased 
numerically which is consistent with studies in other species. The area of CYP1A1 
expression in AT-II cells, relative to the total area of AT-II cells showed a significant 
reduction suggesting that the new hyperplastic AT-II cells do not express CYP1A1 in 
proportion to their number and size. This result supports our findings in rats that CD 
exposure leads to production of a new population of alveolar type II cells with decreased 
CYP1A1 expression. The mechanism of downregulation of CYP1A1 associated with 
cellular proliferation should be further investigated. However, in the rat liver with 
hyperplastic nodules, induced by diethylnitrosamine and partial hepatectomy, the total 
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amount of microsomal CYP enzymes was reduced 50% compared to the control (Degawa 
et al, 1995). Moreover, the inducibility of CYP1A by inducers decreases slightly in the 
rat liver bearing hyperplastic nodules (Degawa et al, 1995). Consistent with that, the 
inducibility of CYP1A1 by BNF was markedly reduced in early lung hyperplastic foci 
associated with urethane exposure and the lung carcinomas were devoid of expression of 
CYP1A1 protein (Forkert et al, 1998). All of these previous studies suggest that CYP 
protein is downregulated in proliferating cells - - a finding which is consistent with the 
downregulation of CYP1A1 induction and CYP2B in our study of CD-exposed lambs. 
To assess the local inflammatory reaction of sheep lung in response to the inhaled 
CD particles, the AM and PMN were counted in BAL. The percentage of AM and PMN 
showed a modest, but significant increase. This result suggests that an inflammatory 
process accompanied the CD instillation in sheep. Interstitial pneumonia with 
accumulation of dust-laden AM in the interstitial tissue were the hallmarks of 
histopathological changes in lung sections of CD-exposed lobes in sheep.  In spite of the 
local inflammatory reaction, no systemic reaction was observed as there was no 
significant change in the neutrophil count, monocyte count, or total leucocyte count 
between CD-exposed and control sheep. This result suggests that CD instillation into a 
localized region of the lung is not associated with a systemic reaction in lambs at the dose 
instilled (500 mg/sheep). The local inflammatory process was also associated with non-
significant enhancement of LDH (marker of cytotoxicity) and albumin levels (marker of 
pulmonary-blood barrier in the lung) of the CD-exposed group compared to control. This 
suggests that CD exposure in sheep is associated with an inflammatory response, which 
involves the interstitium consistently. 
In conclusion, the general response of sheep lung to the CD-mediated suppression 
of BNF-induced CYP1A1 is similar to that observed in rats. The sheep results are also 
comparable to the CYP1A1-downregulation observed in acute and chronic silicosis in 
rabbits. Therefore, if the suppression of CYP1A1 by particle exposure occurs in 3 animal 
species (rats, rabbits, and sheep), it is also likely to happen in any other species, such as 
the human.  
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CHAPTER 6 
SOME MECHANISTIC INTERACTIONS ASSOCIATED WITH PARTICLE-
MEDIATED SUPPRESSION OF CYP1A1 INDUCTION IN RATS 
ABSTRACT 
CYP1A1 induction was suppressed by pulmonary exposure to coal dust and 
crystalline silica. However, the mechanism of induction suppression was not completely 
elucidated. Therefore, we investigated some of the alterations associated with suppression 
of BNF- induced CYP1A1 in rat lungs. We hypothesize that the inflammatory response 
and induction of apoptotic proteins are two potential mechanisms associated with 
CYP1A1 downregulation. To investigate this hypothesis, male Sprague Dawley (SD) rats 
were intratracheally (IT) exposed to 2.5, 10, 20, and 40 mg/rat coal dust (<5 µm) or 
vehicle (saline). Three days prior to sacrifice, rats were intraperitoneally (IP) injected 
with 50 mg/kg BNF (CYP1A1 inducer). At necropsy, bronchoalveolar lavage (BAL) was 
collected to evaluate pulmonary inflammation by measuring BAL alveolar macrophage 
(AM) and polymorphonuclear (PMN) cell counts, AM chemiluminescence (CL), and 
nitric oxide (NO)-dependent AM CL. Pulmonary cytotoxicity was assessed by measuring 
the BAL lactate dehydrogenase (LDH). In a parallel experiment, immunofluorescence 
triple labeling was conducted to identify the interaction between CYP1A1, cytokeratins 
8/18, and Bax expression. BAL analysis showed a dose-responsive enhancement of PMN 
and LDH by CD exposure (r2=0.661, p<0.0001; r2=0.174, p= 0.0139 respectively), a 
significant increase of AM count in all groups exposed to CD and BNF compared to 
control BNF-treated rats, and a significant enhancement of NO-dependent AM CL in rats 
exposed to the highest dose (40 mg/rat) of CD and BNF compared to rats treated with 
BNF alone (p= 0.004). Immunofluorescence (IF) triple labeling showed an inverse 
relationship between CYP1A1 expression and Bax expression in alveolar type II cells. 
Because Bax is a pre-apoptotic protein, we investigated the role of Bax expression and 
apoptosis on the CD-mediated suppression of CYP1A1 induction. To explore this 
mechanism, male SD rats (50-70 gm) were IT instilled with 40 mg/kg coal dust or vehicle 
(saline). At days 0, 5, 9, 10, 11, 12, 13 post instillation, rats were IP injected with the pan-
caspase inhibitor, Q-VD-OPH (20mg/kg), or vehicle (DMSO). Three days before 
sacrifice, all rats were administered BNF IP (50 mg/kg). EROD and PROD activities 
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were measured in microsomes of the right lobe. Histopathology, IF for CYP1A1, 
cytokeratins 8/18, and Bax, as well as TUNEL assays were conducted on tissue sections 
of the left lobes. EROD and PROD were significantly lower in CD-exposed rats 
compared to control. CD-exposed rats with caspase inhibitor did not show statistical 
difference in PROD and EROD activities compared to DMSO-injected rats. By IF, the 
area of CYP1A1 expression within alveolar septum of CD and BNF exposed rats was 
significantly lower than rats exposed to BNF without CD, but was unaffected by caspase 
inhibition with Q-VD-OPH. In single label IF, Bax expression measured as area (µm2) or 
number of cells/field was significantly lower in CD-exposed rats with Q-VD-OPH than 
CD-exposed rats with DMSO, but significantly higher than saline-exposed rats with Q-
VD-OPH. TUNEL assay showed a significant increase of percentage of apoptotic cells in 
CD-exposed rats with BNF compared to rats receiving BNF alone. CD-exposed rats with 
Q-VD-OPH had a significant reduction of percentage of apoptotic cells compared to the 
CD-exposed rats with DMSO. Taken together, these results suggest that CD exposure 
enhances the pulmonary inflammatory response in a dose-dependent manner, upregulates 
the Bax expression in AT-II cell, and induces apoptosis in lung cells. CYP1A1 induction 
and activity was not significantly affected by the Q-VD-OPH-mediated inhibition of 
caspases but caspase inhibition decreased Bax expression and apoptosis. This suggests 
that CD-associated suppression of CYP1A1 is associated with inflammation and 
associated with, but not caused by, Bax expression. 
INTRODUCTION 
The pathogenesis and mechanisms of suppression of CYP1A1 induction by intra-
pulmonary deposition of respirable particles are important processes in understanding the 
modification of the xenobiotic-associated lung cancer by downregulation of pulmonary 
enzymatic systems. In the previous 3 chapters, we have demonstrated a downregulation 
of CYP1A1 protein expression and its dependent activity, EROD by pulmonary exposure 
to CD and silica.  At the cellular level, the suppression of induction was demonstrated in 
alveolar type II cells, non type II cells, and the entire alveolar septum in three animal 
species, rats, rabbits and sheep. However, the mechanisms associated with this cellular 
behavior in response to particle exposure were not entirely clear. Pulmonary 
inflammation and lipoproteinosis were demonstrated by histopathological examination of 
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particle-exposed lung tissue and were associated with reduced CYP1A1 induction. In this 
study, we investigated the inflammatory response to CD exposure by examining 
bronchoalveolar lavage (BAL) fluid collected from rats exposed to coal dust particles. 
We examined the relationship between increasing levels of inflammation and increased 
suppression of CYP1A1 induction. Since the sensitivity of tissue to apoptosis is increased 
when expression of cell-death regulator proteins, such as Bax is upregulated (Guinee et 
al, 1997), we also investigated the relationship between the upregulation of Bax 
expression and apoptosis induction in alveolar cells and the CD-mediated suppression of 
CYP1A1 induction.  
Apoptosis is programmed cell death that is essential for homeostasis (Wang et al, 
2002) and tissue remodeling (Stanley et al, 1992). Apoptosis helps eliminate cells that 
have improperly developed, have been produced in excess, or have sustained genetic 
damage (Thompson, 1995). Apoptosis is characterized by cell shrinkage, nuclear 
condensation, DNA fragmentation, cytoplasmic blebbing and formation of apoptotic 
bodies (Wyllie et al, 1980). Because the plasma membrane is intact during programmed 
cell death, there is limited tissue injury and inflammation (Savill et al, 1993). Two 
common mechanisms are associated with cellular apoptosis: receptor-dependent and 
mitochondrial-dependent (Mayer and Oberbauer, 2003). The receptor-dependent 
mechanism is mediated through specific receptors, such as tumor necrosis factor 
receptors (TNFR). Stimulation of these receptors by extracellular stimuli, such as 
cytokine release or an inflammatory process, results in recruitment and activation of 
caspase 8. Activated caspase 8 can activate a cascade of downstream caspases that 
eventually produce DNA fragmentation and apoptosis (Peter and Krammer, 1989). In the 
mitochondrial pathway, intrinsic stimuli, such as ischemia and ionizing radiation (Mayer 
and Oberbauer, 2003) enhance the release of apoptotic proteins, such as caspase 9, or 
apoptosis inducing factor (AIF) from the mitochondrial outer membrane. These apoptotic 
factors activate caspase 8 and caspase 3, resulting in apoptosis (Peter and Krammer, 
1989). Some pre-apoptotic proteins, such as Bax, may be activated and translocated from 
cytosol to mitochondria, enhancing the release of cytochrome c and stimulating the 
mitochondrial-induced apoptotic mechanism (Aiba-Masago et al, 2002).  
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In our coal dust response study, we demonstrated a dose-dependent increase of 
Bax expression in alveolar cells by CD exposure. On the other hand, our previous 
experiments showed a reduction of CYP1A1 expression in alveolar cells by CD 
exposure. This suggests an association between increased Bax expression and reduced 
CYP1A1 induction. In addition, the Bax gene has 2 AhR response elements that play a 
role in PAH-mediated apoptosis of ovarian oocytes in mice (Matikainen et al, 2002). 
Since agents triggering pulmonary inflammation, such as silica (Lim et al, 1999; Lyer et 
al, 1996) and bleomycin (Kuwano et al, 2000), can also induce apoptosis of lung cells, 
we investigated the effect of CD, which also triggers lung inflammation, on alveolar cell 
apoptosis. Because apoptosis can be inhibited by specific caspase inhibitors, such as 
zVAD-fmk (Kitamaka et al, 1997) and Q-VD-OPH (Rebbaa et al, 2003), we investigated 
the effect of caspase inhibition on suppression of Bax-associated apoptosis and CYP1A1 
induction. We demonstrated that CD increases the number of apoptotic lung cells, and the 
caspase inhibitor, Q-VD-OPH inhibits both Bax expression and apoptosis. However, the 
suppression of CYP1A1 by CD exposure was not reversed by injection of the caspase 
inhibitor, suggesting that the suppression occurs by a mechanism other than Bax 
expression or apoptosis of pulmonary cells. 
MATERIAL AND METHODS 
Experimental Design 
 In the coal dust dose response experiment, 40 male SD rats (220-270 gm body 
weight at time of exposure) were randomized into 5 groups (8 rats/group) by a 
randomizer program (www.randomizer.org). Rats were exposed to 2.5, 10, 20, or 40 
mg/kg CD suspended in sterile saline or saline by intratracheal instillation (IT). Eleven 
days later, BNF was administered IP as a suspension in sterile corn oil at a dose of 50 
mg/kg for CYP1A1 induction. Three days after the BNF injection, rats were euthanized 
and BAL was collected as described later.  
In the caspase inhibitor (Q-VD-OPH) experiment, 24 male SD rats, (~67-93 gm 
body weight at time of exposure) were randomized into 4 groups (Table 1) using a 
randomizer program (www.randomizer.org). Rats were IT instilled with 40 mg/rat CD 
suspended in 0.3 ml saline or saline. On the day of the exposure, rats were injected with 
the caspase inhibitor, Q-VD-OPD dissolved in dimethylsulfoxide (DMSO) or the vehicle 
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with a dose of 15 mg/kg.  The initial dose of caspase inhibitor or the vehicle was then 
followed by subsequent doses of 10 mg/kg injected at days 5, 9, 10, 11, 12, and 13 post 
exposures. Eleven days post instillation, all rats received 50 mg/kg BNF suspended in 
corn oil as a CYP1A1 inducer by IP administration. Rats were euthanized on day 14. 
Group  Group size (n) CD or saline 
(IT) 
Q-VD-OPH or 
DMSO (IP) 
BNF 
(IP) 
Group 1 6 Saline  DMSO BNF 
Group 2 5 Saline  Q-VD-OPH BNF 
Group 3 7 CD DMSO BNF 
Group 4 6 CD Q-VD-OPH BNF 
 
Table 1.  The treatment groups, group size and type of treatment in the caspase inhibitor 
study. The number of rats per group was selected based upon a power analysis, utilizing 
results of previous experiments. 
Preparation of CD Suspension 
       The CD particulates used in the study are less than 5 microns in diameter with a 
surface area of 7.4 m2/g.  The particles contained 0.34 % total iron of which 0.119 % is 
surface iron.  The particles were heat sterilized in an oven at 160 ºC for 2 h.  Coal dust 
suspensions were made up daily from heat sterilized samples using pyrogen-free, sterile 
0.9% saline (Abbott Laboratories, North Chicago).  Suspensions were vortexed directly 
after preparation and shaken well before instillation. 
Intratracheal Instillation 
The CD particles were suspended in sterile saline at a concentration of 8.3, 33.3, 
66.6, and 133.3 mg/ml.  Rats received either 0.3 ml of this suspension (~2.5, 10, 20, and 
40 mg/rat) or 0.3 ml of saline (vehicle). The IT instillation was conducted as previously 
described (Porter et al, 2002). Briefly, rats in the CD response experiment were 
anesthetized by intraperitoneal (IP) injection of sodium methohexital (Brevital, Eli Lilly 
Indianapolis, IN) and were intratracheally instilled using a 20-gauge, 4-inch ball-tipped 
animal feeding needle. Rats in the caspase experiment were instilled using the same 
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procedure except that an 18 gauge, 1.5 inch animal feeding needle was used for the 
instillation  
Preparation and Injection of Caspase Inhibitor, Q-VD-OPH 
 The Q-VD-OPH (Quinoline-Val-Asp (Ome)-VH2-OPH) (Enzyme Systems 
Products, Inc., Livermore, CA), is a broad spectrum caspase inhibitor with potent 
antiapoptotic properties (Caserta et al, 2003). The mechanism of action depends upon the 
formation of an irreversible thioester bond between the active site cysteine of the caspase 
and the aspartic acid residue in the inhibitor (Melnikov et al, 2003). The Q-VD-OPH was 
injected in rats to block the caspase-dependent apoptosis in pulmonary cells. Solutions of 
2 % of the pan-caspase inhibitor were prepared in endotoxin-free dimethyl sulphoxide 
(DMSO) (Sigma Chemical Co., St. Louis, MO). Rats received 15 mg/kg in the first 
injections (day 0) and 10 mg/kg in the following injections (days 5, 9, 10, 11, 12, and 13 
post exposure) by IP administration. 
 Preparation of BNF 
To prepare BNF suspension, the vehicle (corn oil) was sterilized by filtering with 
non-pyrogenic Acrodisc 25 mm syringe filter (0.2 µm in diameter) (Pall Gelman 
sciences, Ann Arbor, MI). Solutions of 5 % BNF (Sigma, St. Louis, MO) in sterilized 
corn oil (50 mg/ml) were prepared 24 h before injection.  The suspension was vortexed 
and then sonicated 15 minutes in Ultronics sonicator (Mahwa, NJ).  BNF solutions were 
injected IP 72 h before sacrifice. 
Necropsy of Rats 
Rats were euthanized by IP injection of 0.5 ml 26% sodium pentobarbital 
(Sleepaway®, Fort Dodge Animal Health, Fort Dodge, IA).  The abdomen was opened by 
incision in the midline and the lungs and attached organs, including tracheobronchial 
lymph node, thymus, heart, aorta, and esophagus, were removed.  The right mainstem 
bronchus was ligated and the lung lobes were collected and immediately placed in ice for 
isolation of microsomes. The left lung lobe was inflated with 3.0 mls of 10% neutral 
buffered formalin (NBF).  Tracheobronchial lymph nodes, liver, spleen, and right and left 
kidneys were also fixed in 10 % NBF.  Fixed tissues were trimmed the same day, 
routinely processed in a tissue processor and embedded in paraffin the following 
 156
morning. For histopathoological examination, tissue sections of left lungs were stained 
with hematoxylin and eosin (H&E) for histopathology. Additional 5-micrometer sections 
were used for immunofluorescence. 
Microsome Preparation 
Microsomes were prepared as previously described (Flowers and Miles, 1991; Ma 
et al, 2002). Steps of microsomal preparation in rats are described in chapter 3. 
Determination of the Total Lung Proteins  
The protein content of lung microsomes was measured by the bicinchoninic acid 
(BCA) method as previously described (Smith et al, 1985, Ma et al, 2002) using the BCA 
protein assay kit (Pierce, Rockford, IL) in a spectra Max 250 Spectrophotometer 
(Molecular Devices Corporation, Sunnyvale, California). Bovine serum albumin was 
used as the standard. 
Measurement of EROD and PROD Activities 
  EROD and PROD activities were measured as previously described (Burke et al, 
1985 and Ma et al, 2002) using a luminescence spectrometer model LS-50 (Perkin-
Elmer, Norwalk, CT). A 10 µM concentration of 7-ethoxyresorufin (Sigma, St. Louis, 
MO) solution prepared from 2.35 µg 7-ethoxyresorufin in 1 ml DMSO was used for the 
standard curve following each run.  EROD and PROD activities were expressed as 
picomoles of the resorufin produced during the reaction per minute per milligram 
microsomal protein (pmol/min/mg protein). 
Western Blot Analysis 
Western Blot analysis of lung microsomes was conducted as previously described 
(Ma et al, 2002). Using a 15-well Novex tris glycine gel (Invitrogen Life Technologies, 
Carlsbad, CA), 30 micrograms of microsomal protein were loaded and subjected to a 
SDS gel electrophoresis and blotted against nitrocellulose membrane (Invitrogen Life 
Technologies, Carlsbad, CA). The nitrocellulose membrane was incubated with a 
polyclonal rabbit anti-rat CYP1A1 antibody (Xenotech, Kansas city, KS) or a 
monoclonal mouse anti-rat CYP2B1 antibody (Xenotech) at 4ºC overnight. The non-
specific binding was blocked by addition of 1% dry milk in tris-buffered saline/tween 
(TBS/T) for 1 h at room temperature with rocking. The membranes were then incubated 
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with a goat anti-rabbit antibody (Santa Cruz Biotech. Inc., Santa Cruz, CA) for CYP1A1 
detection or goat anti-mouse antibody (Santa Cruz Biotech. Inc., Santa Cruz, CA) for 
CYP2B1 detection for 1 h at room temperature with rocking. For the positive control, 
liver microsomes of BNF-treated rats (Xenotech) were used for CYP1A1 or liver 
microsomes of phenobarbital-treated rats (Amersham, Piscataway, NJ) for CYP2B1.  The 
CYP1A1 and CYP2B1 proteins were detected by an enhanced chemiluminescence (ECL) 
reagent kit (Amersham).  The X-ray films (Fuji Film Corp., LTD., Tokyo, Japan) 
containing protein bands were scanned by the Eagle Eye II scanner (Stratagene,  La Jolla, 
California) with Eagle Sight software. The scanned images were quantified by 
ImageQuant software version 5.1 (Molecular Dynamics, Sunnyvale, CA). The values 
were expressed as a percentage of the CYP1A1 or CYP2B1 positive controls. 
Immunofluorescence Techniques 
1- Single Label Immunofluorescence for Bax. 
 Single label immunofluorecence for Bax was conducted as described in previous 
chapters with minor modification. Briefly, the slides were heated in the oven at 60 ºC for 
15 minutes. The slides were deparaffinized and rehydrated in xylene in 3 sequential 6-
minute immersions, a 3 minute immersion in 100 % alcohol, 3 minutes in 90 % alcohol, 3 
minutes in 80 % alcohol, and 5 minutes in distilled water.  The antigen was retrieved by 
0.01M disodium ethylenediamine tetraacetate (Fischer Scientific, Fair Lawn, New Jersey 
07410), pH 8.0 in a microwave heating procedure.  Non-specific binding was blocked by 
5 % BSA in PBS (IgG free) (Sigma) for 10 minutes at room temperature (RT) followed 
by 5% pig serum in PBS (Biomeda Corporation Foster City, CA) for 10 minutes at RT.  
The slides were then rinsed with distilled water and a polyclonal affinity purified rabbit 
anti-Bax antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) was applied 
overnight at a dilution of 1:20 with phosphate buffer saline (PBS) at room temperature. 
For the negative control, one slide was incubated with non-immune rabbit serum 
(BioGenex, San Ramon, CA). To maximize the antibody binding, slides were incubated 
for 2 h at 37 ºC the following day after which slides were washed and Alexa 594-
conjugated goat anti-rabbit antibody (Molecular probes, Eugene, Oregon) was applied for 
2 h at RT in the dark. 
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2- Double Label Immunofluorescence for CYP1A1 and Cytokeratins 8/18 
 The double-label immunofluorescence was carried out by the same method 
described in chapter one. 
3- Triple Label Immunofluorescence for Bax, CYP1A1 and Cytokeratins 8/18 
 Triple label immunofluorescence for Bax, CYP1A1, and cytokeratins 8/18 was 
conducted to localize the expression of Bax and CYP1A1 in AT-II cells (with 
cytokeratins 8/18 marker) or NT-II cells. The technique was similar to the single label 
and double label procedure. The only difference was the application of three polyclonal 
antibodies for Bax, CYP1A1, and cytokeratins 8/18, which were added to the same slide 
simultaneously. For Bax, a polyclonal affinity purified rabbit Bax antibody (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA) was applied at a dilution of 1: 20 with PBS.  For 
CYP1A1, a polyclonal affinity purified goat antibody (Santa Cruz Biotechnology Inc., 
Santa Cruz, CA) was applied at a dilution of 1:10 with the diluted Bax antibody. For 
cytokeratins 8/18, a polyclonal Guinea pig anti-cytokeratins 8/18 (Research Diagnostic, 
Inc., Flanders, NJ) was applied at a dilution of 1:5 with the diluted mixture of and Bax 
CYP1A1 antibodies. The mixture of the polyclonal antibodies was applied by the aid of 
capillarity between folded slides and kept in the humidity chamber overnight at RT. For 
the negative control, one slide was incubated with rabbit serum (BioGenex, San Ramon, 
CA). On the second day and after 2 h incubation of the slides at 37 ºC, a mixture of 
appropriate secondary antibodies was applied on the slides for 2 h at RT in the dark. This 
mixture contains an Alexa 594-conjugated donkey anti-rabbit (Eugene molecular probe), 
Alexa 350-conjugated donkey anti-goat (Molecular Probes), and FITC-labeled donkey 
anti-G pig (Research Diagnostic, Inc., Flanders, NJ) antibodies for detection of Bax, 
CYP1A1, and cytokeratins 8/18, respectively.  
Morphometry of Immunofluorescence 
In all kinds of immunofluorescence, single, dual, or triple, five images were 
captured from the proximal alveolar (PA) regions, where most of the instilled particles 
were deposited. PA regions are areas of the lung that are located next to visible alveolar 
ducts. PA regions are different from random alveolar (RA) regions, which are areas 
without visible alveolar ducts. We concentrated on immunofluorescence in alveolus 
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rather than airways because we have previously demonstrated that in CD-exposed rats, 
changes in CYP1A1 expression principally occur in the alveolus. The threshold ranges 
for red (Bax), blue (CYP1A1) and green (cytokeratins 8/18) fluorescence were held 
constant throughout the morphometric analysis of all images. The slides were examined 
under a fluorescent photomicroscope (Olympus AX70, Olympus American Inc., Lake 
Success, NY) and images were captured using the 40x objective and a Quantix cooled 
digital camera (Photometrics, Tucson, AZ) with QED camera plugin software (QED 
Imaging, Inc., Pittsburgh, PA). 
1- Morphometry for Immunofluorescence of Bax Alone (Single Label) 
 The area of Bax expression in the alveolar septum was measured by commercial 
morphometry software (Metamorph Universal Image Corp., Downingtown, PA) and 
expressed as µm2. In addition, the number of cells expressing Bax in the tissue sections 
was counted and expressed as number per 40x field. 
2- Morphometry for Double Label Immunofluorescence 
 Morphometry of images captured from slides stained for CYP1A1 and 
cytokeratins 8/18 was conducted by the same method described in the previous chapters. 
3- Morphometry for Triple Label Immunofluorescence 
 The morphometric analysis of immunofluorescence triple labeling for Bax, 
CYP1A1, and cytokeratins 8/18 was mainly intended to investigate the sites of 
localization of CYP1A1 and Bax expression and investigate the effect of caspase 
inhibition on the expression of both proteins.  Quantification of triple-label 
immunofluorescence includes the following: 
A- Quantification of Bax Expression in the Entire alveolar Septum 
The total red area (representing Bax) expressed in the whole alveolar septum 
(including AT-II and NT-II cells) per 40x field was directly quantified by commercial 
morphometry software (Metamorph Universal Image Corp.). The total Bax area was 
expressed in µm2 and designated as Q. 
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B- Quantification of CYP1A1 Expression in the Entire Alveolar Septum 
The total blue area (representing CYP1A1) expressed in the whole alveolar 
septum (including AT-II and NT-II cells) per 40x field was measured directly by the 
commercial morphometry software (Metamorph Universal Image Corp.). The total 
CYP1A1 area was expressed in µm2 and designated as T. 
C- Quantification of Cytokeratins 8/18 Expression in the Entire Alveolar 
Septum 
The total green area (representing cytokeratins 8/18) per 40x field was measured 
as an indicator of AT-II cell hypertrophy and hyperplasia. This area was also measured 
by the commercial morphometry software (Metamorph Universal Image Corp.) and 
expressed in µm2. 
D- Quantification of Bax Expression in AT-II Cells 
 The area of Bax expression in AT-II cells was quantified and expressed as µm2 by 
measuring the red area (representing Bax) colocalized to the green area (representing 
cytokeratins 8/18 in AT-II cells) by the following mathematical formula: 
A = P x Q where; 
A is the area of Bax that co-expressed (colocalized) with cytokeratins 8/18 in 
alveolar type II cells, 
P is the percent of Bax expressed in type II cells measured by the Metamorph 
software, and 
Q is the total Bax area expressed in the whole alveolar septum (including alveolar 
type II and non-type II cells) measured by Metamorph software as in A. 
 In addition to the area measured, the number of type II cells expressing Bax was 
counted per field. 
E-Calculating the Proportional Bax Expression Colocalized Within AT- II Cells 
The proportional colocalization of Bax within type II cells was obtained by the 
following calculation: 
A (The area of Bax colocalized in type II cells as calculated in D, expressed as µm2) 
Total green area of cytokeratins 8/18 expression, expressed as µm2 
  
 161
 This calculation helped to investigate the relationship of Bax expression in the 
AT-II cells. Because AT-II cells increased in number and size in CD exposure, this 
estimate was normalized Bax expression per area of AT-II cells. 
F-Quantification of the area of CYP1A1 Colocalized with Bax 
The area of blue color (representing CYP1A1) colocalized (co-expressed) with 
red area (representing Bax) expressed as µm2 was calculated from the following formula:  
M=G x Q where; 
M is the area of CYP1A1 that co-expressed (colocalized) with Bax 
G is the percentage of CYP1A1 expression colocalized with Bax when measured 
by the Metamorph software, and 
Q is the total Bax area expressed in the whole alveolar septum (including alveolar 
type II and non-type II cells) measured by Metamorph software as in A. 
 G- Calculating the Proportional CYP1A1 Colocalized Within Bax Area 
 The proportional CYP1A1 expression within Bax area was calculated by the 
following formula: 
M (the area of CYP1A1 colocalized with Bax as calculated in E, expressed as µm2) 
         Q (the total area of Bax expression, expressed as µm2) 
 
This measurement is very important as it reflects the changes in CYP1A1 
expression relative to Bax expression in CD exposure. 
H-Quantification of CYP1A1 Colocalized with Cytokeratins 8/18 (in AT-II 
Cells). 
The area of CYP1A1 colocalized with cytokeratins 8/18 in AT-II cells (expressed 
as µm2) was obtained by the following formula:  
C = R x T where; 
C is the area of CYP1A1 that co-expressed (colocalized) with cytokeratins 8/18 in 
alveolar type II cells, 
R is the percent of CYP1A1 expressed in type II cells measured by the 
Metamorph software, and 
T is for the total CYP1A1 area expressed in the whole alveolar septum (including 
alveolar type II and non-type II cells) measured by the Metamorph software. 
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I- Proportional CYP1A1 Expression in AT-II Cells 
 The proportional CYP1A1 expression in AT-II cells was calculated as follows. 
C (the area of CYP1A1 colocalized with cytokeratins 8/18, expressed as µm2) 
Total green area of cytokeratins 8/18 expression, expressed as µm2 
 
This measurement reflects the CYP1A1 expression in AT-II cells but adjusts for 
area increases associated with the hypertrophy and hyperplasia of AT-II cells. 
J- Counting AT-II cells with Colocalized CYP1A1 and Bax 
 Since CD exposure was associated with AT-II hyperplasia, the number of AT-II 
cells that concomitantly express both CYP1A1 and Bax was counted per field of triple-
stained sections and the percentage of these cells from the total number of AT-II cells 
was calculated as follows:    
Number of AT-II cells with Bax and CYP1A1  X  100 
  Total number of AT-II cells 
 
This percentage adjusts the number of cells expressing both Bax and CYP1A1 for 
the increased number of AT-II cells associated with CD exposure. 
TUNEL Assay 
 Apoptosis of pulmonary cells was determined by terminal deoxynucleotidyl 
transferase-mediated dUTP nick end-labeling (TUNEL) assay using a TUNEL assay kit 
(Promega, Madison, WI) as previously described (Wang et al, 2002). In this apoptotic 
detection system, the fragmented DNA of apoptotic cells is measured by catalytically 
incorporating fluorescein-12-dUTP at the 3/- OH end of the DNA using the enzyme 
Terminal Deoxynucleotidyl Transferase (TdT) to form a polymeric tail in a TdT-
mediated dUTP Nick-End labeling process as previously described (Gavrieli et al, 1992). 
Briefly, the formalin-fixed, paraffin embedded lung sections were deparaffinized by 3 
sequential immersions in xylene, 3 minute each followed by rehydration with ethanol 
(100%, 95%, and 80%), 3 minutes each. The slides were then incubated with protease 
type 1 (Sigma) diluted with PBS at a concentration of 4%. For a positive control, a 
positive control slide was prepared by incubating the slide with DNase 1 (Sigma Aldrich 
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Co, St. Louis, MO) for 30 minutes at room temperature. All slides were then incubated 
with the equilibration buffer for 10 minutes, during which the reaction mix per slide was 
prepared by addition of 10 µl of the nucleotide mix to 90 µl equilibration buffer and 2µl 
terminal deoxynucleotidyl transferase (TdT) enzyme, according to the manufacturer 
instruction. For negative control, the 2 µl of TdT was replaced by 2 µl distilled water in 
the fluorescein-12-dUTP reaction mix. The slides were then incubated for 1 h at 37 ºC in 
the dark. Propidium iodide (100 µl/slide) (Sigma) was applied for 2 minutes as a counter 
stain, after which slides were rinsed in distilled water and cover slipped using anti-fade 
Gel/Mount (Biomeda, Foster City, CA) and kept at 4 ºC in the dark until examined. The 
slides were examined under a fluorescent photomicroscope (Olympus AX70, Olympus 
American Inc., Lake Success, NY) and images were captured using the 40x objective and 
a Quantix cooled digital camera (Photometrics, Tucson, AZ) with QED camera plugin 
software (QED Imaging, Inc., Pittsburgh, PA). Five images were randomly captured from 
PA regions and another five images were randomly captured from the RA regions. The 
number of positive and negative (normal) cells per field was counted. The results were 
expressed as a percentage of the positive apoptotic cells. 
 Bronchoalveolar Lavage (BAL) and Cell Differentials 
Lungs were lavaged and cells collected as previously described (Hubbs et al, 
2001). To assess pulmonary inflammation, cell counts of alveolar macrophages (AM) and 
polymophonuclear leukocytes (PMN) were obtained using a Coulter Multisizer II 
(Coulter Electronics, Hialeah, FL) as previously described (Castranova et al, 1990) 
BAL Fluid Albumin Concentration 
BAL fluid albumin concentrations were determined as an indicator of the integrity 
of the blood-pulmonary barrier.   BAL fluid albumin was measured colorimetrically at 
628 nm based on albumin binding to bromcresol green (Doumas et al, 1971) using a 
commercial assay kit (Albumin BCG diagnostic kit, Sigma Chemical Company, St.  
Louis, MO) and a COBAS MIRA Analyzer (Roche Diagnostic Systems, Montclair, NJ). 
BAL Fluid Lactate Dehydrogenase Activity 
BAL fluid lactate dehydrogenase (LDH) activities were determined as a marker of 
cytotoxicity, and were determined by monitoring the LDH catalyzed oxidation of lactate 
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to pyruvate coupled with the reduction of AAD+ at 340 nm (Gay et  al, 1968) using a 
commercial assay kit (Roche Diagnostics Systems, Montclair, NJ) and a COBAS MIRA 
Analyzer (Roche Diagnostic Systems, Montclair, NJ). 
Zymosan-Stimulated AM Chemiluminescence 
AM chemiluminescence was determined as an indicator of reactive oxygen and 
nitrogen species production by AM.  The use of unopsonized zymosan in the 
chemiluminescence assay allows only AM chemiluminescence to be measured, because 
unopsonized zymosan stimulates AM chemiluminescence (Castranova et al, 1987) but 
not PMN chemiluminescence (Hill, 1977; Allen, 1977).  The assay was conducted in a 
total volume of 0.50 ml HEPES buffer.  Resting AM chemiluminescence was determined 
by incubating 1.0 x 106 AM/ml at 37°C for 20 minutes, followed by the addition of 5-
amino-2,3-dihydro-1,4-phthalazinedione (luminol) to a final concentration of 0.08 µg/ml 
followed by the measurement of chemiluminescence.  To determine zymosan-stimulated 
chemiluminescence, unopsonized zymosan was added to a final concentration of 2 mg/ml 
immediately prior to the measurement of chemiluminescence.   All chemiluminescence 
measurements were made with an automated luminometer (Berthold Autolumat LB 953, 
Gaithersburg, MD) at 390-620 nm for 15 minutes.  The integral of counts per minute 
versus time was calculated.  Zymosan-stimulated (total) chemiluminescence was 
calculated as the cpm in the zymosan-stimulated sample minus the cpm in the resting 
sample.  1400W (N-(3-aminomethyl)benzyl)acetamidine•HCl), an inhibitor of nitric 
oxide synthase, was used to determine the component of zymosan-stimulated (total) 
chemiluminescence that is attributable to reactive nitrogen species.  1400W sensitive 
chemiluminescence was determined by subtracting the zymosan-stimulated 
chemiluminescence from cells pre-incubated with 1 mM 1400W from the zymosan-
stimulated (total) chemiluminescence from AM without 1400W. 
Histopathology 
 Tissue sections from control and CD- exposed lungs were routinely stained with 
hematoxylin and eosin (H&E) to assess histopathological changes. The changes were 
evaluated by a board-certified veterinary pathologist while blinded to the exposure status. 
The changes of interest that have been evaluated were: alveolitis (alveolar inflammation), 
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and AT-II cell hyperplasia and hypertrophy. The histopathologic changes were scored on 
a scale ranging from 0 to 5 for each of the severity and distribution scores to produce a 
sum pathology score of 0 to 10 for each slide, as previously described (Hubbs et al, 
1997).  
Statistical Analyses 
The dose responsive effects of coal dust instillation on quantity of AMs, PMNs, 
levels of albumin, LDH, AM CL, NO-dependent CL for BAL fluid, Bax area and cells 
with Bax/field, we used Proc Reg for the regression analysis.  All analyses were 
performed with SAS version 8.2 and using Proc Mixed or using Proc Reg. In all other CD 
response study comparisons, where we compared between groups, the model was single 
factor repeated measures analysis of variance.  In the case of comparison between PA 
with RA, the model was three factors repeated measures analysis of variance. In all other 
caspase inhibitor study comparisons, where we compared between groups, the model was 
two factors repeated measures analysis of variance. All pairwise comparisons were 
performed using a pooled variance estimate and Fisher’s LSD (Least Significant 
Difference). All results were considered statistically significant at p<0.05. 
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RESULTS 
Effect of CD Exposure on Bronchoalveolar Lavage Fluid (BALF) Analysis  
CD-exposed rats had a dose-dependent increase in polmorphonuclear leucocytes 
(PMN) (r2=0.974, p= 0.002) (Figure 1A).  The alveolar macrophage (AM) count was 
significantly increased in the BALF of all rats exposed to CD and BNF compared to rats 
treated with BNF alone (Figure 1B). AM CL and NO-dependent CL were significantly 
increased in rats exposed to 40 mg CD and BNF compared to rats treated with BNF alone 
(Figures 2A and B, respectively). The intrapulmonary deposition of CD particles 
produced pulmonary cytotoxicity manifested by elevation of LDH activity in a dose-
dependent fashion (r2=0.963, p=0.003) (Figure 3A). The blood barrier in the lung was 
also damaged in CD- exposed groups as shown by elevation of BALF albumin, which 
was statistically significant following exposures to 20 and 40 mg/kg CD and BNF 
compared to BNF alone (Figure 3B).  
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Figure 1. CD exposure increased the BALF PMN count in a dose-dependent manner (A). 
A significant PMN increase is shown in rats exposed to 10, 20, and 40 mg/rat CD and 
BNF compared to control saline and BNF. Alveolar macrophages cell count was 
significantly higher in all groups exposed to CD and BNF compared to the control saline 
with BNF (B). The bars are values of means and SE for each treatment. *Significantly 
different from control group at P < 0.05.  
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Figure 2. In A, AM CL was significantly higher in rats exposed to 40 mg CD and BNF 
compared to control saline and BNF. In B, the NO-dependent AM CL was also 
significantly increased in rats exposed to CD 40 mg and BNF compared to control saline 
and BNF. The bars are values of means and SE for each treatment. *Significantly 
different from control group at P < 0.05. 
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Figure 3. The effect of coal dust exposure on pulmonary cytotoxicity and vascular 
leakage in BNF-exposed rats. In A, CD exposure causes a dose-dependent increase in 
LDH that indicates pulmonary cytotoxicity (r2=0.963, p=0.003). In B, CD increased BAL 
albumin in all CD-exposed rats that was statistically significant in rats exposed to 20mg 
and 40 mg/rat CD compared to control indicating pulmonary vascular damage. 
*Significantly different from control group at P < 0.05.         
 
Effect of CD Exposure on Bax Expression in Lung Cells 
 By using single label immunofluorescence, Bax was mainly localized within cell 
cytoplasm (Figure 5). The area of Bax expression quantified by morphometric analysis 
was increased in a dose-dependent manner by CD exposure in rats (r2= 0.6541, p<0.001). 
In addition, the average number of lung cells expressing Bax counted per field was 
increased in a dose-dependent fashion by the CD exposure (r2= 0.903, p<0.001) (Figure 
4).  
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Figure 4. Bax expression is enhanced in a dose dependent manner by CD exposure in 
rats. In A, the area of Bax expression in lung cells measured in µm2 is increasing in a 
dose responsive fashion by exposure to 2.5, 10, 20, and 40 mg/rat CD. Similarly, the 
number of positive cells for Bax is increased in a dose dependent manner by exposure to 
2.5, 10, 20, and 40 mg/rat CD. * significantly different from saline/BNF at p<0.05. 
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Relationship Between Bax Expression and CYP1A1 Induction 
 To investigate a relationship between Bax expression and the suppression of 
CYP1A1 induction mediated by CD exposure, tissue sections were labeled for Bax, 
CYP1A1 and cytokeratins 8/18 (AT-II markers) (immunofluorescence triple labeling). In 
this procedure, cells containing CYP1A1 fluoresce blue, cells containing Bax fluoresce 
red, and cells containing cytokeratins 8/18 fluoresce green (Figure 7). The proportional 
CYP1A1 expression within Bax area was calculated with the aid of morphometric 
analysis as described in the Materials and Methods. The proportional CYP1A1 
expression within area of Bax expression was gradually reduced by increasing CD 
exposure (Figure 6A) suggesting that the probability that cells concomitantly expressed 
Bax and CYP1A1 decreased with CD exposure. In contrast, the proportional expression 
of Bax colocalized with cytokeratins 8/18 (AT-II cell markers) gradually increased by 
increasing the CD exposure (Figure 6B) suggesting that CD exposure increases Bax 
expression in AT-II cells. In addition, the percentage of AT-II cells that concomitantly 
expressed both Bax and CYP1A1 gradually decreased with increasing the CD exposure 
(Figure 6C) suggesting an inverse relationship between CYP1A1 induction and Bax 
expression in AT-II cells. In contrast, the percentage of AT-II cells expressing Bax only 
gradually increased with the CD exposure (Figure 6D) 
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Figure 6. Graphical representation of morphometric analysis of tissue sections stained for 
CYP1A1, Bax, and cytokeratins 8/18 showing the relationship between CYP1A1 
induction and Bax expression in AT-II cells. In A, the area of CYP1A1 colocalized with 
Bax in AT-II cells is reduced with CD exposure. In B, the area of Bax expression in AT-
II cells is increased by the CD exposure. In C, the percentage of AT-II cells expressing 
both CYP1A1 and Bax is gradually decreased by CD exposure. In D, the percentage of 
AT-II cells expressing Bax alone is gradually increased by CD exposure. 
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Effect of Caspase Inhibitor, Q-VD-OPH on EROD  
 BNF-induced EROD activity was significantly reduced in CD-exposed rats but 
not affected by the caspase inhibitor, Q-VD-OPH (Figure 9).  
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Figure 9. The pan-caspase inhibitor, Q-VD-OPH, did not alter the inhibition of EROD 
activity by CD exposure.  No significant change is observed between rats receiving the 
inhibitor and those receiving the vehicle (DMSO).  CD-exposed rats with DMSO have a 
significant reduction (P=0.03) of EROD activity compared to saline-exposed rats with 
DMSO.  Also, CD-exposed rats with the Q-VD-OPH caspase inhibitor have a significant 
reduction (p=0.001) of EROD activity compared to saline-exposed rats with the inhibitor. 
* and □ mean significant difference at p<0.05 from rats unexposed to CD. 
 
Effect of Caspase Inhibitor, Q-VD-OPH on PROD  
 CD significantly reduced PROD activity in BNF-treated rats and this effect 
persisted when caspases were inhibited by Q-VD-OPH.  PROD activity in CD-instilled 
rats injected with Q-VD-OPH was not significantly different from CD-exposed rats 
injected with the vehicle (DMSO) (Figure 10). 
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Figure 10. Effect of the caspase inhibitor, Q-VD-OPH on PROD activity. CD-exposed 
rats injected with the inhibitor are not significantly different from CD-exposed rats 
injected with vehicle (DMSO). PROD activity in rats exposed to CD and injected with 
DMSO is significantly (p=0.003) reduced compared to saline-exposed rats and injected 
with DMSO. PROD activity in rats exposed to CD and injected with the caspase inhibitor 
is significantly lower (p=0.001) than that in saline-exposed rats and injected with the 
inhibitor. è and * significantly different from saline/BNF/DMSO and  
saline/BNF/Inhibitor at p<0.05, respectively. 
 
Effect of Caspase inhibitor on CYP1A1 Induction by Western Blot 
 The CYP1A1 apoprotein measured by western blot analysis was not significantly 
changed in Q-VD-OPH-exposed rats. As observed in previous studies, CYP1A1 protein 
was significantly reduced in CD-exposed rats compared to BNF controls 
(Saline/BNF/DMSO). In rats injected with Q-VD-OPH, CD exposure reduced induction 
by BNF, albeit not significantly (Figure 11).  
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Figure 11. Western blot showing the effect of the Q-VD-OPH on CYP1A1 protein. The 
CYP1A1 protein is significantly reduced in CD-exposed rats with DMSO compared to 
saline-exposed rats with DMSO. The CYP1A1 protein is reduced (not significantly) in 
CD-exposed rats with Q-VD-OPH compared to saline-exposed rats with Q-VD-OPH. No 
significant change in CYP1A1 protein in CD-exposed rats with Q-VD-OPH vs. CD-
exposed rats with DMSO. The designation of lanes is described above the blot. C is the 
positive control. MW is the molecular weight marker. * significantly different from 
saline/BNF/DMSO at p<0.05. 
 
Effect of Caspase Inhibitor on CYP2B1 by Western Blot 
 The amount of CYP2B1 was not significantly affected by caspase inhibition with 
Q-VD-OPH. (Figure 12). 
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Figure 12. Western blot analysis of CYP2B1. In A, CD-exposed rats injected with DMSO 
have non significant reduction of CYP2B1 protein compared to saline-exposed rats 
injected with DMSO.  In B, CD-exposed rats injected with caspase inhibitor have non 
significant reduction of CYP2B1 protein compared to saline-exposed rats injected with 
caspase inhibitor. No significant change is observed between CD-exposed rats injected 
with caspase inhibitor and CD-exposed rats injected with DMSO. C. Quantification graph 
of CYP2B1 protein in different treatment groups. The designation of lanes is described 
above the blot. C is the positive control. MW is the molecular weight marker. 
 
Effect of Caspase Inhibitor on CYP1A1 Induction in PA regions by 
Immunofluorescence Double Labeling 
 By using the morphometric analysis of immunofluorescent double stained tissue 
sections for CYP1A1 and cytokeratins 8/18 (Figure 14), the areas of induced CYP1A1 
expression were highly significantly reduced in NT-II cells (p<0.001), the entire alveolar 
septum (p<0.001), but not significantly reduced in AT-II cells by CD in BNF-exposed 
rats with DMSO compared with BNF exposed rats (Figure 13B, C, A). The proportional 
CYP1A1 expression in AT-II cells was significantly reduced (0.0028) by CD in BNF-
exposed rats with DMSO relative to BNF-exposed rats (Figure 13D).   Similar results 
were obtained when caspases were inhibited. In rats treated with both Q-VD-OPH and 
BNF, CD exposure reduced the area of CYP1A1 expression in NT-II cells, the entire 
alveolar septum as well as the proportional CYP1A1 expression in AT-II cells (p<0.001, 
p<0.001, p<0.001, respectively) (Figure 13B, C, and D, respectively), but not 
significantly reduced the area of CYP1A1 expression in AT-II cells (Figure 13A). 
However, the areas of CYP1A1 expression in AT-II cells, NT-II cells, and the entire 
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alveolar septum as well as the proportional CYP1A1 expression were not significantly 
changed in CD-exposed rats with inhibitor compared with CD-exposed rats with DMSO 
(Figure 13A, B, and C, respectively).  
 The injection of caspase inhibitor did not produce significant changes in AT-II 
cell hyperplasia and hypertrophy in CD-exposed rats (data not shown). 
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Figure 13. Morphometric analysis of dual immunofluorescence for BNF-induced 
CYP1A1, and cytokeratins 8/18 in the PA regions of rats receiving either the caspase 
inhibitor, Q-VD-OPH or the vehicle (DMSO) and IT CD or vehicle (saline). In A, the 
area of CYP1A1 expression in AT-II cells is not significantly decreased in rats receiving 
CD (CD/BNF/DMSO or CD/BNF/Inhibitor) and not significantly affected by caspase 
inhibition (Saline/BNF/Inhibitor or CD/BNF/Inhibitor). In B, the area of CYP1A1 
expression in NT-II cells is highly significantly decreased in rats receiving CD 
(CD/BNF/DMSO or CD/BNF/Inhibitor) and not significantly affected by caspase 
inhibition (Saline/BNF/Inhibitor or CD/BNF/Inhibitor). In C, the area of CYP1A1 
expression in the entire alveolar septum is highly significantly decreased in rats receiving 
CD (CD/BNF/DMSO or CD/BNF/Inhibitor) and not significantly affected by caspase 
inhibition (Saline/BNF/Inhibitor or CD/BNF/Inhibitor). In D, the proportional CYP1A1 
expression in AT-II cells is highly significantly or significantly decreased in rats receiving 
CD (CD/BNF/DMSO or CD/BNF/Inhibitor, respectively) and not significantly affected 
by caspase inhibition (Saline/BNF/Inhibitor or CD/BNF/Inhibitor). ** indicate highly 
significant change at p<0.001. * indicates significant difference at p<0.001. 
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Effect of the Caspase Inhibitor on Bax Expression in PA regions 
 Single label immunofluorescence for Bax (Figure 16) showed that the injection of 
the caspase inhibitor, Q-VD-OPH in CD-exposed rats highly significantly reduced the 
area of Bax expression (p<0.001) (Figure 15 A) and significantly decreased the number 
of cells expressing Bax (p=0.001) (Figure 15B) compared to CD-exposed rats injected 
with the vehicle (DMSO). However, the CD exposed rats injected with caspase inhibitor 
had a significant increase in the Bax area and highly significant increase in number of 
cells expressing Bax (p=0.005, p< 0.001, respectively) compared to saline-exposed rats 
injected with the inhibitor, suggesting that caspase inhibitor reduced Bax expression but 
not to the level of control values. These results were also confirmed by 
immunofluorescence-triple labeling for Bax, CYP1A1, and cytokeratins 8/18 (data not 
shown). 
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Figure 15. Morphometric analysis of single-labeled immunofluorescence for Bax in the 
PA region of BNF-treated rats after IT exposure to CD or saline with and without caspase 
inhibition with Q-VD-OPH. In A, the letter a above the bar indicates highly significant 
increase in the area of Bax expression in CD/BNF/DMSO group relative to 
saline/BNF/DMSO group. Bax expressed as area (µm2) is highly significantly reduced by 
the caspase inhibitor (letter b above the bar), but still significantly increased relative to 
Saline/BNF/inhibitor group (letter c above the bar). In B, the letter d above the bar 
indicates highly significant increase in the number of cells expressing Bax 
CD/BNF/DMSO group compared to saline/BNF/DMSO group. The number of cells 
expressing Bax is significantly lower in CD/BNF/inhibitor group relative to 
CD/BNF/DMSO group (letter e above the bar), but highly significantly higher than 
Saline/BNF/inhibitor group (letter f above the bar). Letters a, b, d, and f indicate highly 
significant difference at P<0.001. Letters c and e indicate significant difference at 
P<0.05. 
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Effect of the Caspase Inhibitor on CD-Induced Apoptosis.  
 In the TUNEL assay, the apoptotic cells were identified by their green 
fluorescence, while the non-apoptotic nuclei were identified by their red color (Figure 
18). The percentage of apoptotic cells was highly significantly increased (P<0.001) in 
CD-exposed rats in the absence of caspase inhibition with Q-VD-OPH. In addition, the 
percentage of apoptotic cells was significantly increased (P<0.048) in CD-exposed rats 
injected with caspase inhibitor compared to saline-exposed rats injected with caspase 
inhibitor. In the CD-exposed rats, injection of caspase inhibitor significantly decreased 
the percentage of apoptotic cells (p=0.013) (Figure 17). 
 Comparison of the percentage of apoptotic cells in PA regions vs. RA regions 
revealed a significant increase in the PA regions compared to the RA regions in all 
groups including Saline/BNF/DMSO, CD/BNF/DMSO, Saline/BNF/inhibitor, and 
CD/BNF/Inhibitor with p<0.013, <0.001, 0.025, and <0.001, respectively (Figure 17). 
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Figure 17. TUNEL assay results showing the percentage of apoptotic cells in BNF-
treated rats after IT exposure to CD or saline with and without Q-VD-OPH caspase 
inhibitor. The percentage of apoptotic cells is highly significantly increased in rats with 
CD/BNF/DMSO compared rats with saline/BNF/DMSO (letter b above the bar). Rats 
with CD/BNF/inhibitor have a significant lower percentage of apoptotic cells than rats 
with CD/BNF/DMSO (letter f above the bar). Caspase inhibition does not entirely 
abrogate the CD-induced apoptosis and the apoptotic cell percentage in rats with 
CD/BNF/inhibitor is significantly higher that in rats with saline/BNF/inhibitor (letter e 
above the bar). The percentage of apoptotic cells in the PA region is significantly higher 
than that in the RA regions of all groups (letters a, c, d, and g above the bars). Letters a, d 
and e, and f indicate significant difference at p<0.05. Letters b, c, and g indicate highly 
significant difference at p<0.001. 
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Histopathological Changes 
 Histopathological alteration associated with CD exposure included histiocytic and 
suppurative alveolitis with accumulation of dark brown particles within the cytoplasm of 
many alveolar macrophages. No significant difference was observed in CD-exposed rats 
injected with the caspase inhibitor compared to those injected with vehicle (Figure 19) by 
scoring the severity and distribution of these changes. AT-II hyperplasia and hypertrophy 
was demonstrated in CD-exposed rats (Figure 20). No histopathological changes were 
observed in rats exposed to BNF or BNF and the caspase inhibitor, Q-VD-OPH 
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Figure 19. Histopathological score of the severity and distribution of alveolitis and AT-II 
hyperplasia in CD-exposed rats injected with caspase inhibitor or DMSO. No significant 
change is noted between rats with CD/BNF/DMSO and rats with CD/BNF/Inhibitor. 
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DISCUSSION  
In this study, the pathogenesis of suppression of CYP1A1 induction in rat lung by 
coal dust exposure was investigated. Because alteration of pulmonary xenobiotic 
metabolism is an interplay with the inflammation (Ma and Ma, 2002), the inflammatory 
reaction to CD exposure was assessed by examining the BALF. We demonstrated that 
CD exposure enhanced the pulmonary inflammatory reaction in a dose-responsive 
fashion. This inflammatory reaction was illustrated by a significant increase of the AM 
and a dose-dependent recruitment of PMN in the BALF (Figure 1). The inflammatory 
reaction to CD instillation was previously investigated by Blackford and coworkers 
(Blackford et al, 1997) who demonstrated that CD had a less inflammatory effect than 
silica but a more potent effect than carbonyl iron and titanium oxide in inducing 
pulmonary inflammation. Activation of AM by CD exposure was also statistically 
significant in the highest dose (40mg/rat) as shown by measuring the AM CL (Figure 
2A). 
BAL Fluid Analysis: AM 
Alveolar macrophages are free lung cells located on the surface of the small 
airways and the alveoli (Weibel, 1973). These cells act as the lung’s first line of defense 
against the toxic effects of inhaled particles, as they play a major role in the protection of 
lung against these particles. The reaction of alveolar macrophages to the inhaled particles 
is complex. Upon contact with the particles, AM release superoxide anion (Sweeney et 
al, 1981), which can be monitored by the measurement of chemiluminescence (Miles et 
al, 1978; Castranova et al, 1980). Eventually, AM engulf these foreign particles and 
attempt to digest them by releasing lysosomal enzymes into phagocytic vacuoles (Myrvik 
and Evan, 1967). By histopathological examination of CD-exposed rats, dust-laden AM 
were localized in the alveolar spaces and interstitial tissue as a dark brown pigment 
(Figure 20). 
BAL Fluid Analysis: LDH  
LDH is an intracellular enzyme; therefore, its presence in the acellular BALF 
indicates cytotoxicity (Porter et al, 2002). The elevation of LDH, in a dose-dependent 
fashion, with CD exposure (Figure 3A) suggests that the reduction of CYP1A1 
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expression in alveolar septa could partly be attributed to cellular injury and cytotoxicity 
caused by CD exposure. Dinsdale and co-workers (Dinsdale and Verschoyle, 2001) 
showed a reduction of CYP2B1 expression and protein activity in rat lung following 
selective destruction of alveolar type I cells by pneumotoxic and nonpneumotoxic 
trialkylphosphrothiolate. In addition, the significant release of albumin in CD-exposed 
rats (Figure 3B) indicates damage of the blood-pulmonary barrier. Damage of the 
endothelial cells of alveolar septum by CD exposure could contribute to the total 
reduction of the CYP1A1 induction, since these cells are considered as NT-II cells that 
express CYP1A1 (Pairon et al, 1994). 
BAL Fluid Analysis: Nitric Oxide  
Nitric oxide is a short lived inter- and intracellular messenger produced by a 
family of enzymes known as nitric oxide synthases (NOSs) and brings about a number of 
bioregulatory functions (Kim and Sheen, 2002).  The inducible nitric oxide synthase 
(iNOS) gene expression and NO production by BAL cells can be measured indirectly as 
NO-dependent chemiluminescence (John et al., 1997).  The NO-dependent AM CL was 
significantly increased in rats exposed to 40 mg/rat CD with BNF compared to control, 
which suggests that CD induces nitric oxide synthesis by alveolar macrophages. This 
result is consistent with those reported by Blackford et al (1997) who concluded that coal 
mine dust is among the various dusts that induce iNOS by the recruited PMN into the 
alveolar spaces. In addition, Bingham et al, 1977, reported that in vivo exposure of rats to 
coal dust results in an increase in mRNA for the inducible form of nitric oxide synthase 
and elevated nitric oxide production by pulmonary phagocytes. The significant reduction 
of EROD activity and CYP1A1 protein (as shown by western blot) in rats exposed to 
40mg/kg CD with BNF with enhancement of the NO-dependent AM CL of the same 
group suggests a possible relationship between nitric oxide and CYP1A1 expression and 
activity.  Since NO reacts with hemeproteins, CYP1A1, being a heme-containing protein 
may represent a target of NO within the cells (Wink et al., 1993).  Therefore, a number of 
studies have investigated the effect of NO on CYP450s. Nitric oxide binds to the heme 
moiety of the P450s forming an iron-nitrosyl complex in rat hepatic cells in a reversible 
phase, subsequently preventing the binding of oxygen which normally occurs in the 
course of catalytic sites and suppresses CYP1A1 functional activity (Wink et al, 1993). 
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The same study also showed irreversible inhibition of CYP1A1 and CYP2B1 activity due 
to destruction of the integrity of the primary structure of hemeprotein, resulting from the 
action of nitrogen oxides produced from the oxidation of nitric oxide by oxygen. Not 
only does nitric oxide inhibit CYP1A1 activity, but in vitro studies on Hepa I cells (Kim 
and Sheen, 2002) suggest that nitric oxide also down-regulates the CYP1A1 expression 
by inhibition of CYP1A1 promoter activity. 
Bax Expression and CD exposure: Effect of the Caspase Inhibitor 
Our results showed that Bax expression was increased in a dose dependent 
manner by CD exposure (Figures 4 and 5). In single label immunofluorescence, the Bax 
staining was mainly localized in the cytoplasm of cuboidal cells, suggestive to be AT-II 
cells. In triple label immunofluorescence, the proportional Bax expression in AT-II cells 
as well as the percentage of AT-II cells expressing Bax  were gradually increased by 
increasing the exposure to CD particles (Figure 6B and 6D, respectively), suggesting that 
Bax was upregulated in the hyperplastic AT-II cells. These findings were consistent with 
those of Guinee et al (1997) who demonstrated that Bax expression was increased in 
diffused alveolar damage and was confined to hyperplastic AT-II cells. The proportional 
CYP1A1 expression localized in the area of Bax as well as the percentage of cells 
expressing both Bax and CYP1A1 were decreased by CD exposure (Figures 6A and 6C, 
respectively). Thus, by increasing the dose of CD exposure, the Bax expression was 
increased, but the CYP1A1 expression was reduced, suggesting an inverse relationship 
between the expression of both proteins.   
Bax is a pre-apoptotic protein related to BCL-2 family (Oltvai et al, 1993) that 
predisposes cells to apoptosis (Narasimhan et al, 1998). We initially hypothesized that 
the overexpression of Bax in lung cells increased the apoptosis of these cells and was 
etiologically associated with the depression of CYP1A1 induction observed in CD. To 
investigate this relationship, we used the newly developed pan caspase inhibitor, Q-VD-
OPD, which is known to inhibit caspases 1, 3, 8, and 9 to block the apoptotic pathway. 
Apoptosis of lung cells, assessed by TUNEL assay, showed that CD significantly 
increased the percentage of apoptotic cells (Figures 17 and 18) and rats injected with the 
caspase inhibitor had a significantly lower percentage of apoptotic cells. This finding 
indicated that Q-VD-OPH suppressed caspase-dependent apoptosis in pulmonary cells. 
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This result coincided with that obtained by Caserta et al, (2003) who demonstrated the 
effectiveness of  the Q-VD-OPH in blocking three different pathways of apoptosis; 
caspase 9/3, caspase 8/10, and caspase 12. Although the caspase inhibitor significantly 
reduced the apoptosis, the percentage of apoptotic cells remained significantly elevated 
by IT CD exposure, suggesting that the caspase inhibitor did not completely inhibit the 
apoptotic pathway. In addition, the caspase inhibitor significantly suppressed the Bax 
expression in lung cells, but the area of Bax expression was significantly higher than the 
control saline, suggesting that the caspase inhibitor down-regulated but did not prevent 
all Bax expression in alveolar cells.  
Although Bax expression and apoptosis in pulmonary cells were significantly 
suppressed by Q-VD-OPH, the BNF-induced CYP1A1-dependent EROD activity, 
CYP2B1-dependent PROD activity, the CYP1A1 and 2B1 proteins measured by Western 
blot, and the CYP1A1 measured by immunofluorescence, were not significantly affected. 
These findings suggested that the CD-associated suppression of CYP1A1 was not caused 
by cellular apoptosis and Bax expression. Moreover, it seemed that Bax expression was a 
feature of hyperplastic alveolar cells and the association of Bax with CYP1A1 expression 
was a simple association.  
Effect of Caspase inhibitor, Q-VD-OPH on Pulmonary Inflammation 
Histopathological alterations, such as alveolitis and AT-II hyperplasia and 
hypertrophy were not significantly different between CD-exposed rats injected with the 
caspase inhibitor and the CD-exposed rats injected with DMSO. This result suggested 
that the caspase inhibitor did not suppress the inflammatory process associated with CD 
exposure. Other pan caspase inhibitors, such as N-benzyloxy-carbonyl-Val-Ala-Asp- (O-
methyl)-fluoromethyl ketone (zVAD-fmk) and BOC-Asp-(O-methyl)-fluoromethyl 
ketone (BOC-Asp-fmk) were reported to reduce the neutrophil accumulation in the lungs 
of silicotic mice by 50 % (Borges et al, 2002). However in our study, the principally 
histiocytic inflammatory reaction in the lungs of CD-exposed rats was not significantly 
suppressed by the injection of Q-VD-OPH. While previous studies have used Q-VD-OPH 
mostly in mice (Borges et al, 2002; Melnikov et al, 2002), our study clearly demonstrated 
inhibition of both Bax and apoptosis, but not pulmonary morphologic changes induced by 
CD. In addition, inhibition of Bax expression and apoptosis by caspase inhibition did not 
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significantly affect downregulation of CYP1A1 induction associated with CD. This 
suggested that neither caspase pathways, Bax, nor apoptosis was the cause of inhibition 
of CYP1A1 induction in alveolar cells.  
Studies from a number of laboratories, principally investigating the liver or using 
in vitro systems, have noted an association between inflammation or inflammatory 
mediators and decreased activity of CYP isoforms including CYP1A, CYP2A, CYP2B, 
CYP2D9, CYP3A, CYP2E1 and CYP4A (Warren et al, 1999; Siewert et al, 2000; Jover 
et al, 2002; Carcillo et al, 2003).  Recent studies suggest that diesel exhaust particles and 
carbon black downregulate CYP2B1 in the rat lung (Rengasamy et al, 2003).  Consistent 
with these findings, we have found that respirable coal dust exposure also downregulated 
CYP2B1 in the rat lung.  In addition, the induction of CYP1A1 was downregulated by 
respirable coal dust exposure in the rat lung.  In our studies, the downregulation of 
CYP2B1 and induced CYP1A1 was positively associated with the severity of 
inflammation.   
Previous studies suggest that during inflammation, some mediators and 
transcription factors, such as tumor necrosis factor alpha (TNF-α), interleukin 6, nitric 
oxide and the nuclear factor kappa B (NF-κB) are upregulated and turned on (Ke et al, 
2001; Baldwin, 1996; Hubbard et al, 2002; Jover et al, 2002) and suppress CYP1A1. A 
physical association between the RelA subunit of the NF-κB and the AhR has been 
demonstrated in vitro by immunoprecipitation (Tian et al, 1999) producing an inactive 
complex that prevents the AhR from binding to the enhancer sequences of CYP1A1 (Ke 
et al, 2001). Moreover, NF-κB has been demonstrated to inhibit the ligand-induced 
acetylation of histone H4 at the CYP1A1 promoter area, especially around the TATA box 
region, thus preventing the AhR/Arnt heterodimer from binding to the XRE at the DNA 
resulting in downregulation of the CYP1A1 expression (Tian et al, 2002). TNF-α 
suppresses the activity of RNA polymerase II, resulting in interference with the CYP1A1 
elongation in Hepa1c1c7 cells (Tian et al, 2003). TNF-α also enhances the FasL-
mediated apoptosis in T lymphocytes (Bonetti et al, 2003), which occurs upstream of Bax 
activation. Another inflammatory mediator released during pulmonary inflammation is 
nitric oxide (Fubini and Hubbard, 2003).  Nitric oxide demonstrated a high binding 
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affinity to the heme moiety of the P450s forming an iron-nitrosyl complex in rat hepatic 
cells suppressing the CYP1A1 metabolic activity (Wink et al, 1993). Nitric oxide is also 
associated with induction of apoptosis in IC-21 macrophage cell line, which was 
inhibited by the nitric oxide synthase inhibitor (Siewert et al, 2000). However, Sutherland 
et al (2001) concluded that the macrophage-derived nitric oxide provides an antiapoptotic 
mechanism that protects AT-II cells from undergoing apoptosis and enhancing the lung 
injury. NF-κB seems to play an important role in protection against apoptosis (Ravi et al, 
2001) because the RelA-/- mouse fibroblasts are highly sensitive to TRAIL [(Tumor 
necrosis factor (TNF)-related apoptosis-inducing ligand)]-induced apoptosis. In addition, 
TRAIL-induced apoptosis of human hepatoma cells by interferon alpha is associated with   
NF-κB inactivation (Shigeno et al, 2003).   However, other studies showed that, 
activation of NF-κB is correlated with the ability of p53 to induce apoptosis in tumor 
cells (Ryan et al, 2000). Based upon these studies, Chen et al (2003) concluded that 
opposite functions of NF-κB are dependent upon the expression of its subunits, where c-
Rel and RelA function as proapoptotic and antiapoptotic proteins, respectively.  
Consequently, the NF-κB may contribute to or inhibit the apoptotic response in different 
conditions (Ryan et al, 2000). However, inflammation-associated suppression of hepatic 
CYP1A activity in vivo appears to be TNF-α independent but IL-6 dependent.  CYP1A 
downregulation occurs in p55/p75 knockout mice that lack TNF-α receptors (Warren et 
al, 1999) but does not occur in interleukin-6 knockout mice (Siewert et al, 2000).   
Our studies extend these findings to associate the in vivo downregulation of 
pulmonary CYP2B1 and induced CYP1A1 with inflammation that results from respirable 
coal dust exposure.  In addition, we have found that the downregulation of pulmonary 
CYP2B1 and induced CYP1A1 appear inversely related to, but not caused by, Bax 
expression in the cytosol.  Because we found that caspase inhibition had no effect on 
downregulation of CYP2B1 or induced CYP1A1 by respirable particle exposure, a 
possible explanation for these findings would be an event or signaling cascade producing 
both Bax activation and the CYP downregulation.  These would include nitric oxide, NF-
κB and/or initiators of alveolar epithelial proliferation.  It is also possible that Bax 
expression and CYP downregulation are independent events which are both observed in 
response to respirable particle exposures. Additional studies will be needed to fully 
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elucidate how CYP2B1 activity and CYP1A1 induction are inhibited in the particle-
exposed lung. 
In conclusion, CD exposure enhanced the inflammatory processes of rat lung in a 
dose-dependent manner by increasing the recruitment of AM and PMN. In addition, CD 
caused significant cytotoxicity of lung cells and damage of the blood-pulmonary barrier 
as demonstrated by elevation of LDH and albumin levels, respectively. CD also enhanced 
the Bax expression and induced apoptosis in lung cells, changes that were inversely 
associated with suppression of CYP1A1 induction by CD exposure.  
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CHAPTER 7 
GENERAL DISCUSSION 
Cytochrome P450s (CYPs) generate continued interest because these enzymes 
play critical roles in the metabolism of drugs, carcinogens, dietary xenobiotics and steroid 
hormones (James and Whitlock 1999).  The CYP proteins are heme-containing proteins, 
which are members of a gene super-family involving almost 1000 members in species 
ranging from bacteria to plants and animals (Hasler et al, 1999).  Cytochrome P4501A1 
(CYP1A1) has garnered particular interest because of its association with cancer.  
CYP1A1 is involved in the conversion of organic compounds, like polycyclic aromatic 
hydrocarbons (PAH) in cigarette smoke, into carcinogenic intermediates (Crepsi et al, 
1989; Shimada et al, 1989; Eaton et al, 1995) that can bind to DNA producing adducts 
and initiate lung cancer.   Moreover, the expression of CYP1A1 can be induced at the 
transcriptional level by its substrates.  The transcriptional regulation of the CYP1A1 gene 
by PAH is mediated through ligand-dependent activation of the aryl hydrocarbon 
receptor (AhR). Upon activation by binding of specific substrates, AhR translocates to 
the nucleus and dimerizes to the aryl hydrocarbon receptor nuclear translocator (Arnt) 
protein.  This heterodimer binds to the xenobiotic responsive element (XRE) in the 
regulatory region of the CYP1A1 gene inducing expression (Ma and Whitlock 1997; Tian 
et al, 1999).  It has been demonstrated that high inducibility of CYP1A1 is considered to 
be a risk factor for lung cancer in tobacco smokers (Anttila et al, 2001; Ishibe et al, 
2001). Since smokers are exposed to carcinogenic PAH, their CYP1A1 expression is 
induced (Willey et al, 1997). Therefore, modification of the induced CYP1A1 is of great 
importance in smoking populations. 
Coal is a fossil fuel mined all over the world.  Coal mine dust generated during 
underground coal mining results in significant respiratory exposure to coal miners.   In 
addition to the carbon, which is the main component of coal, it also contains oxygen, 
nitrogen, hydrogen, and trace elements, including non-coal minerals.  The trace element 
may include copper, nickel, cadmium, boron, antimony iron, lead, and zinc (Sorenson et 
al 1974).  Some of these trace elements can be cytotoxic and carcinogenic in 
experimental models (Castranova, 2000).  Mineral contaminants include quartz, kaolin, 
mica, pyrite and calcite (Parkes, 1994).  Coal dust inhalation is associated with 
 194
development of a respiratory disease in coal miners called coal workers’ pneumoconiosis 
(CWP). CWP is categorized according to severity into simple and complicated CWP.  In 
the simple form, black dust macules appear and consist of dust-laden macrophages 
concentrated near respiratory bronchioles.  In complicated CWP, also described as 
progressive massive fibrosis (PMF), the nodules are larger (> 1 cm diameter) and more 
numerous.  These nodules contain increased amounts of collagen, coal dust, and 
inflammatory cells (Castranova, 2000). Silicosis is another occupational lung disease 
resulting from exposure to the crystalline form of the mineral silicon dioxide or silica 
(Driscoll and Guthrie, 1997). Silicosis is characterized by inflammation and fibrosis in 
the lower respiratory tract.  
Recently, crystalline silica, but not coal dust, has been classified as a class I 
carcinogen by the International agency for Research on Cancer (IARC, 1997). However, 
epidemiological data demonstrate that lung cancer in coal miners occurs less frequently 
than in the general population after adjustment for age and smoking (Meijers et al, 1991 
and Kuempel, 1995). In addition, lung cancer risk in coal miners exposed to silica and 
PAH was absent or even less than those exposed to silica alone (Cocco et al, 2001). 
Evaluating the lung cancer risk in coal miners is complex because these people are 
usually exposed to a mixture of environmental contaminants, including the particulate 
matter and the PAH in cigarette smoke. In this study, we investigated the hypothesis that 
pulmonary CYP1A1 induction is inhibited by exposure to respirable particles. We also 
investigated whether or not alterations in lung cell populations are associated with 
suppression of CYP1A1 induction. 
Using the rat model alone to investigate these hypotheses was not satisfactory 
because of the existing debate concerning the species differences between rats and 
humans regarding their response to inhaled particles (Mauderly, 1997). Moreover, the 
pattern of particle retention as well as the lung tissue response to respirable particles in 
rats may not be predictive of those of primates who are exposed to poorly soluble 
particles, particularly at high occupational exposures (Nikula et al, 1997). For these 
reasons, we used rabbit and sheep, in addition to rats, to investigate our hypotheses. 
Generally, in any model, the respirable particulate suspension was intratracheally instilled 
by the aid of feeding needle in rats, endotracheal tube and laryngoscope in rabbits, and 
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flexible fiberoptic bronchoscope in sheep. In sheep, the right apical lobes were instilled 
while the left apical lobes were collected as internal controls. Then the CYP1A1 was 
induced in these animals by IP injection of the model PAH, beta-nephthoflavone. 
In general, our results consistently showed that the CYP1A1-dependent EROD 
activity, measured by spectrophotometric assay was significantly lower in BNF-induced 
animals instilled with particles than control animals (receiving BNF alone). The 
suppression of activity was associated with reduction of CYP1A1 protein measured by 
Western blot.  At the cellular level, the amount of CYP1A1 expression quantified by 
immunofluorescence was reduced in AT-II cells, NT-II cells, and the entire alveolar 
septum upon CD and silica exposure. Because particles tend to accumulate in different 
areas of the lung (Nikula et al, 1997), the CYP1A1 expression was compared in areas 
with maximal deposition to areas with minimal deposition. The area with maximum 
deposition was localized in the proximal alveolar regions, near microscopically visible 
alveolar ducts. For comparison, we also selected areas without visible alveolar ducts that 
were designated as random alveolar (RA) regions as internal controls.  We found 
significant reduction of CYP1A1 expression in AT-II cells, NT-II cells and whole 
alveolar septum in the PA regions relative to RA region. This result suggests that the cell-
type specific suppression is localized to areas where the particles aggregate. In addition, 
PROD activity, an indicator of the major constitutive pulmonary CYP which is not 
inducible in lung (CYP2B1, CYB2B4, and CYP2B in rats, rabbits, and sheep, 
respectively) was consistently lower in BNF-exposed animals instilled with particles than 
the controls. 
In our study, the exposure to particles, either CD or silica, produced AT-II 
hyperplasia and hypertrophy. However, the expression of CYPA1 in the hyperplastic and 
hypertrophied AT-II cells was markedly reduced. A number of studies showed that P450 
activities and the level of P450 apoproteins decreased after partial hepatectomy and 
regeneration of hepatic cells (Hino et al, 1974, Presta et al, 1980, Klinger and Karge, 
1987, and Ronis et al, 1992). It was suggested that replication, but not transcription is the 
prioritized activity of DNA to regenerate the cells (Liddle et al, 1989, Waxman, 1989, 
Morgan et al, 1985, and Steer, 1995). In our studies, AT-II cells may behave similarly in 
regenerating other damaged epithelial cells instead of transcripting genes. Consistent with 
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that are the higher levels of CYP2B1 protein expression and mRNA in freshly isolated 
alveolar type II cells, but this level is diminished in cell culture (Lag et al, 1996). 
Moreover, the inducibility of CYP1A decreases slightly in the rat liver bearing 
hyperplastic nodules (Degawa et al, 1995). Consistent with that, the inducibility of 
CYP1A1 by BNF was markedly reduced in early lung hyperplastic foci associated with 
urethane exposure and the lung carcinomas were devoid of CYP1A1 protein expression 
(Forkert et al, 1998). All of these previous studies suggest that CYP protein is 
downregulated in proliferating cells - - a finding which is consistent with the 
downregulation of CYP1A1 induction and CYP2B in our study of CD-exposed rats and 
lambs. 
In rats, CD exposure enhanced the inflammatory reaction in a dose dependent 
fashion by recruiting AM and PMN to the alveolar spaces as demonstrated by BAL fluid 
examination. Cytotoxicity and damage of the pulmonary blood barrier were also 
associated with CD exposure. Alveolitis and accumulation of dust-laden AM in the 
alveolar spaces and interstitial tissue were major findings in histopathological 
examination of CD-exposed sections. These findings were consistent with those 
described by Nikula et al (1997). Kuempel et al (2003) also demonstrated dose-response 
relationships between respirable crystalline silica in BAL collected from coal miners and 
pulmonary inflammation.  AMs become activated after phagocytosis of CD particles and 
release a wide range of mediators including oxidants, cytokines, growth factors, and 
proteases that result in cellular damage or hyperplasia of epithelial cells, such as AT-II 
cells (Schins and Borm, 1999). In vitro exposure of AMs to CD particles elicited a 
significant release of TNF-α and interleukin-6, compared to titanium dioxide that was 
used as a biologically inert control dust (Vanhee et al, 1995). In addition, many other 
mediators such as IL-1, IL-6, TGF-β1, and TGF-β2, and fibronectin are elevated in the 
BALF of miners with radiographically defined CWP (Vallyathan et al, 2000). Our results 
of BALF analysis of rat lung are consistent with the previous studies and support the 
hypothesis that CD triggers inflammatory reactions and changes in cell populations in the 
deep lung in rats. 
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 In sheep, the histopathological changes were comparable to those of rats, although 
relatively modest. Changes were bronchointerstitial pneumonia with accumulation of 
dust-laden alveolar macrophages, mainly in the interstitial tissue with only occasional 
foci of alveolar histiocytosis- - a finding that is consistent with a lavaged lung.  
In rabbit silicosis, pulmonary inflammation varied from histiocytic and 
suppurative to necrogranulomatous bronchointerstitial pneumonia with thickening of the 
alveolar walls. Alveolar lipoproteinosis was a common finding in silica-exposed rabbit 
alveoli. In some rabbit lungs with silicosis, silicotic nodules were demonstrated. 
Consistent with that, previous studies on rats showed that the pulmonary reaction to the 
inhalation of crystalline silica resulted in lung damage, inflammation, and hypertrophy 
and hyperplasia of AT-II cells (Miller et al, 1986; Miller et al, 1990; Castranova et al, 
2002).  
 The association of inflammation with the suppression of cytochrome P450 has 
previously been demonstrated in vitro and in vivo in several model systems. The acute 
inflammatory reaction caused by subcutaneous injection of bacterial lipopolysaccharide 
(LPS) (Morgan, 1989), turpentine (Kobusch et al, 1986), and viral and bacterial infection 
(El-Kadi and Du Souich, 1998) depressed the constitutive hepatic P450 expression. In 
addition, exposure of cultured hepatocytes to inflammatory stimuli decreases total 
microsomal cytochrome P450, P450-catalyzed enzyme activities, and levels of P450 
proteins and mRNAs (Morgan, 1997). A number of proinflammatory mediators may play 
a role in CYP1A1 downregulation during inflammation. For example, TNF-α interferes 
with CYP1A1 elongation during the transcription process by inactivating the RNA 
polymerase II (Tian et al, 2003). In addition, nuclear factor kappa B (NF-κB) interacts 
with AhR and thus interfered with AhR-mediated CYP1A1 induction (Ke et al, 2001). 
NF-κB also inhibited the ligand-induced acetylation of histone H4 at the promoter region 
of CYP1A1 gene and consequently prevented CYP1A1 induction in Hepa1c1c7 cells (Ke 
et al, 2001). Interleukin-6 (IL-6) also depressed multiple hepatic P450 isoforms such as 
CYP1A1, 1A2, 3A4, and 4A1, and IL-1β downregulates 1A2, 2C11, 2D6, 2E1, and 3A 
(Fukuda et al, 1992; Trautwein et al, 1992, Donato et al, 1997, Parmentier et al,  1997). 
In our study, using an in vivo rat model, we demonstrated that CD exposure elicited 
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pulmonary inflammation in a dose-responsive manner and suppressed the CYP1A1-
dependent EROD activity in a dose dependent manner, suggesting an inverse relationship 
between CYP1A1 induction and activity, and pulmonary inflammation. 
 Our data illustrated that CD exposure enhanced the expression of Bax in a dose 
dependent manner suggesting that CYP1A1 suppression of induction was associated with 
upregulation of Bax expression, particularly in hyperplastic AT-II cells. Since Bax is a 
pre-apoptotic protein related to BCL-2 family (Oltvai et al, 1993) that predisposes cells to 
apoptosis (Narasimhan et al, 1998), we investigated whether the suppression of Bax 
expression and cellular apoptosis could ameliorate the suppression of CYP1A1 induction 
by CD exposure. Therefore, the pan-caspase inhibitor, Q-VD-OPH was administered IP 
to inhibit the Bax expression and the caspase-dependent apoptotic cascade. Our data 
showed that although Bax expression and CD-induced apoptosis of pulmonary cells were 
suppressed by the caspase inhibitor, the CD-mediated suppression of CYP2B1 expression 
and CYP1A1 induction was not significantly affected. This suggested that the 
suppression of these CYP isoforms appears to be inversely related to, but not caused by, 
Bax upregulation and apoptosis induction. One possible explanation for this result is that 
an event or signaling pathway initiated by one or more of the inflammatory mediators, 
which such as nitric oxide or NF-κB, produced both Bax expression and CYP 
downregulation. Alternatively, the Bax upregulation and CYP downregulation were 
independent events observed in particle-exposed lung. 
 
 
 
 
 
 
. 
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CONCLUSIONS 
The present study investigated the suppression of CYP1A1 induction by exposure 
to particles and its association with morphological changes in cell populations in the 
particle-exposed lung. To overcome the limitation of using rats alone as a model for 
human, rabbits and sheep were also utilized to explore our hypothesis. Our results 
demonstrated that: 
1- CYP1A1 induction was suppressed by pulmonary exposure to CD and silica.  
2- CYP1A1-dependent EROD activity was inhibited in a dose dependent-manner by CD 
exposure in rats and was significantly suppressed by silica exposure in rabbits and CD 
exposure in sheep. 
3- PROD activity was suppressed in rabbit silicosis and rat and sheep CWP models, 
respectively. PROD activity is dependent upon the major constitutive CYP isoform of the 
lung which are CYP2B1 and its analogs, CYP2B4 and CYP2B in rats, rabbits, and sheep, 
respectively. 
4- CD or silica exposure reduced CYP1A1 expression at sites of alveolar damage with 
reduced expression in alveolar epithelial cells, including AT-II cells and NT-II cells. 
5- Silica and CD increased the size (hypertrophy) and number (hyperplasia) of AT-II 
cells and reduced CYP1A1 expression in these cells.  
6- CD particles induced dose-dependent pulmonary inflammation, manifested by 
recruitment of alveolar macrophages and polymorphonuclear leucocytes.  
7- CD particles upregulated the preapoptotic Bax protein expression in alveolar epithelial 
cells and triggered apoptosis. 
8- Inhibition of cellular apoptosis and Bax expression by the caspase inhibitor, Q-VD-
OPH, did not affect CYP1A1 induction and its suppression by CD exposure 
These findings support the hypothesis that CYP1A1 induction and its metabolic 
activity (EROD) are inhibited by particle exposure and associated with pulmonary 
inflammation.  
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FUTURE STUDIES 
1-Investigating the effect of the nitric oxide produced during particle-associated 
inflammatory processes on CYP1A1 induction by using nitric oxide synthase 
knockout mice. 
2-Investigating the effect of NF-κB and TNF-α on CYP1A1 induction by using 
antisense olignucleotides techniques. 
3- Localization of CYP1A1 expression in different alveolar non-type II cells by using 
makers of alveolar type I cells, endothelial cells, and alveolar macrophages. 
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